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The developing zebrafish ear, along with the inner ear of all jawed vertebrates, must undergo a
symmetry-breaking event as it progresses from an ectodermal placode to an elaborate structure
with morphological and functional asymmetry around the body axes. This asymmetry is apparent
soon after the specification of the otic placode, established through localised domains of expression
across the otic anterior-posterior (AP) axis (reviewed in Whitfield and Hammond 2007). In the
zebrafish it has previously been established that Fibroblast growth factor (Fgf) and Sonic hedgehog
(Shh) signalling are primarily responsible for AP patterning of the otic placode sensory epithelia
and strikingly, alterations of these pathways can produce duplications of the anterior or posterior
otic character. However, the propensity of the equipotent otic placode to adopt either an anterior
or posterior fate is progressively restricted over this early developmental period (Hammond et al.,
2003; Hammond and Whitfield, 2011).
The currently known posterior otic markers are expressed from 24 hours post fertilisation (hpf),
after the zebrafish otic placode is thought to have become restricted in its ability to adopt either
anterior or posterior character. However, there are no markers within the early posterior otic do-
main that might indicate any transcriptional di↵erence prior to 24hpf. The early transcriptional
di↵erences that define anterior otic character are better defined but it is not clear how otic extrinsic
Fgf and Shh signalling are integrated to establish this di↵erential expression.
I have identified two novel markers of the posterior otic domain that are expressed prior to 24hpf,
which appear to reflect di↵erent events occurring across the AP otic axis. Alongside this I have
also demonstrated that the early anterior otic markers hmx3a (previously nkx5.1 ) and hmx2 (pre-
viously nkx5.2 ) represent good candidates for integrating Fgf and Shh signalling to establish the
extent of the anterior otic character. By combining these data I have built upon the previous model
of Hammond et al. proposing a model that better accounts for the dynamic expression observed
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1.1 The zebrafish as a vertebrate model
The use of zebrafish as a vertebrate model has become increasingly popular over the last three
decades. This is because the early development, along with a number of cell, tissue and organ
characteristics, is strikingly conserved between zebrafish and other vertebrates and therefore can
provide insight into the underlying mechanisms. The zebrafish model also has a number of other
advantages over amniote models. The maintenance of large zebrafish stocks have low overheads
compared to other vertebrate models and a high fecundity allows generation of high experimental
numbers. Zebrafish are also oviparous with external fertilisation; this allows easy observation of
development from the single cell stage. The rate at which zebrafish develop is also quicker than
other model vertebrates, with embryos being responsive to contact by 24hpf and able to indepen-
dently feed by 5 days post fertilisation (dpf) (Kimmel et al., 1995).
As well as being diploid, zebrafish are also highly amenable to genetic manipulation. This initially
was exploited through forward mutagenesis screening techniques such as N-Ethyl-N-nitrosourea
(ENU) mutagenesis and retroviral insertion. However, more recently due to increasingly com-
prehensive sequencing of the zebrafish genome, targeted reverse genetic techniques ranging from
transient morpholino knock-down and TILLING mutagenesis to highly-precise CRISPR/Cas9-
based genome editing have been exploited (reviewed in Huang et al. 2012 and Lawson 2016). This
genetic tractability of zebrafish also allows fluorescent transgenics to be generated, which coupled
with the early transparency of zebrafish embryos makes this a powerful tool for imaging (reviewed
in Weber and Köster 2013).
A number of disease models have been established in zebrafish, including a number for deafness
(reviewed in Lieschke and Currie 2007 and Whitfield 2002) (Section 1.6). Along with providinsg
a better understanding of disease pathogenesis; these models, in conjunction with the advantages
of the zebrafish model outlined above, provide an ideal system for the screening of chemical com-
pounds for treatment (Murphey and Zon, 2006).
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1.2 The function and structure of the inner ear
1.2.1 The vestibular system
The role of the inner ear in detecting di↵erent stimuli is reflected in its morphological and func-
tional asymmetry around all three body axes. This is clearly seen in the highly conserved core
structure for detection of vestibular stimuli. The vestibular system is, in part, comprised of three
fluid-filled semicircular canals (SCCs) positioned orthogonally to each other, which gives the otic
vesicle a labyrinthine structure. Each canal has an associated domain of sensory hair cells, the
cristae, at their base within a widened region referred to as the ampulla. This allows the SCCs
to detect angular acceleration along their respective axes through the movement of the canal and
their respective crista, relative to the fluid within. Ventral to the SCCs are endolymph filled
chambers containing the sensory epithelia of the utricular and saccular maculae. The position of
these is largely conserved between vertebrates, with the utricle situated anterodorsal to the saccule
(Figure 1.1). Unlike the cristae, both the utricular and saccular maculae are mounted by calcium-
carbonate deposits known as otoliths or otoconia (Stooke-Vaughan et al., 2012). The attachment
of the otoliths, initially to the tether cells and subsequently the kinocilia of the hair cell bundles,
allows the utricle and saccule to detect linear acceleration and gravity through the movement of the
kinocilia relative to the suspended otolith (Riley and Moorman, 2000). In fish and avians another
otolithic sensory macula, the lagena, forms later during development (15dpf in zebrafish) branch-
ing o↵ from the saccule. In some vertebrates, such as zebrafish, another non-otolithic macula, the
neglecta, also forms later from the utricle (reviewed in Whitfield et al. 2002 and Wu et al. 1998).
Figure 1.1: Schematic of the zebrafish, chick and mouse inner ear structure
Comparison of the inner ear structure of zebrafish, chick and mouse shows a highly conserved dorsal
vestibular apparatus with a clear di↵erence in the ventral domains associated with auditory perception.
BP: Basilar Papilla, L: Lagena, LM: Lagenar macula, ooC: organ of Corti, SVG: Spiral and Vestibular
Ganglion, U: Utricle. Sensory (red), neuronal (blue). Reproduced with kind permission from T.Whitfield
Current Opinion in Genetics & Development 2015, 32:112–118.
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The dorsally positioned endolymphatic sac and duct, which extends from the dorsomedial region
of the ear, is another conserved structure within the vertebrate inner ear. This endolymphatic
system regulates the endolymph, a unique ionic extra-cellular fluid, within the ear. The presence
of endolymph is necessary during development of the otic vesicle for otolith formation, with a later
role also in hair cell depolarisation and maintaining pressure within the labyrinth of the inner ear
(Li et al., 2013; Abbas and Whitfield, 2009) and reviewed in Nin et al. 2016.
1.2.2 The auditory system
Whilst the vestibular system, which requires morphological asymmetry to function, retains a highly
conserved function and morphology between vertebrates as discussed above, the auditory system
shows a greater degree of variation between vertebrates (Figure 1.1). In teleosts such as zebrafish,
the utricle is thought to primarily detect vestibular stimuli, whereas the saccule is thought to
predominantly play a role in the detection of auditory stimuli (Lu and DeSmidt, 2013; Riley and
Moorman, 2000; Popper and Fay, 1973). However, in chick and and mouse auditory stimuli are
detected by a specialised ventrally-located organ called the cochlear duct. The cochlear duct di↵ers
structurally and functionally between mammals and avians, with the auditory sensory epithelium
in mammals being referred to as the organ of Corti compared to the basilar papilla in avians and
reptiles. Despite their di↵erences both are tonotopic, being organised along their length according
to frequency sensitivity (reviewed in Alsina et al. 2009 and Whitfield 2015).
The variation in the auditory system is also reflected in the manner in which sound is conducted
from the external environment to the auditory sensory epithelium. In mammals and avians, this
is achieved through the ossicles, of which mammals have three but avians only one. These ossicles
conduct the movements of the tympanic membrane of the outer ear in response to pressure waves
to the respective auditory epithelium (Thompson et al., 2012; Zou et al., 2012). In adult zebrafish,
due to the constraints of an aquatic environment, the initial detection of sound is thought to be
primarily achieved through deflections of the inflated swim-bladder wall. These deflections are
subsequently conducted to the sensory utricle and lagena of the inner ear via the Weberian ossi-
cles; a structure unique to the otophysi series of teleosts (Popper and Fay, 1973; Bang et al., 2001).
However, direct stimulation of the maculae by particle motion has also been observed in zebrafish
and due to the swim-bladder only inflating around 4-5dpf, it is also likely to be the primary method
of auditory detection in embryonic and larval zebrafish (Lu and DeSmidt, 2013).
1.3 Early development of the inner ear; the otic placode
1.3.1 The otic-epibranchial placodal domain
In all vertebrates the intricately structured inner ear is firstly specified as a cranial sensory placode.
This simple thickening of non-neural ectoderm arises from the posterior domain of a horseshoe-
shaped region of preplacodal ectoderm extending around the anterior edge of the neural plate
(Figure 1.2A) (reviewed in Ladher 2016). The initial competence to form the preplacodal ec-
toderm in zebrafish is dependent on the expression of a self-regulating network of transcription
factors, tfap2a and tfap2c, foxi1 and gata3, which are induced within this ectodermal region early
during gastrulation (⇠6hpf) primarily by members of the Bone Morphogenetic Protein (BMP)
family, which are ventrally expressed within the ectoderm (Figure 1.2A-1) (Kwon et al., 2010;
Bhat et al., 2013; Tucker et al., 2008; Dick et al., 2000). Whilst the requirement for TFAP2 in
establishing the preplacodal ectoderm in mouse and chick is unreported, Foxi3 and Gata3 show
similar expression in these vertebrates to foxi1 and gata3 in the zebrafish preplacodal ectoderm
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and have been shown to be required in a comparable manner (Khatri and Groves, 2013; Ohyama
and Groves, 2004; Khatri et al., 2014; Birol et al., 2016).
The expression of tfap2a/c, foxi1 and gata3 within the preplacodal ectoderm permits the expres-
sion of other transcription factors belonging to the dlx, six, eya to follow shortly, being expressed
by the mid-gastrula stages (⇠8hpf). This expression of the various dlx, six, eya transcription fac-
tors within this ectodermal domain are thought to further establish the preplacodal domain both
in zebrafish and other vertebrates (reviewed in Ladher 2016). The Pax, Eya and Six transcrip-
tion factors are though to act in a network with another cofactor, Dach in the development of a
number of placode-derived sensory structures in vertebrates (reviewed in Streit 2007). However,
it is not clear if this network is acting during establishment of the preplacodal ectoderm (Ham-
mond et al., 2002). The expression of the six and eya family members within the preplacodal
ectoderm during its establishment has also been reported to be dependent on the attenuation of
ventrolateral sources of BMP via the dorsal expression of BMP antagonists (Kwon et al., 2010;
Wang et al., 2011; Yao et al., 2014). In zebrafish, the expression of such an antagonist, cv2, within
the preplacodal ectoderm appears to be dependent on dlx3b/4b (Figure 1.2A-2) (Esterberg and
Fritz, 2009). The preplacodal expression of the six and eya family members has also been shown
to be weakly dependent on Fibroblast growth factor (Fgf) and Platelet-derived growth factor A
(Pdgf) signalling in zebrafish, with Foxi1, Gata3 and Dlx3b/4b all appearing to regulating Fgf
signalling within this region (Esterberg and Fritz, 2009; Yao et al., 2014; Kwon et al., 2010). A
similar requirement for Fgf signalling in inducing expression within the preplacodal is also seen in
chick and mouse (reviewed in Ladher 2016).
Adjacent to the preplacodal ectoderm, bordering the medially-positioned neural plate ectoderm, a
domain of premigratory neural crest (NC) cells is also established mid-way through gastrulation
(7-8hpf) (Figure 1.2A-2.) (Wang et al., 2011). These NC cells eventually migrate from this dorsal
position and contribute to the cartilage within the head along with pigment, neuronal and glial
cell lineages (reviewed in Knecht and Bronner-Fraser 2002). In zebrafish this border domain is
established through the expression of a number of genes such as foxd3, snai1b and members of
the pax3/7, irx and zic families are induced during gastrulation (reviewed in Simões-Costa and
Bronner 2015). A number of genes expressed within the preplacodal ectoderm such as tfap2a/c
and the members of the SoxE transcription family, sox9a,sox9b and sox10, also show overlapping
expression within the neural crest domain (Figure 1.2A) (Dutton et al., 2009; Li and Cornell,
2007).The expression of these genes within this domain is thought to occur in a step-wise manner,
responding to Wnt signalling emanating from the vegetal (posterior) marginal zone and an adja-
cent dorsoventral domain of ectoderm, as well as dorsal sources of Fgf signalling, low-levels of BMP
signalling from the ventrolateral ectoderm and localised-Notch signalling (reviewed in Stuhlmiller
and Garćıa-Castro 2012). Similar to the the preplacodal ectoderm establishing this border domain
is also likely dependent on regulation of BMP and Wnt signalling through the expression of their
antagonists within this region (Steventon et al., 2009; Wang et al., 2011). Establishment of this
neural crest domain on the neural plate border via BMP, Wnt and Fgf is though to be similar in
chick and mouse (reviewed in Groves and LaBonne 2014.
By mid-late gastrulation (⇠9hpf), localised FGF signalling from the adjacent neural ectoderm of
the presumptive mid-hindbrain boundary and rhombomere 4, along with Wnt8 signalling, which
by late gastrula is expressed in a similar domain (Figure 1.2A-2.), induce expression of the paired-
box transcription factor pax8 within the preplacodal ectoderm (Lekven et al., 2001)(Phillips et al.,
2004). This dorsolateral source of Fgf signalling is also required for expression of the SoxB1 family
transcription factor sox3 within a similar domain to pax8 (Sun et al., 2007; Padanad and Riley,
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2011). This expression of pax8 and sox3 within the posterior domain of preplacodal foxi1 expres-
sion establishes an otic-epibranchial placodal domain (OEPD), which will give rise to both the otic
and epibranchial tissues (Hans et al., 2004; Solomon et al., 2004, 2003; Lekven et al., 2001; Phillips
et al., 2004). This localisation of FGF and Wnt within the neural ectoderm also subsequently
leads to the progressive restriction of foxi1 expression to this posterior domain at approximately
1ss (⇠10.5hpf) (Hans et al., 2013; Yao et al., 2014; Padanad et al., 2012). Expression of another
preplacodal marker, gata3, also shows a later restriction to this region by 10ss (14hpf) (Bhat
et al., 2013). The localisation of Fgf signalling adjacent to the OEPD also appears to be required
for the persistent expression of dlx3b and sox9a/b within this domain in zebrafish (Liu et al., 2003).
Shortly after the induction of pax8 within the posterior preplacodal ectoderm, Dlx3b and Dlx4b,
Pax8 and Fgf signalling induce the expression of pax2a within this domain by 3ss (11hpf), with the
broader expression of foxi1 thought to specify a neuronal ground state for OEPD neuronal deriva-
tives within this domain in zebrafish (Figure 1.2C) (Hans et al., 2013, 2004; Solomon et al., 2004).
In chick, mouse and zebrafish, the dorsal source of Wnt signalling is then thought to maintain
high expression of pax2 within the dorso-medial region by 6ss (12hpf) to specify the otic placode
with low Wnt signalling within the ventrolateral region leading to low pax2 expression, specifying
the epibranchial placode (Figure 1.2B) (Freter et al., 2008; McCarroll et al., 2012; Ohyama et al.,
2006). In zebrafish, this medial domain of high pax2a expression, in combination with pax8 further
drives otic di↵erentiation via a down-regulation of Foxi1 (Padanad and Riley, 2011). A paralogue
of pax2a, pax2b is also expressed within the domain of pax8, albeit slightly later than pax2a and
has been suggested to act redundantly with pax2a (Mackereth et al., 2005). Later pax2a expression
is restricted to the sensory structures of the maculae and cristae, likely dependent on Dlx3b/4b,
with pax8 expression being progressively lost from the otic tissue (Hans et al., 2013) (reviewed in
Whitfield et al. 2002).
After the induction of pax2a expression within the OEPD (⇠11hpf), expression of sox3 is pro-
gressively lost (⇠12hpf) from the future otic domain expressing pax8 and high pax2a, resulting
in a lateral domain of expression within the domain fated to become the developing epibranchial
placodes (Figure 1.2). This maintenance of sox3 within the lateral epibranchial domain of the
zebrafish OEPD has been suggested to result from a balance of otic Fgf24 signalling and later
lateral BMP signalling within this domain rather than reflecting otic specification through Pax2a
(Sun et al., 2007; Padanad and Riley, 2011). From 10ss (14hpf) in zebrafish another member of the
SoxB1 family, sox2, is also broadly expressed within a broad medial domain of the otic placode,
later refining to the two sensory domains marking the sensory epithelia of the utricle and saccule
and is required for maintenance and regeneration of the hair cells within these domains (Millimaki
et al., 2010). A similar role for Sox2 has also been reported in chick and mice (Neves et al., 2011;


























































































































































































































































































































































































1.4 Patterning of the zebrafish otic placode across the anterior-
posterior axis
Once established, the otic placode in fish progressively undergoes cavitation to form the otic vesi-
cle, with the otic placode in aminotes invaginating to form an otocyst following an intermediate
otic cup stage. However, before these morphological changes occur otic asymmetry across all three
body-axes has been established. In zebrafish, asymmetry across the mediolateral (ML) axis of
the otic placode is the first apparent with a ML gradient of pax2a expression in response to a
hindbrain source of Wnt signalling, present at around 3ss (11hpf), as discussed above (McCarroll
et al., 2012). This specification of the ML axis is quickly followed by the AP otic axis, which is
reported to show anterior-localised expression of hmx3a from 4ss (11.5hpf) onwards (Feng and Xu,
2010). The dorsoventral (DV) axis appears to be specified later in zebrafish with dlx3b expression
appearing dorsally localised from 14ss (16hpf) and eya1 expression ventrally localised from 22ss
(20hpf) onwards, both restricting from initially broad domains of expression (Sahly et al., 1999;
Ekker et al., 1992) (reviewed in Whitfield and Hammond 2007).
A feature of the otic anterior-posterior axis is that it appears prone to adopt either the ante-
rior or posterior character following perturbation early during its development with this being
shown from as early as the 1930s in salamanders following rotation of the otic tissue and a similar
result also being reported in chick more recently (Harrison, 1936; Wu et al., 1998). In zebrafish
and xenopus, it has also been shown that duplications of the anterior-posterior axis can show
mirror symmetry of both the anterior and posterior sensory structures and expression of normally
localised genes (Waldman et al., 2007; Hammond et al., 2003; Hammond and Whitfield, 2011).
These results support the importance of exogenous signalling pathways action on the early otic
tissue in establishing anterior and posterior character across an initially equipotent tissue and also
highlight the value of this system as a model for generally understanding the mechanisms involved
in establishing asymmetry across tissues during development. Therefore both this project and
the remainder of the introduction are focussed on the signalling events and character assignment
occurring across the otic anterior-posterior axis.
1.4.1 Signals acting across the zebrafish otic anterior-posterior axis
Fibroblast growth factor (Fgf)
From late gastrulation until around prim-5 (24hpf) fgf3 is strongly-expressed within rhombomere
4 (R4), which by the end of gastrulation is positioned anteriorly to the otic placode (Maves et al.,
2002). This is also augmented by sources of Fgf3 present within the ventral mesoendoderm un-
derlying the otic placode (McCarroll and Nechiporuk, 2013) (Figure 1.3). Fgf8a is also expressed
strongly within the anlage of the mid-hindbrain boundary (MHB) and R4 during the induction of
the otic placode, persisting within this domain until around 8ss (13hpf) after which it is primarily
expressed within the anterior mid-hindbrain boundary (Maves et al., 2002).
Later, fgf3 is also expressed within the zebrafish otic ectoderm in an anterior domain from 20-
26ss (19-22hpf) (Millimaki et al., 2007) (Figure 1.3). From the 18ss (18hpf) fgf8a is also expressed
within an anterior otic domain and later (prim-5, 24hpf) also shows weak and transient expression
within a posterior otic domain (Figure 1.3) (Léger and Brand, 2002). A similar otic expression
profile is seen with fgf10a being expressed in an anterior otic domain from 10-14ss (14-16hpf)
onwards and later in a posterior domain (Figure 1.3) (McCarroll and Nechiporuk, 2013).
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However, this posterior expression of fgf10a is not lost as with fgf8a, persisting to eventually
be present within the posterior crista (Thisse and Thisse, 2004; Ma and Zhang, 2015).
Along with being required for establishing the otic placode (see Section 1.3), Fgf3 and 8a signalling
both external to and within the otic tissue is also crucial for patterning the anterior domain of
the otic placode in zebrafish. Perturbation of the hindbrain and the R4 domains of fgf3 and 8a
expression resulting in corresponding changes in the expression of anterior and posterior markers
within the otic tissue (Kwak et al., 2002b). Mutations or knock-down of either fgf3 or fgf8a, de-
spite having di↵erences in their phenotypes, have both also been shown to lead to a reduction in
expression of genes known to be required for normal development of the anterior sensory domains
with loss of fgf3 also having been shown to result in a partial loss of anterior sensory morphol-
ogy (Léger and Brand, 2002; Hammond and Whitfield, 2011). This supports fgf3 and 8a having
some redundancy in their ability to assign anterior otic character in zebrafish. This redundancy
is further supported by inhibition of Fgf signalling using the pan-Fgf inhibitor, SU5402, which
shows a stronger reduction in anterior otic character than loss of either fgf3 or fgf8a individually
(Léger and Brand, 2002; Hammond and Whitfield, 2011). Misexpression of either fgf3 or fgf8a
also emphasises the ability of both these Fgfs to duplicate anterior markers (Sweet et al., 2011;
Hammond and Whitfield, 2011). Whilst fgf10a has also been suggested to play a role in patterning
the anterior otic domain in zebrafish, its e↵ect on this appears to be very weak (McCarroll and
Nechiporuk, 2013).
Two other Fgfs, fgf17 and fgf24, have also been reported to be expressed later within anterior
and broadly posterior domains of the zebrafish otic placode respectively. However, neither has
been reported to be associated with determining either anterior or posterior otic character (Reifers
et al., 2000; Padanad and Riley, 2011; Draper et al., 2003).
Sonic hedgehog (Shh)
Induction of the posterior otic domain in zebrafish has been shown to be dependent on Sonic
hedgehog a and b (Shh), signalling redundantly from the ventrally-position, midline structures of
the floorplate and notochord (Figure 1.3) (Hammond et al., 2003). This ventral source of Shh
signalling also appears to be important in influencing the dorsoventral (DV) axis of the zebrafish
otic placode (Hammond et al., 2010). Expression of canonical read-out genes for Hedgehog sig-
nalling, ptch1 and ptch2 from >20ss reflect the ventral sources of Hh signalling, being expressed
in a ventromedial otic domain. Ptch2 is reported to be initially expressed across the AP axis at
15ss (16.5hpf), progressively strengthening in a domain midway along the AP length of the otic
tissue and extending weakly into the posterior domain (Hammond et al., 2003). The lack of ptch
expression within the anterior otic domain has been suggested to possibly reflect the combina-
tion of the anterior otic domain being further away from the midline structures and also roughly
adjacent to the anterior limit of the notochord (Figure 1.3) (Hammond et al., 2003). However,
brachyury mutants, which lack a di↵erentiated notochord, do not show any defects in posterior
otic morphology suggesting this is not the main factor (Hammond et al., 2003).
The data discussed above have led to a model for specification of the zebrafish otic anterior-
posterior axis, whereby a gradient of Fgf signalling from the anterior hindbrain and anteroventral
mesoendoderm is responsible for assigning anterior otic identity with Shh signalling across the
length of the otic placode, originating from the ventral midline structures, assigning posterior
identity (Hammond and Whitfield, 2011).
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In patterning the otic AP axis, Fgf and Shh have been shown not to directly inhibit the signalling
of the other, based on the expression of canonical Fgf and Shh signalling targets (Hammond
and Whitfield, 2011). This infers that the di↵erence in anterior and posterior identity is due to
di↵erential regulation of intrinsic otic gene expression by both of these pathways.
Retinoic acid (RA)
RA cannot be visualised directly due to it being a metabolite of vitamin A, therefore the expres-
sion of RA synthesising aldehyde dehydrogenase enzymes have been used in lieu as an indicator of
sources of free RA within embryos. This use of aldehyde dehydrogenase expression as an indicator
of RA within the embryo is supported by transgenic RA sensors, which appear to correlate with
the expression domains of the aldehyde dehydrogenases (Mandal et al., 2014; Waxman and Yelon,
2011). In contrast, the expression of RA metabolising cytochrome p450 enzymes within various
regions of the developing embryo are thought to represent sinks for free RA within the embryo and
together with the aldehyde dehydrogenases create source-sink gradients of free-RA (White et al.,
2007). Such a RA source-sink gradient has been proposed to be present across the otic domain,
with a domain of aldehyde dehydrogenase 1 family, member A2 (aldh1a2) expression in a ventrolat-
eral domain, posterior to the otic placode in zebrafish from 16hpf (14ss) onwards and an anterior
medial domains of the cytochrome p450 enzyme, cyp26c1 expression present later at around 22hpf
(Figure 1.3) (Maier and Whitfield, 2014). Later, from 22ss (20hpf), as the posterior expression of
aldh1a2 becomes weaker another aldehyde dehydrogenase, aldh1a3 is expressed within the anterior
otic tissue (Figure 1.3) (Maier and Whitfield, 2014).
In zebrafish, RA signalling is involved in patterning the hindbrain during gastrulation (Hans and
Westerfield, 2007). However, it has not been reported to directly a↵ect the development of the
anterior-posterior character of the otic tissue, instead having a clear role in regulating the balance
between the anterior sensory and neurogenic domains relative to the posterior non-neurogenic do-
main along the ventral otic edge (Figure 1.3) (Radosevic et al., 2011; Maier and Whitfield, 2014).
Wnt and Bone morphogenetic proteins (BMP)
At the time during which the developing otic placode is thought to be patterned in zebrafish
(>11hpf), a number of Wnt family members are expressed in the dorsal hindbrain adjacent to the
otic placode. Wnt1,3a, 7a, 7b and 10b, all appear in the hindbrain posterior to the otic placode
by 16ss (14hpf) with wnt8b, which at late gastrula stages is present along with wnt8a in a domain
of neuroepithelium adjacent to the OEPD (Section 1.3), showing restricted expression within R3
and R5 by 14ss (16hpf) (Beretta et al., 2011; Lecaudey et al., 2007; Buckles et al., 2004; Lekven
et al., 2003, 2001; Kelly et al., 1995).
Misexpression of wnt8a in zebrafish, as well as altering the size of the OEPD due to its role
in establishing this domain as discussed in Section 1.3, can lead to changes in the expression of
fgf3 and fgf8a within the hindbrain (Phillips et al., 2004). Such changes in hindbrain pattern-
ing can indirectly alter the anterior-posterior patterning of the otic vesicle (Lecaudey et al., 2007).
























































































































































































































































































































































































































































































































































Other Wnt family members are also unlike to directly influence otic anterior-posterior pat-
terning, with knock-down of wnt8b alone, as well as knock-down of wnt3a in a wnt10a mutant
background, not being reported to result in changes in otic AP patterning or morphology in ze-
brafish (Buckles et al., 2004; Hans and Westerfield, 2007). This is supported by inhibition of
canonical Wnt signalling through misexpression of the Wnt antagonist, dkk1 (Phillips et al., 2004;
Kawano and Kypta, 2003). This misexpression of dkk1 results in otic vesicles with a smaller but
seemingly normal morphology, as highlighted by the otolith position. Whilst these various alter-
ations in Wnt signalling may have subtle or unobserved a↵ects on the transcription of markers of
otic anterior-posterior character, overall it appears that despite the presence of these numerous
Wnt sources close to the otic placode, Wnt signalling does not appear to be directly patterning
the otic anterior-posterior axis.
BMP signalling, despite being important in establishing the otic domain (see Section 1.3) has
not been implicated in patterning the anterior-posterior axis of the developing zebrafish ear. Bmp
ligands do show localised expression within the zebrafish otic tissue with bmp2b expressed in a dor-
sal domain that extends posteriorly and bmp7 expressed within a ventral posterior domain (Figure
1.3). Other mediators of the BMP pathway also show localised expression within both the anterior
and posterior lateral domains. However, all these components are expressed >22ss (20hpf), after
the period over which anterior and posterior otic character are thought to be assigned (Mowbray
et al., 2001). Bmp2b and Bmp7 also are reported to be involved in patterning events other than AP
patterning, with Bmp2a being required for development of all three canals and Bmp7 implicated
in mediating neurogenic di↵erentiation in response to Tfap2a (Kantarci et al., 2015; Hammond
et al., 2009).
1.4.2 Transcriptional di↵erences across the anterior-posterior otic axis
The medial otic domain
Early transcriptional di↵erences across the AP axis in response to extrinsic sources of Fgf and Shh
localised across the early otic AP axis are crucial in defining anterior and posterior otic identity,
which manifest as morphological di↵erences within the anterior and posterior domains as develop-
ment progresses (Figure 1.4). Expression of such markers associated with developing anterior and
posterior otic character is primarily within a more medial domain of the otic tissue in zebrafish
from which the sensory maculae form and marked by an initially (<prim-5, 24hpf) broad domain
of pax2a (Riley et al., 1999).
The earliest localised expression across the anterior-posterior axis of this medial domain is that
of the homeobox H6 family transcription factor hmx3a (previously nkx5.1 ) from 4ss (11.5hpf)
onwards. Hmx3a is expressed within a ventromedial anterior domain and is shortly followed by
expression of another Hmx family member, hmx2 (previously nkx5.2 ) at 10-12ss (14-15hpf) within
the same region, which has been reported to act redundantly with Hmx3a in specifying anterior
otic character (Figures 1.3 and 1.4) (Feng and Xu, 2010). The anterior and posterior semi-circular
canals also later form on the edge of this medial domain of hmx2 and hmx3a expression in zebrafish,
although interestingly knock-down of both does not lead to a loss of these structures possibly due
to redundancy with other Hmx family members (Feng and Xu, 2010). Hmx3a and Hmx2, along
with extrinsic Fgf signalling also maintain the later onset of pax5 expression (16ss, 17hpf) within
the same otic domain (Figures 1.3 and 1.4) (Feng and Xu, 2010). In zebrafish, Pax5 is required
for maintaining anterior sensory hair cells later in development (prim-5 onwards, 24hpf). However,
this does not appear to be through regulation of the other anterior otic markers and a similar
requirement for pax5 in maintaining hair cells has not been reported in other vertebrate models
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(Kwak et al., 2006). Hmx3a and Hmx2 have also been shown to be required for expression of fgf3,
fgf8a and fgf10a within this anterior otic domain (Feng and Xu, 2010). These Fgfs are progres-
sively expressed within this otic domain, with fgf10a first seen at 10ss (14hpf) and fgf8a, followed
by fgf3, expressed later (Section 1.4.1, Figures 1.3 and 1.4) (Léger and Brand, 2002; McCarroll and
Nechiporuk, 2013).
The presence of fgf3, 8a and possibly fgf10a within the anterior otic domain also likely reflects a
feedback loop acting within this domain to reinforce and maintain anterior otic character. This is
supported by data showing that in zebrafish loss of fgf3 or fgf8a leads to the reduction/loss of the
anterior otic markers, hmx2, hmx3a and pax5, of which hmx2, hmx3a are required for maintain-
ing expression of these Fgfs within the anterior domain (Kwak et al., 2006; Feng and Xu, 2010;
Léger and Brand, 2002). Conversely misexpression of either fgf3 or fgf8a also leads to a posterior
expansion of these anterior otic markers (Sweet et al., 2011; Hammond and Whitfield, 2011). In-
terestingly, it has also been reported that two of the anterior otic markers, pax5 and fgf8a, show
transient expression within the posterior otic domain around 24hpf (Figure 1.3) (Léger and Brand,
2002; Kwak et al., 2006). However, no suggestion as to what this might be reflecting has been made.
Duplications of the anterior markers, pax5 and fgf8a, have also been reported in the sox10 (previ-
ously colourless, cls) mutants, although interestingly without any corresponding anteriorisation of
the posterior macula morphology (Dutton et al., 2009). The reason for this is unclear, especially
given sox10 appears uniformly expressed across the otic anterior-posterior axis past prim-5 (24hpf)
(Dutton et al., 2001).
Within the posteromedial otic domain in zebrafish, the earliest published markers are pou3f3b
(previously zp23 ); a POU class homeobox transcription factor, bmp7 and follistatin A (fsta); a
glycoprotein, which is a canonical antagonist of BMP (Hauptmann and Gerster, 2000). All three
are reported to be expressed within this otic domain from prim-5 (24hpf) (Figures 1.3 and 1.4)
(Dutton et al., 2009; Kwak et al., 2006; Mowbray et al., 2001). Whilst the functions of Pou3f3b,
BMP7 and Fsta in regulating posterior otic character are unknown, both pou3f3b and fsta appear
to reflect changes in posterior otic character. This is based on the observation that their posterior
expression is lost in response to misexpression of fgf3 with fsta also being expressed within the
anterior domain after inhibition of Fgf signalling (Kwak et al., 2002a; Hammond and Whitfield,
2011). However, given the progressive restriction in the otic placode to duplicate anterior iden-
tity within the posterior domain between 14-20hpf, prior to the reported onset of these posterior
markers, it is highly likely that a response from other earlier targets of Hh within this domain are
needed to establish posterior otic character.
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Figure 1.4: Timing vs asymmetric gene expression within the otic medial domain
Onset of expression either within the medial anterior (pink) or posterior (blue) domains for genes
associated with developing otic character.
1= Feng and Xu 2010, 2= McCarroll and Nechiporuk 2013, 3= Kwak et al. 2006, 4= Léger and Brand
2002, 5= Millimaki et al. 2007, 6= Maier and Whitfield 2014, 7= Mowbray et al. 2001, 8= Maulding
et al. 2014, 9= Thisse and Thisse 2004, 10= Hammond et al. 2003, 11= Hammond and Whitfield 2011.
Asterisks highlight transcripts that are only transiently present within the posterior.
The lateral otic domain
Similar to the medial otic domain, the ventrolateral otic domain also shows early asymmetric gene
expression across the anterior-posterior axis (Figure 1.3, bottom row). However, this asymme-
try rather than reflecting di↵erences in anterior and posterior otic character represents the early
segregation of an anterior neurogenic domain from which neuroblasts will delaminate to form the
statoacoustic ganglion and a posterior non-neurogenic domain from which the ventral pillar of the
lateral canal will later form.
An early marker within this ventrolateral domain is the transcription factor tbx1, which is ex-
pressed posteriorly within this domain from 10ss (14hpf) (Figure 1.3). In zebrafish, tbx1 has been
shown to define this region as non-neurogenic through its induction of the bHLH proneural antago-
nist her9. The induction of her9 within this posterior region is then thought to limit the expression
of the proneural neurod1 to a defined anterior neurogenic domain, later also marked by neurog1,
that establishes a population of delaminating neuroblasts that migrate anteriorly to establish the
statoacoustic ganglion (Radosevic et al., 2011). Within the mid-region of the ventrolateral domain
marked by tbx1, the transcription factor otx1b is also expressed from 18hpf (Figure 1.3). Expres-
sion of otx1b within this region is dependent on Tbx1 and whilst Otx1b has been suggested to also
act in limiting the extent of the adjacent neurogenic domain, it is also required for formation of
the ventral pillar from this epithelium around which the lateral semicircular canal forms (Whitfield
et al., 1996a; Maier and Whitfield, 2014; Hammond and Whitfield, 2006).
Other later (>28hpf) markers of this lateral domain in zebrafish are hmx1 and hmx4 (previ-
ously SOHo). Both of these are reported to also show expression within the anterior statoacoustic
ganglion and later the anterior and posterior cristae but their functions in zebrafish otic develop-
ment are currently unknown (Feng and Xu, 2010).
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The initial expression of tbx1 within this posterolateral domain is dependent on early posterior
RA signalling, likely resulting from aldh1a2 expression within the somitic mesoderm posterior to
the otic placode and later within a ventrolateral domain closer to the otic placode (Figure 1.3)
(Grandel et al., 2002; Mandal et al., 2014). Unlike the markers of the posterior medial domain,
tbx1 expression within the posterior lateral otic placode appears inhibited by Shh signalling prior
to 18ss (18hpf) from the ventral midline structures, which has been suggested to limit expression
of tbx1 to the lateral otic domain (Radosevic et al., 2011). Similarly, expression of tbx1 and otx1b
are reported to be upregulated by Fgf signalling rather than inhibited, as seen with markers of the
posterior medial domain (Maier and Whitfield, 2014). Interestingly, Fgf also positively regulates
the anterior sensory and neurogenic domains with neurod1 showing a duplicated domain of expres-
sion adjacent to the posterior otic vesicle after misexpression of fgf3 (Hammond and Whitfield,
2011). However, the establishment of the lateral neurogenic domain doesn’t appear to be directly
linked to anterior otic character as a similar duplication of neurod1 is not seen after inhibition of
Hh signalling during the period over which the otic anterior-posterior axis is thought to be specified
(Radosevic et al., 2011).
Anterior Fgf signalling has also been reported to induce expression of RA-producing aldh1a3 within
an anterior domain between the sensory and neurogenic domain from 22ss (20hpf) onwards (Fig-
ure 1.3). This anterior source of otic RA has been proposed to further balance the maturation of
the delaminating neuroblasts from the neurogenic domain and the anterior limit of the posteriorly
situated non-neurogenic domain (Maier and Whitfield, 2014).
1.4.3 Competence of the otic placode to adopt anterior-posterior identity
A key feature of the developing zebrafish ear and why it represents a good model for understanding
patterning across the otic anterior-posterior axis in vertebrates is its ability to duplicate either
anterior or posterior otic character. This has been clearly shown by Hammond et al. in response
to manipulation of either Fgf or Shh signalling (Hammond et al., 2003; Hammond and Whitfield,
2009, 2011). However, the duplication response seen after changes in either Fgf or Shh signalling
appears to be dependent on the temporal and spatial competence of the otic tissue to respond,
as discussed below. Di↵erent alterations of Fgf or Hh signalling also result in varying degrees of
change in either anterior or posterior otic character highlighting that both the competence of the
otic tissue to respond and the signalling environment are important for determining the ultimate
duplication phenotype observed (Maier and Whitfield, 2014; Hammond et al., 2010; Hammond and
Whitfield, 2011; Léger and Brand, 2002).
Temporal
The equipotent nature of the zebrafish otic placode to duplicate anterior otic character in response
to misexpression of fgf3 is reported to be restricted to a period of early otic development. Duplica-
tion of the anterior otic morphology and expression of anterior markers is observed after heat-shocks
from the 10ss (14hpf), with the ability of the otic tissue to produce such duplicated morphology
appearing to be progressively lost by the 16ss (17hpf) (Hammond and Whitfield, 2011). Misex-
pression of fgf8a from the 10ss (14hpf) in zebrafish has also been shown to produce an anterior
duplication but this has only been reported in the expression of anterior markers rather than the
otic morphology (Sweet et al., 2011). A similar progressive loss of competence to duplicate anterior
otic character is seen in ears treated with the Hh signalling inhibitor, cyclopamine. Here treat-
ment prior to 15ss (16.5hpf) is reported to show a strong duplication of anterior morphology but
similar treatments at later time points results in progressively less extreme duplication phenotypes
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(Hammond et al., 2010).
Intriguingly, the morphological duplication of posterior otic character seen in the ears of ptch1;2
mutants, where Hh signalling is constitutively activated, can be rescued by treatment with the
Hh signalling inhibitor cyclopamine from the 17ss (17.5hpf) (Hammond et al., 2010). This sug-
gests that the anterior otic domain is still competent to respond to changes in to the signalling
environment at this later time point.
Spatial
Another interesting characteristic of these axial duplications is seen when these are generated
through misexpression of fgf3, pan-Fgf inhibition by SU5402, constitutive activation of Hh sig-
nalling by inhibition of PKA inhibition or injection of Shh RNA. Rather than resulting in the
expression of markers associated with either anterior or posterior otic character across the entire
AP axis of the otic tissue, as might be expected given the loss of AP-localised positional infor-
mation, under these conditions certain AP markers are reported to display discrete domains of
expression duplicated at either end of the AP axis by prim-15 (30hpf) (Figure 1.5A) (Hammond
et al., 2010; Hammond and Whitfield, 2011; Hammond et al., 2003). This suggests that only
certain regions of the otic tissue are competent to maintain a transcriptional response following
the previously mentioned changes in signalling. A similar response is also observed in the sen-
sory maculae under similar duplicating conditions. In these duplicated maculae the morphology
and hair cell polarity, which has distinct regional directionality associated with the anterior and
posterior maculae, appears mirrored around the AP axis rather than showing two patches with
identical/expanded directional polarity or with no polarity altogether (Figure 1.5B) (Hammond
et al., 2003; Hammond and Whitfield, 2011).
The mirrored response observed could reflect the duplication of either an otic extrinsic or intrinsic
organiser in response to changes in Fgf or Hh that establishes the localisation of the duplicated
domains of expression and maculae morphology at either end of the otic AP axis and also influences
the polarity of the hair cells. Whilst hindbrain sources of Fgf signalling have been shown to be
important for establishing the anterior domain of markers, patterning of the hindbrain is reported
to appear normal in SU5402-treated and double ptch1;2 mutants with only a slight expansion of
rhomobomere 5 observed after misexpression of fgf3 (Lecaudey et al., 2007; Hammond and Whit-
field, 2011; Kwak et al., 2002a). This suggests that a duplication of a hindbrain signalling source
is unlikely under these duplicating conditions. However, changes in ventral signalling sources such
as the epibranchial endoderm could be occurring but there is currently no evidence reported to
support any such changes.
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Figure 1.5: Transcriptional and sensory maculae phenotypes seen under conditions that
duplicate the otic AP axis.
Phenotypes seen in the A) transcriptional response or B) the sensory maculae after manipulation of
either the Fgf or Hh signalling pathways, where positional information is lost either transiently or
persistently. In B) the top duplicated hair cell polarity diagram reflects an anterior duplication after
misexpression of fgf3, whereas the bottom diagram reflects a posterior duplication due to constitutive
activation of Hh signalling in ptch1;2 mutants. Dotted lines are to highlight symmetry around the AP
axis and black dots are where the directional polarity could not be determined.
The red line in the normal polarity map in B) represents the stereotypical anterior line of polarity
reversal along the AP axis. Polarity diagrams in B are based on those from Hammond and Whitfield
2011; Hammond et al. 2010. All diagrams are from a lateral perspective with the anterior to the left.
Another model has been proposed by Hammond et al., where by extrinsic Fgf and Shh signals
induce anterior and posterior character onto an established pre-pattern already present across the
otic placode, which establishes organising centres at either pole within the otic tissue (Hammond
and Whitfield, 2011). Two potential candidates for establishing such a pre-pattern are the pro-
neural genes, atoh1b and atoh1a. In the zebrafish otic placode, atoh1b is thought to initially specify
the tether cells around which the utricle and saccule sensory epithelia form through subsequent
rounds of hair cell specification, dependent on atoh1a. Both atoh1b and atoh1a show AP pole-
localised expression by 10ss (14hpf), the time from which the otic anterior-posterior axis appears
susceptible to changes in patterning, resolving from an initially broad domain of expression (Mil-
limaki et al., 2007). The early segregation of atoh1b and atoh1a into these two domains appears
una↵ected by inhibition of either Fgf or Hh signalling, despite these conditions ofter later resulting
in fused maculae (Millimaki et al., 2007; Sapède and Pujades, 2010; Hammond and Whitfield, 2011;
Hammond et al., 2010).
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However, expansion of these atoh1b/atoh1a expressing sensory domains after the >18ss (18hpf)
does appear positively regulated by Fgf signalling in zebrafish with Notch signalling possibly acting
as a negative regulator of such expansion (Millimaki et al., 2007; Sweet et al., 2011).
The misexpression of atoh1a can also lead to a posterior expansion of fgf3 and fgf8a, as well
as the anterior markers hmx3a and pax5 along the medial otic domain (Sweet et al., 2011). This
is despite knock-down of atoh1a/b not leading to an obvious decrease in anterior otic expression
of anterior markers such as fgf3 and fgf8a by prim-5 (24hpf), possibly reflecting the influence of
external Fgf signalling on maintaining this anterior expression (Millimaki et al., 2007; Léger and
Brand, 2002; Hammond and Whitfield, 2011; Lecaudey et al., 2007). Therefore, such a feedback
loop between the pre-patterned Atoh1a/b and the anterior otic markers could reflect why expres-
sion of anterior markers after misexpression of fgf3 are maintained in these discrete domains rather
than across the otic tissue (Figure 1.6A).
Figure 1.6: Possible mechanism by which an Atoh1a/sensory domain pre-pattern might
result in localised transcription within the AP poles of the zebrafish otic vesicle
A) A proposed localised feedback loop between Atoh1a present within the sensory domains localised at
either end of the OV, even under duplicating conditions, and factors known to be involved with
establishing anterior otic identity. The dotted line indicates that Atoh1a may not be directly regulating
pax5 and hmx3a as these are known to be downstream of Fgf signalling within the otic tissue. B) Whilst
no evidence has yet been reported for a regulatory link between Atoh1a and markers of posterior otic
character, the localised sensory domain may still act to regulate these markers.
1= Millimaki et al. 2007, 2= Sweet et al. 2011, 3= Feng and Xu 2010 and 4= Hammond and Whitfield
2011.
For posterior duplications, the posterior marker fsta is the only marker reported to show discrete
duplicate domains of expression within the otic tissue and only under certain conditions (Hammond
et al., 2010, 2003). It is also not clear whether Atoh1a or b plays any regulatory role with any of
the markers of posterior character and localised Hh signalling has not been reported within the
otic tissue either during normal development or under duplicating conditions.
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This does not mean that there is not a regulatory relationship between the posterior markers
and the sensory epithelium expressing atoh1a or b, which would support the pre-pattern model
mentioned above but further work is required to confirm this (Figure 1.6B).
The mechanism by which the polarity of the hair cells in relation to one another within the sensory
maculae of the ear are defined in vertebrates is still poorly understood but it is clearly possible to
alter this polarity in zebrafish using the duplicating changes in Fgf and Hh signalling mentioned
above (reviewed in Sienknecht 2015. However, there must be another level of organisation to en-
sure that given the loss of positional information from extrinsic sources of signalling, the hair cells
of the duplicated patches rather than becoming disorganised show a mirrored symmetry (Figure
1.5B).
In the zebrafish lateral line, which also has directionally polarised hair cells, the polarity of these
hair cells has been reported to be influenced by both the Notch and planar cell polarity (PCP)
intercellular pathways (Mirkovic et al., 2012). The PCP pathway has also being linked to deter-
mining hair cell polarity in the chick and mouse cochlea (Davies et al., 2005; Tarchini et al., 2016;
Piast et al., 2005). As a loss of Notch signalling is not reported to clearly perturb the directional
polarity of the hair cells within the sensory maculae of the zebrafish ear, the PCP pathway may
play a role in determining this (Haddon et al., 2000). The direction of polarity produced through
the cell-cell interactions in PCP, whilst having a level of self-patterning can also be biased by
external cues such as non-canonical Wnt and possibly Hh signalling (Goodrich and Strutt, 2011;
Aw and Devenport, 2016). Therefore, this could represent a mechanism by which changes in sig-
nalling cues could also influence the polarity of the hair cells within the otic sensory epithelia. It
has also been suggested that the directional polarity of hair cells within regions of the maculae
are dependent on asymmetric expression of certain genes such as emx2 in vertebrates, including
zebrafish, which might influence downstream e↵ectors of the PCP pathway (Jiang et al., 2017).
Such modifiers of the PCP pathway could also represent another point at which external signals
could influence determination of hair cell polarity. However, a clear role for the PCP pathway
in specifying hair cell directional polarity in the maculae of the zebrafish ear has not yet been
reported and the signalling environment that could be influencing the directional polarity of the
hair cells within the maculae of the otic tissue through a di↵erent mechanism. It is also unclear as
to which signalling sources could produce such symmetry around the AP axis.
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1.5 Patterning of the chick and mouse otocyst along the
anterior-posterior axis
Early otic patterning in both chick and mouse shows a high degree of similarity in the signalling
pathways and transcriptional responses observed across the otic axes to those in zebrafish (reviewed
in Whitfield and Hammond 2007 and Groves and Fekete 2012). However, the manner in which
these signals and transcriptional responses regulate patterning across the three axes in the chick
and mouse ear show some di↵erences when compared to zebrafish, as discussed below.
During otic development in zebrafish, Fgf signalling has been shown to have a clear role in es-
tablishing anterior otic character with transcriptional and morphological duplications observed in
the medial region of the ear following changes in the Fgf signalling environment (see Section 1.4).
Yet a similar role for Fgf signalling in anterior-posterior patterning during the otic development of
mouse and chick is less clear, despite the similar localisation of Fgf expression within the hindbrain
and underlying mesoderm adjacent to the developing otic placode in all three model vertebrates
(Alvarez et al., 2003; Alsina et al., 2004; Schimmang, 2007). In mice, it is thought that rather
than acting to specify the anterior-posterior axis as in zebrafish, Fgf signalling primarily patterns
the dorsal domain of the dorsoventral otic axis with loss of dorsal markers common to both mice
and zebrafish such as Dlx5 and Gbx2 observed in the mouse Fgf3 mutants (Hatch et al., 2007;
Whitfield and Hammond, 2007; Solomon et al., 2003). Fgf signalling during chick otic development
is similarly though to primarily pattern the dorsoventral otic axis. However, there is less direct
evidence for this role and it is in part based on the observation that the dorsal semi-circular canals
(SCCs) are truncated following alterations to the hindbrain, where Fgf3 and Fgf19 are expressed,
and a concomitant removal of the ventral midline structures (Liang et al., 2010).
In all three vertebrate models, localised expression of Fgf10 within the three sensory cristae has
also been reported (Sánchez-Guardado et al., 2013; Pauley et al., 2003; Thisse and Thisse, 2004).
This may represent a possibly conserved role for Fgfs in DV otic patterning, as whilst it has not
been observed in zebrafish, in both chick and mouse the localised expression of Fgf10 has been
shown to be required for regulating development of the associated, dorsally-derived, SCCs (Pauley
et al., 2003; Chang et al., 2004). Interestingly, localised expression of Fgfs are also seen within
another otic sensory epithelium, the maculae. In all three vertebrate models mentioned, persistent
expression of certain Fgf family members within the presumptive maculae have been reported.
Fgf expression within the maculae does not appear to be restricted to just the anterior utricle or
posterior saccule, with Fgf expression reported in both, which may suggest a possible conserved
requirement for Fgf signalling in developing both maculae (Olaya-Sánchez et al., 2016; Pauley
et al., 2003; Thisse and Thisse, 2004).
Shh signalling in zebrafish has been well document as being crucial for establishing posterior otic
character across the the anterior-posterior otic axis in zebrafish (see Section 1.4). Hh signalling
in mouse and chick has been not been reported to play a similar role in defining the posterior
otic character but instead has been implicated in opposing the dorsalising activity of Fgf, defining
the ventral auditory structures (Hatch et al., 2007; Bok et al., 2005; Riccomagno et al., 2002).
The dorsoventral gradient of Hh signalling from the midline structures in chick and mice has been
suggested to be reflected by a proposed gradient of the Hh transcriptional e↵ector Gli3 Activator
(Gli3A), which with an opposing gradient of Gli3 Repressor (Gli3R) has been suggested to specify
di↵ering otic fates across the DV axis in chick and mice (Bok et al., 2007b; Ohta et al., 2016).
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In both mouse and chick, reduction of Hh signalling results supports such a model with loss of
the ventral cochlear duct with a concomitant ventral expansion of common dorsal markers such as
Dlx5 and Hmx3 observed. Selective loss of Hh within the mouse otocyst also shows the maculae
and cristae to be unaltered suggesting that, unlike in zebrafish, Hh signalling is not required for
patterning these sensory epithelia (Brown and Epstein, 2011). Despite this seemingly di↵erent
role for Hh in the otic patterning of zebrafish and the other vertebrate models, the role of Hh
signalling in dorsoventral patterning may reflect a common function between zebrafish, chick and
mouse. Hammond et al. reported that in zebrafish, aberrant Hh signalling as well as producing
a duplication of posterior otic character resulted in severely ventralised ears, which showed a loss
of the dorsal endolymphatic duct and SSC structures (Hammond et al., 2010). This suggests a
consistent ventralising role for Hh signalling in zebrafish, mouse and chick. It is also interesting to
note that Hh signalling in all three vertebrates models appears to be associated with specification
of the sensory domains that primarily detect auditory stimuli, with Hh signalling also thought to
regulate the tonotopic gradient of the cochlea and basilar papilla in mouse and chick, respectively
(Son et al., 2015; Popper and Fay, 1973).
Another seemingly striking di↵erence between the specification of the anterior-posterior axis in
the vertebrate models discussed is the suggestion that an anterior to posterior gradient of RA
across the mouse and chick otocyst, similar to that proposed to be present across the zebrafish
placode, is primarily responsible for patterning the AP axis (see Section 1.4) (Bok et al., 2011;
Niederreither et al., 1997; Fujii et al., 1997). This is based on the ability of transient application
of exogenous RA to produce a morphological duplication of the posterior SSC and the associate
crista in chick, although these embryos also lose all other otic sensory epithelia. However, a sim-
ilar transient application of exogenous RA also resulted in a transcriptional duplication of the
posterior ventrolateral marker Tbx1, as well as a loss of the anterior neurogenic domain markers,
Lunatic Fringe (Lfng) and Neurod1 in both mouse and chick (Bok et al., 2011). This is consistent
with the role of RA in zebrafish in regulating the extent of the posterolateral non-neurogenic and
anterolateral neurogenic domains in the developing zebrafish ear, which are also marked by tbx1
and neurod1, respectively (see Section 1.4.2). The anterior neurogenic domain in chick and mouse,
unlike zebrafish, also have expression of Fgf10 and Fgf3, respectively, which have both been shown
to expand in Tbx1 mutants but appearing reduced after treatment with high levels of RA (Raft
et al., 2004; Cadot et al., 2012). This therefore supports RA in zebrafish, chick and mouse acting
in a well conserved network for regulating the neurogenic versus non-neurogenic domains along the
AP axis of the ventrolateral domain rather than patterning the sensory AP axis. Whilst the loss
of the maculae in chick embryos following RA exposure makes it hard to observed any changes to
the patterning of the sensory epithelium, mouse mutants for the RA-synthesising enzyme, Raldh3
are not reported to show any morphological changes in the maculae (Romand et al., 2013).
It is not clear why the chick ear appears more sensitive to RA, given no morphological dupli-
cations of the posterior semicircular canal have been reported in zebrafish or mice in response to
elevated RA, it could reflect di↵erent sensitivities of the downstream e↵ectors such as tbx1 to RA as
zebrafish tbx1 show a complete loss SSC formation and fused maculae, highlighting its importance
in patterning otic morphology (Maier and Whitfield, 2014; Cadot et al., 2012; Whitfield et al.,
1996b)
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In zebrafish, expression of hmx3a and hmx2 represent the earliest markers induced in the an-
terior otic placode in response to Fgf signalling. However, by 48hpf both also show two patches of
dorsal expression at either end of the ear with hmx3a also showing a patch of expression within a
dorsomedial domain (Feng and Xu, 2010; Hammond and Whitfield, 2011). Hmx3 in chick along
with Hmx2 and Hmx3 in mouse, initially show a similar early anteromedial localisation within the
otocyst (from HH10 and E9.5, respectively) before later appearing to be primarily localised to the
dorsal otic domain (Wang et al., 1998, 2001; Herbrand et al., 1998).
Loss of Hmx2 and Hmx3 in mice leads to vestibular defects with a loss of the SCCs consistent
with their putative role as markers of the dorsal otic epithelium. However, loss of either Hmx3
alone or both Hmx2 and Hmx3 in mice also leads to a reduction or loss of the sensory utricle and
saccule with a merging of the two chambers, suggesting Hmx2 and Hmx3 may have an e↵ect on
sensory AP patterning (Wang et al., 1998, 2001, 2004). Whilst knock-down of hmx2 and hmx3a in
zebrafish is not reported to result in a similar loss of the SCCs, the maculae appear merged with a
loss of anterior hair cell polarity, similar to the phenotype observed in the mouse knock-outs (Feng
and Xu, 2010). Whilst loss of Hmx2 and Hmx3 have not been studied in chick, the similarity
between the mouse knock-out and zebrafish knock-down phenotypes could indicate a conserved
function for Hmx2 and Hmx3 in otic patterning in vertebrates.
Despite the similarity in the expression of Hmx2 and Hmx3 observed between model vertebrates
and a similar negative regulation by Hh signalling, albeit observed across di↵erent axes, in both
chick and mice Fgf signalling appears to negatively regulate expression of Hmx3 in contrast to ze-
brafish where Fgf signalling has been shown to positively regulate otic hmx3a expression (Naidoo
et al., 2014; Hatch et al., 2007; Hammond and Whitfield, 2011; Freter et al., 2008). Slight di↵er-
ences in regulation of otic transcription factors such as these could reflect why changes in Fgf and
Hh signalling do not result in a similar changes to the sensory otic tissue in these vertebrates, as
discussed above.
Another well-used, reliable marker of anterior character in zebrafish is pax5, which is required
with maintaining hair cells within the utricular macula (Kwak et al., 2006). In chick, Pax5 has
been also bee identified as being expressed within the sensory domains of the ear in a transcriptional
profiling but its function has not been directly assessed (Kwak et al., 2006). In contrast to zebrafish
and chick, Pax5 is reportedly not expressed or necessary for otic development in mice, indicat-
ing Pax5 likely does not have a strongly conserved role in otic development (Bouchard et al., 2010).
The two markers of zebrafish posterior otic character often used, follistatin (fsta) and pou3f3b
do not have any documented expression or function within the developing chick or mouse otocyst
making it hard to identify any conserved role in establishing the early posterior otic domain across
vertebrates.
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1.6 Congenital hearing loss
The importance of patterning during the development of the inner ear is highlighted by a number
of congenital human syndromes with associated hearing and balance dysfunction. Many of these
have been identified as having underlying mutations in genes associated with a conserved function
in specifying domains of the ear during early development in vertebrates such as zebrafish, chick
and mouse, such as those discussed above (Table 1.1) (Whitfield, 2002). This has meant that ze-
brafish models for many of these diseases have been established either through reverse or forward
genetics approaches.
Due to the genetic tractability of zebrafish, this model system is ideal for generating such models
and testing the genetics underlying these diseases. The use of zebrafish as disease models also has
many other benefits such as their upkeep being low, having a short developmental time period,
their reproduction being oviparous with high fecundity. These advantages also make it possible
to screen therapeutic approaches in a high-throughput manner. However, the use of zebrafish as
disease models also has its drawbacks with zebrafish being more highly diverged from humans than
other vertebrate models. They also have many di↵erences in their physiology and anatomy as well
as having duplication of many genes due to genome duplication (reviewed in Ali et al. 2011).
Table 1.1: Congenital human syndromes associated with hearing and balance loss
The table list congenital human hearing and balance syndromes that have a causative mutation in genes
known to be involved in early patterning of the vertebrate inner ear.
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1.7 Aims and objectives
The aim of this project was to develop a better model to account for how relatively simple direc-
tional cues from extrinsic signalling sources acting across the early otic AP axis are integrated into
the highly dynamic expression seen within the early otic placode, with a focus on the establishment
of the posterior otic domain.
1.7.1 Aims
• Identify novel markers of the posterior otic domain.
• Place any novel posterior markers identified within the current model for patterning of the
otic AP axis based on their expression and function.
• Build upon the current model for AP patterning across the zebrafish otic placode proposed
by Hammond et al. by identifying how Fgf and Hh signalling pathways are integrated to
pattern the already known markers of the anterior and posterior domains.
1.7.2 Objectives
• Initially identify markers which show restricted expression to the posterior domain over the
period in which the AP axis are thought to be specified (14-20hpf). This will be approached
in two ways;
– A search of expression pattern data using the ZFIN database
– Analysis of the transcriptome for di↵erential gene expression in early (<18hpf) otic
tissue with posterior character.
• Characterise the expression of any candidate early posterior markers and interrogate these
under AP duplicating conditions.
• Disrupt the function of any candidate early posterior markers through knock-down or gene
editing techniques to identify any role in defining AP otic identity.
• Integrate this expression and any function with the current model for defining the AP otic
axis in zebrafish.
• Study the early response of known otic markers to changes in Fgf and Hh signalling.
• Identify mechanisms by which their expression of otic markers may be localised to either
pole.
• Fit the early integration of Fgf and Hh signalling with the previous model and any new early






All water used was ultrapure water, which had been purified using a Synergy Water Purification
System with a DNase/RNase filter from Merck Millipore.
Chemicals
All chemicals used were analytical grade or equivalent and purchased from Sigma Aldrich, VWR




Adult fish were kept in circulating water, maintained at 28.5oC with a 14 hour light/10 hour dark
cycle. All experiments were carried out according to Home O ce regulations on use of animals in
scientific research under the project licence; 40/3655 and personal licence; ID1586BAB.
Embryo collection
Fish were setup either as pairs in single containers which have a mesh bottom over a collection
tank and removable partition to allow mating to be timed or marbled as a whole tank, with a
container containing marbles and a mesh bottom placed over a collection tank within the main
tank to allow spawning from the onset of the light cycle. Embryos were collected in system water





) with methylene blue, again at 28.5oC.
Embryo staging
Embryos were staged according to Kimmel et al., 1995 (Kimmel et al., 1995). If needed, embryo de-
velopment was slowed by placing embryos at 22.5oC after the 70% epiboly stage.
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2.2.2 Zebrafish lines
All wild-type fish used were from the AB line as maintained in the University of She eld Aquaria.
Transgenic and mutant lines used during the project;
Transgenic/Mutant Reference Homozygote Identifier
fgf8ati282a (previously ace) Reifers et al., 1998 Clear loss of cerebellum
(Reifers et al., 1998)
fgf3 t21142 (previously lia) Herzog et al., 2004 Small otic vesicle and PCR
(see table, Hammond and
Whitfield., 2011)
fgf10atbvbo (previously dae) Norton et al., 2005 PCR (see table, Norton et
al., 2005)
Tg(hs:fgf3 ) Lecaudey et al., 2008 Oedema after heat shock and
GFP Mres heart marker
Tg(hs:fgf8a)x17 Millimaki et al., 2010 Oedema after heat shock
smohi1640 Chen et al., 2001 U-shaped somites that lack a
horizontal myoseptum and a
ventrally curved body, also
PCR (see table, Chen et al.,
2001)
ptch1tj222;ptch2hu1602 Koudjis et al., 2008 Flattened somites and PCR
(see table, Koudjis et al.,
2008)
mib1ta52b Itoh et al., 2003 Indistinct posterior somites
at 22-somite stage and PCR
(Zhang et al., 2007)
TgBAC(sp7:kaede) Generated during the project eCFP CryA lens marker
cdr2l4bp Del Generated during the project PCR (see table)
cdr2l5bp InDel Generated during the project PCR (see table)
Table 2.1
2.2.3 Microscopy
All lateral images are orientated with the anterior to the left and dorsal images with the anterior
at the top.
Brightfield, DIC and Epifluorescence microscopy
Live and fixed embryos were generally imaged using an Olympus BX-51 compound microscope,
which has brightfield, DIC and epifluorescence optics, with CellB image acquisition software. For
fluorescent imaging requiring large fields of view, a Zeiss Zoom V16 fluorescence stereo microscope
with Zen acquisition software was used. FIJI (Fiji Is Just ImageJ) (Schindelin et al., 2012) was
used for all image processing.
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Confocal microscopy
Fluorescently stained embryos were imaged on a Nikon TIRF A1 using NIS Elements for image
acquisition. Again FIJI was used for image processing.
2.2.4 PCR
Primers
All primers for PCR amplification were purchased from IDT (Integrated DNA Technologies).
Primers were re-suspended in MQH
2
O to give a 100µM stock concentration and diluted to a
working concentration of 10µM. Both were stored at -20oC.
PCR Reactions
PCR reactions were assembled in PCR tubes or 96 well plates whilst on ice. Two polymerases
were utilised; for genotyping, 2x Taq Reddymix (ThermoFisher) and for cloning or PCR template
synthesis, the high-fidelity polymerase, Q5 (NEB). The reactions were set up as recommended by
the manufacturer. The annealing temperatures used for 2x Taq Reddymix reactions were generally
5oC below the melting temperature (Tm) of the primers and for Q5 reactions the NEB Tm calcu-
lator (http://tmcalculator.neb.com) was used (although usually approximately 3oC above the Tm).
2.2.5 Injection
Glass injection needles were prepared by placing glass capillaries into to a needle puller (Sutter
Instrument Company) which produced needles with a tip of specified length/thickness. Needle tips
were broken using forceps under a dissection scope and filament capillary needles (Harvard Appara-
tus) filled through capillary action (for morpholinos) with non-filament capillary needles (Harvard
Apparatus) filled using microloader tips (Eppendorf) (for RNA and construct injection). The
injection needle was then attached to a PV800 Pneumatic microinjector (Precision Instruments)
with the settings adjusted until the droplet size of the desired volume was achieved, injecting into
mineral oil over a graticule.
For injection a fresh glass slide was placed in a petri dish lid and washed with distilled H
2
O
to support the embryos. Once embryos were collected, those identified as being healthy and fer-
tilised at the one-cell stage were transferred to the edge of the glass slide and the solution injected
into the yolk as close to the cell as possible.
2.2.6 Morpholino (MO) knockdown
Morpholino oligos are comprised of nucleic acid base with a modified morpholine ring and phos-
phorodiamidate backbone which sterically block binding of endogenous RNA (Summerton, 1999).
MO were purchased from and designed by Gene Tools LLC with the cdr2l MO designed against
the mRNA NM205564.1 transcriptional start site (see Table 2.2). The cdr2l MO was re-suspended
in MQH
2
O to give a stock concentration of 1mM and was initially stored at room temperature in
a parafilm-wrapped glass vial, as recommended by Gene Tools LLC. However in the later stages of
the project due to concerns over evaporation the MO was aliquoted out and stored at -20C. The
non-specific control (CD63 mismatch) MO was kindly provided by Dr S.Greaves and kept at -20C
throughout.
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Prior to injection, aliquots of the MO were thawed and heated to 65oC for 5-10 minutes to ensure
the MO was in solution before being cooled at room temperature.
MO name Activity Sequence (5’-3’)





Table 2.2: Morpholino oligos
2.2.7 cdr2l :eGFP construct injection
A DNA construct encoding enhanced Green Fluorescent Protein (eGFP) fused 3’, via a Glu-Phe
linker, to the coding sequence (CDS) of cdr2l along with its upstream Kozak sequence and the
cdr2l ATG MO binding site was synthesised (Figure 2.1). To achieve this, the eGFP CDS and
cdr2l CDS were amplified via a Q5 PCR with the same restriction sites attached 3’ and 5’ to the
primers and restriction site complementary to the multiple cloning site in the vector backbone
at the alternate ends to allow ligation of the two sequences together and then into the plasmid
backbone. These PCR products were purified and then used in a double restriction digest before
being ligated together with ExpressLink T4 ligase (ThermoFisher) over-night. Once confirmed that
the PCR products had ligated together, the DNA construct was ligated with linearised pCS2+, a
plasmid designed for in vivo expression with a cytomegalovirus (CMV) promoter regulatory region
5’ to the multiple cloning site to drive constitutive expression and a 3’ polyA sequence. This
construct was then transformed into DH5a (NEB) competent cells and successful transformants
were selected and grown up in a Carbenicillin (50µg/mL) LB preparation over-night before being
spun down and the plasmid isolated (Qiagen). The construct was injected at a concentration of
150ng/µL.
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Figure 2.1: cdr2l :eGFP construct map
2.2.8 CRISPR Mutagenesis
Oligo design
The CRISPR system is derived from the prokaryotic Clustered, Regularly Interspaced, Short Palin-
dromic Repeats (CRISPR)/Cas9 system. For genomic editing in zebrafish a method based on
Hruscha et al, 2013 was used (Hruscha et al., 2013). Here a guide RNA (gRNA) is designed with
a 20bp targeting sequence that binds adjacently to a genomic trinucleotide, 5’-NGG-3’, proto-
spacer adjacent motif (PAM). This targeting sequence is fused to a 5’ sca↵old sequence and In vivo
this gRNA forms a tertiary RNA structure that binds to a Cas9 nuclease and can induce double
stranded-breaks approximately 3bp 5’ of the PAM sequence with subsequent non-homologous end
joining (NHEJ) resulting in small insertions or deletions.
For this project a 20bp targeting sequence adjacent to a PAM within the genomic sequence of cdr2l
(NC 007114.6) was designed utilising the Zhang lab CRISPR design tool (http://crispr.mit.edu).
This targeting sequence was chosen due to its early position within the second exon of cdr2l and
because it covers an AluI restriction site located 3bp 5’ of the PAM site to allow for genotyping.
The targeting sequence should also ideally be designed to have a 5’ GG dinucleotide adjacent to the
T7 binding site for optimal transcription (Gagnon et al., 2014). However for this project a 5’GC
dinucleotide was used due to a limited availability of ideal early sites within the cdr2l sequence.
An antisense oligo ultramer with a gRNA sca↵old sequence 5’ of the target primer sequence and












Table 2.3: CRISPR oligo design
gRNA Synthesis
The oligo ultramer was suspended to 100µM and 5µmoles of this was annealed to 5µmoles of
a T7 primer in the reaction; 1.5µL 100µM oligo, 1.5µL 100µM T7 in 27µL linker bu↵er (linker
bu↵er: 50 mM Tris-HCl pH 8, 100 mM NaCl, 1 mM EDTA).This mixture was incubated for 5
minutes at 95oC before being cooled slowly (to allow annealing) at room temperature for 5 hours.
Transcription was carried out using a MEGAshortscript T7 kit (Life Technologies) with the 20µL
reaction containing;











Table 2.4: MEGAshortscript T7 gRNA transcription reaction
The reaction was incubated for 2 h at 37oC with 1µL of TURBO DNase then added and the reaction
incubated for a further 15 min at 37oC. 115µL of nuclease-free water and 15µL of ammonium
acetate stop solution were then added and the reaction transferred to an RNase-free Eppendorf
tube where 2 volumes (300µL) of ethanol were added and the reaction incubated for >15 min at
-20oC to precipitate the RNA. After the -20oC incubation the reaction was centrifuged at 4oC for
15 min at max speed. The supernatant was then removed carefully and the pellet resuspended in
20µL MQH
2
O, being stored at -80oC.
gRNA/Cas9 protein injection
An injection solution of 400ng/µL gRNA, 1µg/µL of Cas9 protein (kindly provided by Dr H Isaacs)
and 0.5µL of phenol red was made up to 4.5µL in RNase-free H
2
O with 1nL injected per embryo.
For the cdr2l exon 2 CRISPR, embryos from an AB incross were injected. Prior to loading, the
solution was kept on dry ice and the loaded injection solution and needle were replaced hourly to
ensure protein activity.
2.2.9 Recombineering
Recombineering is based on homologous recombination allowing targeting constructs with homol-
ogous ”arms” (HA) of sequence to be integrated into bacterial artificial chromosomes (BACs)
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utilising bacteriophage-encoded homologous recombination functions. In this project this tech-
nique was used to place the photo-convertable protein Kaede within the sequence of sp7, a gene
expressed within the otic vesicle at an early developmental stage (DeLaurier et al., 2010) contained
in BAC CH73-243G6, along with iTol2 transposase long-terminal repeats for subsequent embryo
transgenesis.
BAC preparation
BAC CH73-243G6 was ordered from the CHORI BACPAC resource (http://bacpac.chori.org/),
with the DH10B cells grown out on LB agar chloramphenicol (Cm, 12.5µg/mL) plates. Four
colonies were then selected and used to setup four 50mL LB chloramphenicol over-night preps.
These were subsequently checked for the presence of the sp7 CDS via PCR and the remaining
culture spun down, with the pellet being frozen at -20oC. The pellet for one of the colony preps
was then used with a Nucleobond Xtra midi kit (Macherey-Nagel) to isolate the BAC which was
resuspended in 15µL 1/10th TE with MQH
2
O and left over-night at 4oC.
Targeting DNA
Two ultramer oligos were used; one was designed using primer-BLAST (www.ncbi.nlm.nih.gov/tools/primer-
blast/) with 20bp of homology to the 5’ the Kaede CDS and 60bp of homology to exon 2 of the sp7
coding sequence. The second ultramer, was previously designed by Delaurier et al, with homology
to a more 3’ region of the CDS and 3’ domain of the pCRII backbone. The pCRII backbone to
which these two primers have homology contains the Kaede CDS along with a selectable KanR
cassette flanked by Flippase (Flp) frt recognition sites (See Table 2.5).
Oligo ultramer Sequence








Table 2.5: Sp7 exon 2/kaede frt:kanR:frt targeting oligos
Using the above oligos at a working concentration of 10µM, a Q5 (NEB) 100µL reaction, split
into 5x20µL aliquots, was setup (see Table 2.6).
Component Volume (µL)
Kaede frt:KanR:frt pCRII plasmid Variable (200ng)
Q5 Bu↵er 20µL
dNTPS 4µL
L(5’) HA primer 5µL





O up to 100µL
Table 2.6: Targeting DNA PCR
The reactions were pooled and 2µL of DpnI (Promega) added at 37oC for 1 hour to remove the
plasmid DNA. The whole reaction was then run on a 1.5% SYBRsafe (ThermoFisher) electrophore-
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sis gel before the bands were isolated on a safe imager light box (ThermoFisher) and purified with




For recombineering, electro-competent cells that contain temperature-sensitive recombination pro-
teins and an arabinose-inducible flpe gene are required. Therefore the EL250 strain of E coli were
used (Lee et al., 2001) and transformed with the CH73-243G6 BAC prior to recombineering, as
outlined below.
A culture of EL250 cells was grown from a glycerol stock in no-salt LB to an OD600 of 0.4 to
0.7 and subsequently washed and pelleted. A pellet was then resuspended in 44µL of ice cold ster-
ile water and 300ng in 6µL of resuspended BAC added. This was transferred to an ice-cold gene
pulse cuvette (Biorad) and electroporated at 25 µF, 1.3kV and 200 Ohms (MicroPulser, Biorad).
Immediately after electroporation, 1ml of SOC (NEB) was added and the suspension transferred to
a capped round-bottom falcon tube (Fisher Scientific) before being incubated at 32oC for 90 min-
utes at 250 rpm. After incubation, 0.2 mL were plated onto five Cm (12.5µg/mL) plates and grown
at 32oC over-night. The following day five colonies were picked and were individually resuspended
for use in a 3mL over-night no-salt chloramphenicol LB prep grown at 32oC and a diagnostic PCR
alongside a non-electroporated EL250 control.
Once confirmed to contain the BAC, a 3ml prep was subsequently used to setup a 20mL no-
salt chloramphenicol LB prep for electroporation with the targeting construct. This was incubated
at 32oC until the culture reached an OD600 of approximately 0.6 (<4 hours) with 10mL of this
then transferred to a pre-warmed glass flask in a shaking (200rpm), 42oC water bath for 15 mins
to induce the recombination enzymes.
kaede frt:kanR:frt / BAC recombineering
In the cold room, 10mL of the EL250/BAC prep was then aliquoted into 5 x 2mL pre-chilled ep-
pendorf tubes and spun briefly with the media then removed and 1mL of ice-cold MQH
2
O added
to first two tubes. The 1mL re-suspensions were then added to the next two tubes and resuspended
before being washed, as previously, and added to the final tube. This final tube was resuspended
in 2mL before being washed, twice and placed in a new pre-chilled eppendorf tube, which was then
spun down and resuspended with 300ng of the sp7 exon 2/kaede frt:kanR:frt targeting construct
amplicon targeting construct in a 50µL total volume of ice cold water. This suspension was trans-
ferred to an ice cold cuvette and electroporated at 1.8kV with 1ml of SOC added immediately
afterwards and the suspension transferred to a capped round-bottom falcon tube before being in-
cubated at 32oC for 90 minutes at 250 rpm.
After incubation, 0.2 mL were plated onto five Cm (12.5µg/mL) plates and grown at 32oC over-
night. Five colonies were picked and on Kan (10ug/ml) plates were re-streaked and dotted along
with being dotted on ampicillin (Amp, 50µg/mL) and Cm (12.5µg/mL) plates, before being grown
at 32oC . The desired colonies will be Cm and Kan resistant but Amp sensitive with any Amp
resistance due to contaminating template plasmid not destroyed by Dpn1. From a plate streaked
with a CmR, KanR and AmpS identified colony, a 3mL Kan (50µg/mL) culture was setup and
grown over-night at 32oC. To remove the KanR cassette from the kaede frt:kanR:frt sequence in-
serted into the sp7 -containing BAC, 0.4ml of the Kan over-night prep were added to total 20 mL
of Cm (12.5µg/mL) containing LB and and grown to OD600 of 0.6 at 32oC. Once at the required
density, 0.2mL of 10% L-arabinose was added to the 20mL prep, which was then incubated at
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32oC to induce the FLP recombinase and remove the Kan selection cassette. A 1:10 dilution of
the 20mL prep in LB with Cm (12.5µg/mL) was then setup and and grown for 1h at 32oC. 5
plates were either spread or streaked with 200µL of this dilution and grown overnight at 32oC.
The following day three post-FLP colonies were suspended in MQH
2
O and spread/dotted on Cm
and Kan plates, respectively being grown overnight at 32oC. From these plates, one CmR / KanS
colony was selected and grow up at 32oC in a 100ml LB Cm culture, subsequently being spun
down as 50ml aliquots and frozen.
iTol2 / BAC recombineering
To help create a stable genomic insertion iTol2, medaka transposase recognition sites were placed
into the post-FLP kaede-containing BAC. Primers with HA for the BAC backbone (pTARBAC2.1)
were used to amplify a targeting DNA with iTol2 sites flanking both a KanR cassette (pCR8GW
backbone) (see Table 2.7) and a crya promoter driving eCFP. Both the HA primers and the con-
struct containing the iTol2 and crya:eCFP sequence were a gift from M.Tomekca (Roehl lab).The
targeting DNA PCR was then setup as before in Table 2.6, digested with DpnI and the product











Table 2.7: iTol2 / crya:eCFP targeting oligos
The post-FLP kaede CH73-243G6 BAC was grown up and pre-heated at 42oC, subsequently
being electroporated with the iTol2 / crya:eCFP PCR product, as outlined in the previous sections.
This was plated on to Amp (50µg/mL) LB agar plates and grown at 32oC. The following day
colonies were selected, suspended and re-plated on Amp and Spectinomycin (50µg/mL) plates, to
test for any residual pCR8GW plasmid, with the suspension also being used for a PCR to confirm
the presence of the sp7 exon 2 CDS and the pTARBAC2.1 backbone with the iTol2 insert. Once a
colony was confirmed to have successfully intergrated the post-FLP sp7 :kaede and iTol2/crya:eCFP
sequences, it was grown up as a 100ml Amp LB prep and isolated using a Nucleobond Xtra midi
kit. This was eluted into six 20µL aliquots which were subsequently pooled.
Recombineered BAC injection
An injection solution of 50ng/µL of sp7 :kaede iTol2/crya:eCFP BAC, 25ng/µL of transposase RNA
(a gift from E Markham, van Eeden lab) and 10% phenol red was made up in MQH
2
O. 1-2nL of
this solution were injected into AB embryos which were subsequently raised after screening.
2.2.10 Screening
After injection and subsequent transgenesis or mutagenesis the mosaic G0 embryos were raised for
approximately 8-12 weeks.
F1 generation: In the case of transgenic G0s, embryos displaying the expected phenotype were
selected prior to raising at 5dpf and after being pair-mated to wildtype ABs, F1 heterozygous
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embryos positive for the expected phenotype were selected and raised. For mutagenised G0s these
fish were pair-mated to wild-type ABs and subsequently the gDNA extracted from multiple pooled
o↵spring in a 96 well plate (three embryos per well) using the HotSHOT method (outlined below).
Using this gDNA, a PCR and restriction digest were used to identify the occurrence of mutations
which would suggest successful germline integration of the induced mutation. These identified
founders were then outcrossed again to AB embryos and the F1 progeny raised.
F2 generation: Transgenic F1 fish were crossed out to wild-type AB fish; if a single trans-
genic genomic insertion is present an expected 50% of these F2 o↵spring would be heterozygous
positive for the transgenic insertion. If a single insertion is indicated then the positive F2 embryos,
which would all be heterozygous for the same transgenic insertion, were raised as a stable line.
Mutagenised F1s were fin-clipped and from this tissue gDNA was extracted for genotyping using
PCR followed by sequencing (see below). Once an ideal mutation was identified in an F1, this
fish was outcrossed to AB embryos and the F2 progeny raised. At 8-12 weeks the population F2s
were screened to identify heterozygous fish positive for the mutation, which were then pooled as a
stable mutation.
2.2.11 Genotyping by sequencing or restriction digest
gDNA extraction
For genotyping genomic DNA (gDNA) was extracted from live adult fin clips or live/fixed embry-
onic tissue using the HotSHOT method described by Meeker et al. 2007 (Meeker et al., 2007).
Briefly, the tissue is heated in 50mM sodium hydroxide at 95oC to lyse cells and denature the
gDNA. The solution is then cooled, neutralised with TRIS pH 7.5 or 8.2 and centrifuged to pellet
cell debris. The supernatant, which contains the gDNA, can then be used in PCR to amplify the
relevant section of gDNA. The PCR products were then used either for a diagnostic restriction
digest or cleaned using ExoSAP (below) and sequenced.
Gene/Mutant Genotyping forward
(5’-3’)














tccgttcttatcgatcctgag TaqI RD (65oC) -











Chung et al, 2008
mib1ta52b tatttaccgtctgtctacccacag attagacgagtttctgtctcctcg NlaIII RD
cdr2l4bp Del ccatatgctgaaacaattatgatgc ctgctctgtacctcgatttcctg Sequencing
cdr2l5bp Indel ccatatgctgaaacaattatgatgc ctgctctgtacctcgatttcctg AluI RD or
Sequencing
Table 2.8: List of genotyping primers
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ExoSAP
To remove unused primers and NTPs from the PCR reaction prior to sequencing, 2µL of SAP
(Shrimp-Alkaline Phosphatase)(NEB) and 0.25µL of Exonuclease1 (NEB) (collectively referred to
as ExoSAP) were added to 8µL of the PCR products, on ice, before immediately being incubated
at 37oC for 45 minutes. After this incubation the reaction was heated to 80oC for 15 minutes to
deactivate the enzymes. This reaction was then sent for sequencing with the relevant sequencing
primer (IDT) (Table 2.8).
2.2.12 Fluorescence-Activated Cell Sorting (FACS) and flow-cytometry
Tissue dissociation
Either dissected tissue or whole embryos (as discussed in the results) were added to a sterile solution
of 0.25% porcine trypsin, 1mM Ethylenediaminetetraacetic acid (EDTA) and 10mg/mL proteinase
K in PBS with gentle agitation using a p200 (Gilson) for approximately 20 minutes before being
stopped with a solution of 1mM CaCl2 and 5% fetal calf serum.
1mL of sterile, chilled PBS was then added to the dissociation solution and the suspension spun
down at 400g for 3 minutes. The PBS supernatant was then removed and the pellet resuspended
in PBS.
For the later experiments utilising FACS, a protocol was developed (outlined below) based on
published protocols from the Lawson Lab (http://lawsonlab.umassmed.edu), The Zebrafish Book
(Westerfield, 2000) and (Baxendale et al., 2009) as well as personal discussion with Dr S Baxendale.
At the time points specified, embryos were dechorionated in pronase (1ml pronase into 3ml of
E3 in a 7ml bijou for 10 minutes).
Embryos were then placed into sterile ca2+-free Ringer’s solution for 10 minutes and passed through
a p200 to try and remove as much yolk as possible. The embryos were then separated from any
detached yolk and transfer into a sterile 35mm glass dish containing 2mL of collagenase/dispase
(1.75mg/mL - Roche) at 28oC. Embryos were then gently pipetted up and down every 10 minutes
with a p200 and after  40minutes the majority of the embryonic tissue was dissociated. The
suspension was then passed through a 40uM filter (Greiner Bio-One) into a sterile 50ml falcon
tube to remove any of the larger remaining pieces of tissue. The dish was then rinsed with 2mL
of sterile room temperature PBS, which was then poured through the filter. This step was then
repeated with the filter alone then rinsed with 2mL of sterile PBS, to give a cell suspension with
a total volume of 8mL.
The cell suspension was then spun down at 400g for 3 minutes at 4oC with the PBS supernatant
then removed and the pellet resuspended in 5mL of PBS. This was then spun down, again at 400g
for 3 mins and the pellet resuspended in 1ml of sterile Hank’s Balanced Salt Solution in a 15ml
falcon for sorting. The cell suspension was kept in the dark when moved to the FACS facility to
prevent UV conversion of Kaede.
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Flow-cytometry (cell counting)
Cells were counted on a CyAn analyser (Beckman Coulter) using a 488nm   excitation laser and
either a FITC 530/40 filter or PE 575/25 detection filter. The 488nm laser will excite GFP as well
as unconverted and converted Kaede. However only the unconverted Kaede will be detected in the
FITC 530/40 (green) channel whereas converted Kaede will be detected in the PE 575/25 (red)
channel (Ando et al., 2002).
FACS (cell sorting)
Cells were sorted on a FACSAria IIu sorter (BD Biosciences) at The University of She eld Medical
School Flow Cytometry Core Facility, using a 488nm   excitation laser and 530/30 detector.
2.2.13 In Situ Hybridisation (ISH)
ISH Probe Synthesis
The DNA templates used for synthesising RNA ISH probes were produced using either two rounds
of PCR with a nested reverse T7 primer or by linearising a modified plasmid containing the cloned
sequence of interest. Both protocols, described in further detail below, used cDNA synthesised
using SuperScript III Reverse Transcriptase (ThermoFisher) with mRNA initially extracted using
TRIzol reagent (Ambion/Invitrogen). Both were carried out as per the manufacturers protocol.
Two-round Nested PCR Template Synthesis
A single forward primer and two reverse primers, one of these being nested at least 50bp 5’ of the
other, were designed against the mRNA sequence (NCBI) for the gene of interest using primer-
BLAST (www.ncbi.nlm.nih.gov/tools/primer-blast/) (Listed in Table 2.9). Primers were designed
to be between 23-25bp in length and to the inner, nested reverse primer, a minimal T7 promoter
sequence (Table 2.10) was attached at the 5’ end. Primers were then ordered from IDT. First
Round PCR; A 25µL Q5 polymerase PCR was then setup using the forward and outer reverse
primer at a working concentration of 10µM and 1µL of cDNA (synthesised using SuperScript
III Reverse Transcriptase following extracted for 35 cycles. This was then checked on a gel to
ensure a clean template band of the expected size was present. Second Round PCR; A 50µL Q5
polymerase PCR was then setup using the same forward and the inner/T7 reverse primer at a
working concentration of 10µM and 0.5µL of the first round PCR for 30 cycles. This was then
checked on a gel to confirm the presence of a clean template band before the reaction was cleaned
using a GenElute kit (Sigma) and eluted into 30µL MQH
2
O and stored at -20oC until required.
A table of the primers used is listed below;
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Table 2.9: List of Primers Used for Nested-PCR ISH Probe Template Synthesis
5’-AATACGACTCACTATAGG-3’
Table 2.10: Minimal T7 Promoter Sequence
Synthesis of a plasmid containing a cloned sequence
>23bp primers were designed against the coding sequence for the gene of interest using primer-
BLAST (www.ncbi.nlm.nih.gov/tools/primer-blast/) (Table 3.0). These were then used to am-
plify the sequence from cDNA in a standard high-fidelity Q5 (NEB) PCR, which was subsequently
cleaned using a PCR clean-up kit (Qiagen or Sigma) and eluted into 30µL of MQH
2
O. 3uL of the
cleaned and original reactions were then run on an ethidium bromide gel to ascertain whether the
PCR had produced an amplicon of the expected length. To ligate the cloned sequenced amplified
by PCR into a pCR II dual-promoter vector a TA Cloning kit (Invitrogen) was used. This requires
3’ A-overhangs to be added to the PCR cloned sequence which is achieved by incubating the PCR
with an equal amount of 2xTaq Reddymix (ThermoFisher) at 72oC for 20 minutes.
The ligation reaction was then setup with 1µL of the 3’ A overhang PCR amplicon added to
2µL of pCR II vector, 1µL of the ExpressLink T4 DNA Ligase and 2µL of Ligation bu↵er in a
10µL reaction on ice before being incubated at 22-25oC (RT) for >15 minutes. The ligation mix-
ture was then added to an aliquot of DH5a competent E.coli (NEB) thawed on ice before being left
on ice for 30 minutes. After this period the mixture was heat-shocked at 42oC for 30-45 seconds
before being immediately returned to ice for 2 minutes. Following this 250µL of RT SOC media
(NEB) were added and the suspension outgrown at 37oC, shaking for 1 hour. From this two dilu-
tions, 101 and 102 were plated onto carbenicillin (50µg/mL) containing (selective) LB agar plates
and incubated overnight (<16 hours) at 37oC.
The next morning six colonies were selected from across the plates and suspended in 7µL of
MQH
2
O. The sterile pipette tip used and 3µL of the suspension were placed in 3ml of LB broth
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Table 2.11: List of Primers Used for Cloning Probe Template Sequences
with carbenicillin added and incubated at 37oC. The remaining colony suspension was used in a
standard 2x Taq Reddymix (ThermoFisher) PCR, albeit with 8 minutes initially at 94oC to ensure
bacterial lysis, and the original primers to identify if the clonal PCR insert was present. Colonies
identified as having the insert had 100µl of the respective LB culture added to 100mL of fresh
LB with carbenicillin and were incubated overnight at 37oC. The following day the cultures were
divided into 50mL aliquots and spun down at full speed, 4oC for 15 minutes. The supernatant was
removed and the pellets stored at -20oC or used in plasmid midiprep column extraction (Qiagen)
where, briefly, the pellet is lysed and cleared before being applied to a tip that selectively binds
the plasmid DNA under low-salt and pH. The plasmid DNA is then eluted in a high-salt bu↵er
and desalted through a IPA precipitation before being finally eluted into 1mL of 1/10th TE in
MQH
2
O and stored at -20oC until required.
Linearisation of plasmid DNA for ISH template
The isolated plasmid containing the cloned sequence was then sent for sequencing and also used
for a diagnostic restriction digest to ascertain the cDNA orientation relative to the polymerase
promoter sites within the plasmid backbone. A unique restriction site within the plasmid backbone
was then identified so that the plasmid could be linearised and used as template in an anti-sense
run-o↵ transcription reaction. 3-5µg of the plasmid were digested in a 100µL reaction before
being cleaned using a GenElute kit (Sigma), eluted into 1/10th TE in MQH
2
O and checked by
gel electrophoresis to ensure successful linearisation. This template was then stored at -20oC
until required. This protocol was also used to linearise published constructs previously used as a
template for ISH probes (listed in Table 3.1).
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Gene Reference Digest and polymerase for
AS transcription
atoh1a Millimaki et al., 2007 HindIII, T7
fsta Hammond et al., 2011 Spel, T7
etv4 Munchberg et al., 1999 NotI, T7
fgf10a McCarroll et al., 2013 EcoRI, SP6
otx1b Li Y et al., 1994 EcoR1, T7
ptch2 Hammond et al., 2003 BamHI, T3
pax5 Hammond et al., 2003 EcoR1, T7
Table 2.12: List of previously synthesised/published ISH template constructs
Transcription of Antisense Labelled-RNA Probes for ISH
The transcription reaction was set up on ice as shown in Table 4 using the anti-sense DNA template
synthesised previously to transcribe digoxigenin (DIG) or fluorescein UTP-labelled antisense RNA
probes. The reaction was incubated for 2-3 hours at 37C before DNase was added and incubated
for a further 20 minutes at 37C to remove the DNA template.
Component Volume (µL)
Template (1µg) variable
Nuclease-free water to 20µL
10x Transcription Bu↵er 2µL
RNase Inhibitor 0.5µL
100mM Dithiothreitol (DTT) 0.5µL
DIG or Fluorescein labelled dNTP mix 1µL
Appropriate polymerase 2µL
Table 2.13: List of primers used for cloning probe template sequences
The reaction was then placed on ice and purified either using an RNeasy spin filter kit and eluted
into 20uL of RNase-free water (Qiagen, 2012-2014) or by precipitation with ammonium acetate
(NH
4
Ac). Briefly, the transcription reaction was added to 10µL of 7.5M NH
4
Ac and 75µL of cold
ethanol before being spun at full speed, 4oC for 20 minutes. The supernatant was then removed
and the pellet washed with 100µL of 70% ethanol being spun down at full speed, 4oC for 5 minutes.
The ethanol wash was then removed and the pellet suspended in 20µL of RNase-free water. 1µL
of the resulting RNA was checked by gel electrophoresis and an equal volume of formamide was
added to the remaining RNA before being stored at -80oC.
ISH protocol
The following protocol is a modified version of Thisse and Thisse., 2008 Nature Protocols.
Embryo Fixation: Embryos were dechorionated and place in 4%PFA over-night at 4oC. These
were then dehydrated through a series of methanol (MeOH) washes at 33%, 66% before finally
being stored in 100% MeOH for at least 2 hours at -20oC.
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Day 1: Fixed embryos were rehydrated, being washed in 66% MeOH/PBSTw, then 33%
MeOH/PBSTw for 5 minutes each. Embryos were then washed four times for 5 mins in PBSTw.
A Proteinase K (10µg/mL in PBSTw - 1/1000 dil. of 10mg aliquot) solution was made and placed
on ice before being added to embryos in a 20oC waterbath for:
<16hpf; 1 min, 16 to 18hpf; 1 1/2 mins, 18 to 22hpf; 2 mins, 22 to 24hpf; 2 1/2 mins, 24 to 26hpf;
4 1/2 mins, 26 to 32hpf; 8 mins, 30 to 36hpf; 16 mins, 36 to 48hpf; 20 mins
After Proteinase K treatment, embryos were transferred from the water bath and placed on ice.
The Proteinase K was removed and embryos rinse with PBSTw, being replaced with 4% PFA for 20
minutes on ice. Embryos were then washed four times for 5 mins in PBSTw. (The following steps
are all carried out at 65-70oC) Embryos were pre-hybridized in 700µL of Hyb+ for 3 hours with
200µL of the RNA probe, diluted 1:450 in Hyb+, subsequently added and incubated at 65-70oC
overnight.
Day 2: Still at 65-70oC, the RNA probe was removed and returned to -20oC for future use.
Embryos were washed in 66% and 33% Hyb- / 2x saline-sodium citrate (SSC) for 10 minutes each,
followed by a 100% 2xSSC washed for 10 minutes. Embryos were then wash twice in 0.2xSSC to
ensure only high-stringency probe hybridisation for 30 mins each. (The following steps are carried
out at room temperature) Following the high-stringency washes, embryos were then progressively
washed with 66% and 33% 0.2xSSC / PBSTw for 10 minutes each. They were then washed twice
in PBSTw for 10 mins and incubated in blocking bu↵er for 3 hours. This was replaced with 200µL
of either anti-DIG or Fluorescein AP-conjugated antibody solution (antibody diluted 1:2000 with
blocking bu↵er) and incubated overnight at 4oC with gentle rocking.
Day 3: The antibody solution was discarded and embryos washed briefly in PBSTw. Embryos
were then washed six times in PBSTw for 30 mins each. Subsequently embryos were washed three
times for 5 minutes each in staining bu↵er. After the last wash embryos were transfer to a 24
well plate and the staining bu↵er replaced with 0.5mL of BCIP/NBT (3.5µL BCIP / 4.5µL NBT
per mL of staining bu↵er) staining solution and placed in a oC incubator, in the dark. When the
desired stain intensity was reached, embryos were returned to their original Eppendorf tubes and
washed three times in PBSTw for 5 mins each to stop the reaction.
Double ISH protocol
For a double ISH the following modifications were made to the above ISH protocol;
Day 1: Both RNA probes, incorporating di↵erently labelled UTPs, were added at 1:450 dilution
after pre-hybridisation.
Day 3: After the staining and three washes in PBSTw, embryos were incubated in 100mM glycine
pH 2.2 for 30 minutes to inactivate the first conjugated antibody. Embryos were then washed three
times in PBSTw for 5 minutes before being transferred into blocking bu↵er for 3 hours. This was
replaced with 200µL of either anti-DIG or Fluorescein AP-conjugated antibody solution (diluted
1:2000 with blocking bu↵er), depending on the first antibody used, and incubated overnight
Day 4: The antibody solution was discarded and embryos washed briefly in PBSTw. Embryos
were then washed three times in PBSTw for 30 mins each before being placed in PBSTw over-night
at 4oC.
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Day 5: The PBSTw washes were continued, with two more 30 minute washes. Embryos were
then washed three times for 5 minutes each in Fast Red (Roche) staining bu↵er and after the last
wash embryos were transfer to a 24 well plate before having 500µL of Fast Red (1 tablet dissolved
in 4mL of staining bu↵er) staining solution applied and being incubated at room temperature in
the dark. When the desired stain intensity was reached, embryos were returned to their original
eppendorf tubes and washed four times in PBSTw for 5 mins each. For both single and double
ISH, if there was little background staining embryos were fixed in PFA after the final PBSTw
washes. However if required, staining was cleared through MeOH washes. For this embryos were
fixed in 4% PFA for 30 minutes before being washed for 5 mins in 33% MeOH, 5 mins in 66% then
100% MeOH for 10 minutes to remove excess staining. Embryos were then taken through the series
in reverse before being washed twice in PBSTw for 10 minutes each. For imaging embryos were
transferred into 37.5% glycerol/H
2
O and washed for >10 minutes before finally being replaced
with 75% glycerol.
ISH solutions
PBSTw 0.1% Tween in PBS
Hyb+ 25mL Formamide, 2mL tRNA (10mg/ml), 12.5mL 20X SSC, 500µL




Hyb- 25mL Formamide, 12.5mL 20X SSC, 500µL 10% Tween-20, 460µL
1M Citric Acid and H
2
O to 50mL.
20X SSC 140.2g 3M NaCl, 65.8g 0.3M Sodium Citrate dihydrate (pH to 7)
then H
2





5mL 1.5M maleic acid, 1mL 5M NaCl and H
2
O to 35mL (pH to 7.5).
Then add 1g blocking reagent (Roche), 500µL 10% Tween-20, 1ml
FBS or sheep serum and make up to 50mL with H
2
O. Heat to 60oC




5mL Tris pH 9.5, 2.5mL 1M MgCl
2






5mL Tris pH 8.2, 2.5mL 1M MgCl
2




Table 2.14: Table of ISH solutions
2.2.14 Phalloidin staining of actin-rich stereocilia
3dpf embryos were fixed in 4% PFA over-night and washed three times in PBS for 10 minutes before
then being permeabilised in 2% triton-X100 (Sigma) for 3-4 days at 4oC. Embryos were the washed
three times in PBS for 5 minutes each and this was then replaced with FITC-phalloidin (1:20
dilution of working stock, Sigma) or Alexa Fluor 647-phalloidin (1:100 dilution, ThermoFisher) in
PBS and left over-night at 4oC. The following day embryos were washed three times in PBS for 1
hour each before being dissected (eyes, forebrain, fins and trunk removed) in PBS and mounted in
Vectashield (Vectorlabs) prior to confocal imaging.
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2.2.15 Joint acetylated-tubulin antibody and phalloidin staining
Initially the kinocilia were labelled using anti acetylated-tubulin. This was then directly followed
by phalloidin staining, carried out as previously described. Polarity maps from these were created
by overlaying the stereociliary bundles with arrows pointing in the direction of the kinocilium in
FIJI,. When polarity could not be determined a dot was used to indicate a hair cell.
2.2.16 Heat-shock inducible misexpression
For standard misexpression,  60 embryos from either a hemizygous transgenic carrier (see Table
2.1) outcross or incross were transferred at the time points described from their incubation at 28oC
to 25ml of preheated E3 in a 39oC water bath. Embryos were then left at this temperature for
30 minutes, as has been describe previously (Padanad et al., 2012). Heat-shocks ranging from 15
minutes to 2 hours at this high temperature have also been reported (Kidwell et al., 2017; Ham-
mond and Whitfield, 2011; Padanad et al., 2012).
After the 39oC heat-shock, embryos were returned to their previous plates of E3, which had been
incubated to 33oC during the heat-shock, before being incubated for a further 30 minutes at 33oC.
This 33oC incubation, likely inducing a very low-level heat-shock response, has been suggested to
extend transgene activation and also reduce cell death following heat-shock (personal communica-
tion with Professor B Riley) (Padanad et al., 2012; Zou et al., 1998).
Following their incubation at 33oC, embryos were returned to 28oC and incubated until they
reached the desired stage for fixation, as described.
2.2.17 Embryo chemical treatment
Embryos applied with small molecule antagonists/agonists (table 14) were treated in 12-well plates
with 3ml of the respective treatment and 30 embryos per well. Embryos treated with compounds
dissolved in ethanol, such as cyclopamine, had their chorions punctured with a sterile hypodermic
needle prior to treatment to allow penetration of the compound. For compounds dissolved in
DMSO, chorion permeability is not an issue and therefore chorions were not punctured (Kais
et al., 2013). All treatments were carried out at 28.5oC and following treatment, embryos were
washed twice in E3 medium before either being fixed or grown on. Vehicle controls consisted of
the solvent alone at the highest treatment concentration used.









RA Retinoic Acid Sigma DMSO
InSolution SU5402 Calbiochem (Merck
Millipore)
DMSO
Table 2.15: Treatment chemicals and their solvents
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2.2.18 Vestibular analysis
To test motor coordination and balance, reflecting the vestibular function of the ear, tests previ-
ously established by Riley and Moorman, were used on 5dpf larvae (Riley and Moorman, 2000).
For motor coordination, individual larvae were observed after a startle response induced by tap-
ping the edge of the plate with the handle of a wooden seeker. Normally following such a startle
response, larvae move rapidly in a straight line, whereas larvae with vestibular dysfunction swim
in irregular patterns. The ability of larvae to balance was defined by whether they rested dorsal
side up one minute after the startle stimulus. Each larvae was tested for both motor coordination
and balance three times, with failure in two or more tests constituting a failure.
2.2.19 Statistics
Statistical analyses were performed in Graphpad Prism. Data normality was assessed using a
D’Agostino-Pearson normality test on residuals (di↵erence between individual measurements and
the group mean for that condition), which were assessed as a whole experiment rather than for
individual conditions. For normally distributed data, parametric tests such as an unpaired T-test
or ANOVA with a post-hoc multiple comparison test such as Dunnett’s, Sidak or Holms-Sidak
were used. If non-normally distributed, non-parametric tests such as the Mann-Whitney test were
used. Percentage data, if normally distributed, was tested using the same tests used for all other
parametric data, whereas non-normally distributed, continuous percentage data was transformed
with a log-10 transformation before being retested and a parametric test applied if appropriate.
For testing association between categorical variables, a two-tailed Fisher’s Exact Test was used.
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Chapter 3
Identification of novel early markers of the
posterior otic domain
3.1 Introduction
The role of the Fgf and Hh signalling pathways in determining the anterior and posterior character
of the developing zebrafish ear have been well reported (see section 1.4.2). However, the tran-
scriptional response by the otic placode to these signals before 24hpf has focused on transcription
factors that have been shown to establish either the anterior sensory and morphological character
or the anteroventral neurogenic domain in zebrafish (see section 1.4.3).
The response of a handful of posterior otic markers such as fsta, pou3f3b and tbx1 to the same
patterning signals have also been characterised in zebrafish. However, the requirement of Fsta and
Pou3f3b in establishing or maintaining the posterior otic domain are not known and Tbx1, whilst
having a well reported role in regulating the extent of the posteroventral non-neurogenic domain
in vertebrates does not appear to respond as would be expected if it were regulating posterior
otic character. This is despite the loss of pillars and fused maculae reported in the zebrafish tbx1
mutants (Whitfield et al., 1996b; Bok et al., 2011; Maier and Whitfield, 2014; Radosevic et al.,
2011).
Another characteristic of the establishment of the otic anterior-posterior (AP) axis in zebrafish
previously reported by Hammond et al is the progressive loss of the posterior otic region’s ability
to adopt a duplicated anterior character by 17hpf (16ss) in response to either misexpression of fgf3
or inhibition of Hh using cyclopamine (Hammond et al., 2010; Hammond and Whitfield, 2011).
This progressive loss of competence could indicate the induction of an early determinant of poste-
rior character with the initially equipotent posterior otic tissue, resisting changes in its posterior
identity. This is unlikely to be either of the posterior markers that could have a role in establishing
posterior otic character, fsta or pou3f3b, as they are first expressed within the zebrafish ear from
24hpf (Hammond et al., 2003; Kwak et al., 2002a).
Therefore to identify new, early markers of the posterior otic domain in zebrafish a comprehensive
search of expression profiles on the ZFIN database, which includes data from a number of in situ
hybridisation screens and published data, was carried out (Ruzicka et al., 2015). Possible novel
posterior markers would be looked for and tested based on the features predicted for markers of
posterior character.
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Initially this would be expression within the posterior otic domain, likely more medially to-
wards the posterior otic sensory epithlium as observed with fsta and pou3f3b, towards the end of
the period during which the posterior otic domain appears competent to adopt anterior identity
i.e around 17hpf (16ss) (Hammond et al., 2010; Hammond and Whitfield, 2011; Millimaki et al.,
2007). Any posterior markers could also be tested against the prediction that if they reflect pos-
terior character, in zebrafish, they should have lost or reduced expression domain after treatments
that are known to lead to the duplication of anterior otic character such as misexpression of fgf3
and the converse, an increase in their expression domain after treatments that are known to lead to
the duplication of posterior otic character (Hammond et al., 2003; Hammond and Whitfield, 2011).
This approach was used as previous mutagenesis screens focussed on the ear have not identified any
genes with a clear role in establishing posterior otic character (reviewed in Whitfield et al. 2002.
A previous adult screen of mutants based on auditory response, a role thought to be primarily
carried out by the posterior saccular macula, only reported mutants with defects in the Weberian
ossicles and swim bladder, which are involved in conduction of auditory stimuli, rather than any
changes in the posterior character of the ear itself (Popper and Fay, 1973; Bang et al., 2002).
The results of these searches and the characterisation of one of the candidates identified, including
in response to changes in Fgf and Hh signalling are presented in this chapter.
3.2 Results
3.2.1 Search of expression data for genes with early restriction to the
anterior and posterior otic domains
It was noted that early expression of pax2a, a marker of early otic induction and later the sensory
hair cells, appeared to show lobed otic expression at the anterior-posterior poles of the otic placode
just prior to the onset of otic AP patterning in zebrafish (10ss, 14hpf) (Hans et al., 2004; Ham-
mond and Whitfield, 2011). It was hypothesised that this expression pattern may reflect an early
patterning event across the otic AP axis. Such an early otic patterning event could be supported
by the preliminary observation of an early (14-15hpf) concentration of cilia at both poles of the
otic placode (Supplementary Figure 1), as the presence of cilia within the otic vesicle have been
reported as being required for regulating Hh signalling in the otic vesicle (Stooke-Vaughan, 2013).
Therefore a search of ZFIN gene expression data to identify other genes showing a similar lobed
or restricted expression pattern to pax2A at early stages (14hpf) was carried out using the search
string ”otic placode between 1-4 to 10-13 somites”.
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Table 3.1: ZFIN search using search terms: ”otic placode” between 1-4 to 10-13 somites
Results from a search of the ZFIN gene expression database and genes with previously published otic
phenotypes removed (for full table, see Supplementary Table S2). Transcription factors are highlighted in
blue.
Fifty genes were identified and those with a known otic function were removed, leaving twenty-
eight candidates (Table 3.1). Whilst a large subset were implicated in cilia function, a diverse range
of possible functions were represented along with a number of transcription factors (highlighted
blue). Of the twenty eight candidates, three, adenylate kinase 8 (ak8), cerebellar degeneration-
related protein 2-like (cdr2l) and lethal giant larval 2 (llgl2), were taken forward for further char-
acterisation. This was based on the fact they represented a broad range of functions and appeared
to have strong otic expression with potential AP localisation at an early stage of otic patterning
(Panayiotou et al., 2011; Simpson et al., 2008; O’Donovan et al., 2010; Tay et al., 2013).
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Figure 3.1: Expression of early otic markers ak8, cdr2l and llgl2 at 13hpf
Genes of interest identified from a ZFIN search for early markers of the otic placode with possible AP
restriction at 8ss (13hpf). Expression of adenylate kinase 8 (ak8) (A, A”); cerebellar degeneration-related
2 like (cdr2l) (B, B”) and lethal giant larvae 2 (llgl2) (C, C”). Images A-C are double in situ
hybridisations for the genes mention and pax2a in red. A–C were taken using bright field with a 10x
objective and A’–C’ using DIC with a 40xW objective. A–C are lateral views and A’–C’ are dorsal views.
Scale bars: A; 200µM and A’; 50µM
Therefore, to confirm this early otic expression pattern, in situ hybridisations were carried out
on wild-type embryos at 8ss (approximately 13hpf) (Figure 3.1). All three showed a broad expres-
sion across the early otic placode as marked by pax2a expression. At the AP poles, expression
appeared to extend slightly medially for all three, possibly explaining why in lateral images this
appears as a strengthening at either end (Figure 3.1A-C”). Out of these three, ak8 expression
appeared the weakest at this early stage and so llgl2 and cdr2l were focused on.
Initially llgl2 and cdr2l were further characterised by in situ hybridisations carried out at a num-
ber of later developmental time points (Figure 3.2). The broad otic domain of cdr2l expression
at 13hpf appeared to be progressively lost in the anterior, being expressed in a single posterior
domain by 18hpf (Figure 3.2A-B’). This posterior domain of otic cdr2l was all but lost by 20hpf
(Figure 3.2C”), although a domain of expression abutting the anterior of the otic vesicle (Figure
3.2C’, white arrow) was observed.
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Figure 3.2: Expression of cdr2l between 16-20 hpf and llgl2 between 18-48 hpf
(A–C”) Expression of cdr2l at 16 to 20hpf shows progressive loss from the anterior and then the posterior
otic domain. At 20hpf weak expression anterior to the otic vesicle (white arrow, C’) and in puncta along
the anterior dorsal trunk (Supplementary Figure 10). At 26hpf, otic expression is not visible with
expression in the adjacent ventrolateral hindbrain, forebrain and two patches lateral to the MHB (White
asterisks, D). (E-G”) Expression of llgl2 between 18 to 48hpf shows the broad otic expression at 18hpf
appearing more ventrally localised by 24hpf. By 48hpf, expression within the ear is localised to the tips
of the pillar projections and apical region of the maculae. Expression is also seen in the nasal placode
(white arrow, G’) and anterior neuromasts (white asterisks, G”). A - G G’ were taken using bright field
with a 10x objective. All other images were taken using DIC with a 40x objective. Scale bars: 50µM.
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At 20hpf, expression of cdr2l within the anterior forebrain also appeared stronger with a do-
main of expression also now seen in a domain lateral to the mid-hindbrain boundary (MHB),
possibly marking the trigeminal placode (Figure 3.2C). Cdr2l expression was also seen in small
dorsal puncta in the anterior trunk, which could be Rohon-Beard mechanosensory neurons (Sup-
plementary Figure 10). At 26hpf cdr2l expression persisted within this domain anterior to the otic
vesicle along with the expression observed in the forebrain. The domain of expression adjacent
to the posterolateral mid-hindbrain boundary appeared stronger by this time (Figure 3.2D, white
asterisks), with a stripe of cdr2l expression also now clearly present in the ventrolateral hindbrain
(Figure 3.2D and D”).
llgl2 expression did not show a similar early localisation to either of AP domains as seen with
cdr2l. Instead at 18hpf llgl2 remained broadly expressed across the otic vesicle although the stain-
ing appeared apically located within the cells (Figure 3.2E-E”). This is interesting as this apparent
apical localisation of the transcript is in contrast to the previously reported basal membrane lo-
calisation of the Llgl2 peptide (Tay et al., 2013). This apically-localised, broad otic transcription
persisted at 24hpf primarily within the ventral otic domain and at 48hpf expression appeared
localised to the apical edge of the sensory patches along with the tips of the protruding pillars des-
tined to form the semi-circular canals (Figure 3.2F-G”). At 48hpf llgl2 was also expressed within
the ciliated and epithelial structures of the neuromasts and nasal placodes (Figure 3.2G’ white
asterisks and arrow, respectively).
The early AP lobed otic expression seen for ak8, cdr2l and llgl2 did not appear to correlate
with any later AP restriction in expression, as shown by the later otic expression of cdr2l and
llgl2 (Figure 3.2). Therefore this early AP restricted, lobed expression may instead reflect the
morphology of the early otic placode rather than a restriction of expression. As this project aimed
to study the dynamics of the patterning of the otic AP axis, a second search of the ZFIN gene
expression database was carried out to identify other genes with posterior otic expression between
14-19 somites. Markers with posterior otic restriction were focused on due to the lack of clear
early markers associated with the posterior otic domain in contrast to the anterior (Whitfield and
Hammond, 2007). This search returned four results, two of which were transcription factors, with
one of these, tbx1 having a previously characterised role in posteroventral otic patterning (Supple-
mentary Figure 3).
For the remaining three, neuron navigator 3 (nav3), nuclear factor, erythroid 2 (nfe2) and zgc:101731,
anti-sense RNA probes were synthesised to characterise their expression during early otic develop-
ment. However, probes designed for nfe2 (NM 175043.2) and zgc:101731 (NM 1025558.2) failed
to give any obvious staining at 24hpf or earlier, in contrast to their recorded expression on ZFIN
(data not shown). Nav3, whilst not showing any otic expression at 14hpf (Figure 3.3A), by 16hpf
showed a weak domain of medial expression within the posterior otic vesicle (Figure 3.3B-B”). At
18hpf the nav3 staining in the posterior domain appeared stronger and now was also expressed
along the dorsomedial otic domain (Figure 3.3C-C”). nav3 has been found to be expressed as two
post-splice isoforms, a longer nav3a transcript with a putative calponin-like domain, which likely
mediates an interaction with actin filaments and a shorter nav3b transcript lacking this domain
(Figure 3.3E) (Klein et al., 2011; Schmidt et al., 2009). The previously used nav3 probe hybridised
to a sequence shared by both transcripts (referred to as nav3a/b Figure 3.3E). Therefore to identify
which isoform was expressed within the developing zebrafish ear, an in situ probe designed against
the 5’ transcript sequence only present in the longer nav3a transcript was designed (Figure 3.3E).
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This showed that the transcript expressed within the dorsomedial and posterior domains of the
otic vesicle at 18hpf is that of nav3a. In contrast, the clear loss of expression in the somites when
compared with the nav3a/b probe suggests this somite expression is that of the nav3b transcript
and also supports the specificity of the nav3a probe (Figure 3.3D-D”).
Figure 3.3: Expression of the posterior otic marker nav3 and the di↵erential expression of
the isoform, nav3a
(A-C”) Expression of nav3 using a probe that hybridizes to both nav3a and b isoforms between 14 and
18hpf. At 14hpf (A), there is no obvious staining within the otic placode. However, by 16hpf (B-B”),
nav3a/b is expressed in the posteromedial domain of the otic placode, which appears both stronger and
expanded across the dorsomedial domain by 18hpf (C-C”). (D-E) Using a probe designed against the first
five exons of nav3, which are divergent between the a and b isoforms, Klein et al, 2011 (E). (D-D”)
Expression of nav3a at 18hpf is present within a similar domain to that seen in C-C” using the nav3a/b
probe but expression within the somites is clearly lost. A-D were taken using bright field with a 10x
objective. B’-D” were taken using DIC microscopy with a 40x objective. Scale bars: A; 200µM with B
and B”; 50µM.
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3.2.2 Cdr2l expression persists in the anterior otic domain after loss of
Fgf signalling but only transiently
As both cdr2l and nav3a represented novel posterior otic markers, I hypothesised that they should
be up-regulated within the anterior otic domain when Fgf signalling is inhibited. This is because
such loss of Fgf signalling during early otic development is known to duplicate posterior otic iden-
tity, including expression of posterior markers with a converse loss of anterior identity (Hammond
and Whitfield, 2011). However, as expression of nav3a within the liver bud has been reported to
be una↵ected when Fgf signalling is reduced in hs:dnfgfR1 embryos, cdr2l was initially focused on
(Klein et al., 2011).
Cdr2l expression was initially observed by in situ hybridisation in the fgf3 (liat21142) mutants,
which have reduced anterior otic identity but not duplicated posterior identity (Hammond and
Whitfield, 2011) (Figure 3.4A-J). Early during otic development at 10ss (14hpf), expression of
cdr2l appears weaker in the fgf3 mutants when compared to the wild-type siblings, although still
appearing to have normal patterning (Figure 3.4A compared to B). In contrast, at 20-21ss (19hpf)
cdr2l expression persists in the anterior otic domain as well as being present within the posterior
domain rather than being lost in the anterior domain as seen in the siblings (Figure 3.4C com-
pared to D). Despite this apparent persistence in the mutants, by 26hpf all otic expression of cdr2l
appears lost in both the mutants and sibling (Figure 3.4E and F). In fgf8a (aceti282a) mutants,
which have a milder reduction in anterior otic identity than fgf3 mutants, expression of cdr2l at
10ss appears weaker and abnormally patterned (Figure 3.4H compared to G) (Léger and Brand,
2002). Yet at the 20-21ss, whilst the otic expression appears weaker, it is localised to the posterior
otic domain rather than persisting at the anterior as seen in the fgf3 mutants (Figure 3.4I). This
suggests that the weaker and abnormally patterned expression seen at 10ss in the fgf8a mutants
might reflect the role of fgf8a in the induction of the otic placode rather than being a direct e↵ect
on cdr2l (Phillips et al., 2001).
The persistence of anterior otic cdr2l expression after loss of Fgf function was also confirmed
by transiently inhibiting all Fgf signalling. This was achieved by treating wild-type embryos be-
tween 14 (10ss) and 19hpf (20ss) with the pan-Fgf inhibitor SU5402, which can also been reported
to duplicate anterior otic identity in zebrafish (Figure 3.4O) (Hammond and Whitfield, 2011). In
embryos treated with 10µM of SU5402, 68% (17/25) showed a broader medial domain of cdr2l
expression across the AP axis, although still appearing stronger in the posterior, compared to the
vehicle controls (Figure 3.4M compared to L) .cdr2l expression in the other 32% (8/25) of treated
embryos appeared stronger in two domains at the AP poles, similar to the phenotype seen in the
fgf3 mutants (Figure 3.4M’). Treatment with a higher concentration of SU5402, 15µM, resulted
in comparable phenotypes to treatment with 10µM of SU5402 but with a higher proportion 46%
(12/26) of embryos displaying stronger expression in two AP-localised domains (Figure 3.4N and
N’). Taken together, these results suggest that whilst Fgf signalling appears to have an inhibitory
e↵ect of cdr2l expression, the loss of cdr2l expression from the otic vesicle must also be in response
to other non-Fgf3 dependent changes.
54
Figure 3.4: Expression of cdr2l between 16-20 hpf and llgl2 between 18-48 hpf
(A-F) In fgf3 (lia) -/- mutants at 10ss (14hpf), cdr2l expression appears weaker in the mutants (B)
compared to their siblings (A). At 20-21ss (19hpf) cdr2l expression persists in the anterior otic domain in
the fgf3 mutants (D) rather than being restricted to the posterior otic domain as seen in the siblings (C).
By 26hpf, cdr2l is lost in the otic vesicle of the fgf3 -/- mutants (F), similar to the siblings (E). (G-J) In
fgf8a (ace) -/- mutants at 10ss (14hpf), cdr2l expression appears weaker and abnormally patterned in the
mutants (H) compared to their siblings (G). Cdr2l expression at 20-21ss is weaker within the posterior
otic domain of the fgf8a mutants (J) relative to the siblings (I). Visible cdr2l expression within the ace
mutants appears to be predominantly localised within the posterior domain as in the siblings, rather
than persisting at the anterior (75% vs 92% with posterior expression only, respectively). (K-N’)
Treatment of embryos with the pan-FGF inhibitor, SU5402. Treatment with 10µM results in either
broad expression of cdr2l across the medial edge (M) or strong expression primarily within two patches
at the AP poles (M’). Treatment with 15µM leads to an increase in embryos showing stronger expression
within two pole patches (N’). Both untreated (K) and the DMSO vehicle controls (L) show clear
posterior otic expression of cdr2l. (O) Schematic of SU5402 treatment protocol. All images are dorsal
views taken using DIC microscopy with a 40x objective. All scale bars: 50µM.
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3.2.3 Otic cdr2l expression appears down regulated in response to over-
expression of fgf3
As cdr2l appeared to persist, albeit transiently, in the anterior otic domain after a loss of Fgf
signalling, over-expression should have the reverse phenotype of down-regulating cdr2l. There-
fore to test this, fgf3 and fgf8a were over-expressed using heat-shock inducible transgenic lines
(Lecaudey et al., 2008; Millimaki et al., 2010). Embryos from a heterozygous incrosses of these
transgenic lines were exposed to a 39oC, 30 minute heat shock at 14hpf, a stage at which over-
expression of fgf3 has been shown to induce a duplication of anterior otic identity (Hammond
and Whitfield, 2011). These embryos were then fixed at 18hpf and assayed for cdr2l expression
by in situ (Figure 3.5A-F). After over-expression of fgf3, all transgenic embryos showed a reduc-
tion in otic cdr2l expression (Figure 3.5B and C). 47% (7/15) of these transgenichs:fgf3 embryos
showed a milder reduction in cdr2l expression within the anterior otic domain when compared to
their siblings (Figure 3.5C).A possible slight increase in expression within the anterior hindbrain
of the embryos was also noted. In the other 53% (8/15), a more dramatic loss in the anterior was
seen (Figure 3.5B). After over-expression of fgf8a, otic cdr2l expression appeared reduced in all
transgenic embryos but again this phenotype appeared variable (Figure 3.5E and F). 43% (9/21)
of these hs:fgf8a transgenic embryos showed reduced anterior otic expression (Figure 3.5F) when
compared to the siblings. However, the majority (57%, 12/21) showed a more evident reduction in
otic expression of cdr2l than observed in the hs:fgf3 embryos, although with a domain of posterior
otic expression still being visible (Figure 3.5E). A stronger up-regulation of expression in the an-
terior forebrain compared to hs:fgf3 was also observed in these embryos (Figure 3.5F, white arrow).
In both hs:fgf3 and hs:fgf8a transgenic embryos heat-shocked at 14hpf, expression of cdr2l whilst
reduced, was not completely lost in the posterior otic domain. This was surprising given the strong
duplication of anterior otic identity previously reported after over-expression of fgf3 using a similar
heat-shock at 14hpf (Hammond and Whitfield, 2011). Therefore to identify whether this was due
to insu cient levels of either fgf3 or fgf8a over this four-hour time period, hs:fgf3 and hs:fgf8a
embryos were given a series of 15 minute, 39oC heat shocks at 14,16 and 18hpf before being fixed at
19hpf (Figure 3.5G-N). In the hs:fgf3 transgenic embryos otic expression of cdr2l again appeared
reduced, although this reduction appeared greater than previously observed after over-expression
at 14hpf (Figure 3.5I and J). In 25% (3/12) of embryos, weak posterior otic cdr2l was observed but
in the majority (75%, 9/12) of the transgenic embryos cdr2l no longer appeared expressed in the
otic domain (Figure 3.5J). hs:fgf8a transgenic embryos also appeared to show a greater reduction
in otic cdr2l expression when compared to embryos heat shocked a single time at 14hpf (Figure
3.5K-N).Interestingly, these serially heat shocked hs:fgf8a embryos showed a less pronounced re-
duction in expression than seen in the hs:fgf3 embryos, the opposite to the phenotypes observed
after over-expression at 14hpf.
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Figure 3.5: Cdr2l expression is reduced in response to over-expression of either fgf3 or fgf8a
(A-F) Expression of cdr2l at 19 hpf after 30-minute, heat-shock induced expression of either fgf3 or fgf8a
at 14hpf. (A-C) In embryos from a hs:fgf3 +/- incross, 8/15 transgenic embryos have weaker cdr2l
expression throughout the vesicle (B). The remaining 7/15 have weaker throughout but still observable
expression in the anterior domain. (D-F) In embryos from a hs:fgf8a +/- incross, the majority of
transgenic embryos (12/21, E) have a stronger reduction in otic expression although retaining posterior
expression than in the siblings.In the remaining 9/21 embryos posterior otic staining appears similar to
that in the siblings although is weaker within the anterior domain (F). These embryos also show slightly
stronger cdr2l staining within the forebrain (white arrow). (G-N) Expression of cdr2l at 19 hpf after 3x15
minute serial heat-shocks.(G-J) In hs:fgf3 +/- incross embryos, cdr2l expression is either only weakly
present (I, 3/12) or lost (J, 9/12). (K-N) ). In hs:fgf8a +/- incross embryos, posterior otic cdr2l
expression is weakly present in all. This is stronger in 4/12 (M) compared to the remaining 8/12 (N).
A-F are lateral views taken using bright field with a 4x(2xmag) objective. G-N were taken using DIC
microscopy with a 40x objective. Scale bars: A and G;150µM, D; 50µM.
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As over-expression of fgf3 or fgf8a resulted in reduced expression of cdr2l by 18-19hpf, I wanted
to observe whether a similar reduction was seen in the strong otic cdr2l expression at 14ss (16hpf)
after over-expression (Figure 3.2). Progeny from a heterozygous hs:fgf3 and hs:fgf8a incross were
therefore heat shocked at 39oC for 30 minutes, but earlier than previously, at 13hpf before being
fixed at 16hpf (Figure 3.6). hs:fgf3 embryos did not show any clear loss of expression across
the AP axis (Figure 3.6A-A”), although expression appeared possibly weaker and less defined to
varying degrees in approximately three-quarters of these (77%, 30/39) (Figure 3.6A and A’). In
16hpf hs:fgf8a embryos heat shocked at 13hpf, again no clear loss of cdr2l expression was seen
(Figure 3.6B-B”). However, there was an apparent variability in otic expression, similar to that
observed in hs:fgf3 (64%, 23/36) (Figure 3.6B-B’). This di↵erence in the severity of reduction in
cdr2l expression between embryos at 16hpf and at 18-19hpf after over-expression of either fgf3 or
8a could reflect the normal di↵erence in cdr2l expression seen between these time points.
Figure 3.6: Cdr2l expression appears slightly reduced by 16hpf in response to
over-expression of either fgf3 or fgf8a at 13hpf
(A–A”) Expression of cdr2l in progeny from a hs:fgf3 +/- incross. In 77% of these (A & A’) cdr2l
expression appears slightly weaker and the domain misshapen compared to A”, which show stronger
expression and likely represent non-transgenic siblings (23%). (B–B”) Expression of cdr2l in progeny
from a hs:fgf8a +/- incross. 64% of these (B & B’) show weaker and irregular domains of cdr2l expression
compared to B” (36%). The embryos represented by B” therefore are likely the non-transgenic siblings.
All images are dorsal views taken using DIC microscopy with a 40x objective. Scale bar in A: 50µM.
3.2.4 Otic cdr2l expression does not appear duplicated or strongly up-
regulated when Hh signalling as constitutively active
If cdr2l is a marker of posterior otic identity, then in ptch1–/–; 2–/– Hh gain-of-function mutants,
which have a duplication of posterior otic character, its expression should persist in the anterior
domain (Hammond et al., 2010). In these mutants at 20ss (19hpf), otic cdr2l expression remained
primarily localised to the posterior domain with no up-regulation observed within the anterior
(Figure 3.7B).
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However, posterior cdr2l expression when viewed laterally did appear to show a slight retention
of expression along the both the dorsal and ventral edges of the otic domain when compared to
the siblings (Figure 3.7D compared to C).
Figure 3.7: Aberrant activation of Hedgehog signalling results in a modest anterior
retention of Cdr2l expression in both the medial and lateral otic domains
(A–E) Expression of cdr2l in sibling embryos. (B–F) Expression of cdr2l in ptch1;2 mutant embryos. (G)
The black-dotted line represents the point at which the transverse trunk sections, B and F were taken
from. A-B are dorsal views, C–D are lateral views and E–F are transverse trunk sections. All images
were taken using DIC with a 40x objective. All scale bars: 50µM.
As Hh signalling is known to be a strong regulator of neuronal patterning, expression of cdr2l
within the neural tube just posterior to the otic vesicle at 19hpf was also observed in transverse
sections (Takamiya and Campos-Ortega, 2006; Cohen et al., 2013) (Figure 3.7E-F). This showed
no clear change in cdr2l expression within the lateral neural tube, either in terms of dorsoventral
positioning or strength in the ptch1–/–; 2–/– mutants (Figure 3.7F).
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3.3 Discussion
In this chapter I have presented data on identification of novel markers of both the early otic
placode and the posterior otic domain through a search of previously published in situ expression
data. This has led to a focus on the previously uncharacterised gene, cdr2l, due to its dynamic
expression across the otic AP axis both during early otic development and in response to Fgf
manipulation.
Using a search of the ZFIN expression database has inherent issues such low quality data and
annotation and, as with all potential reverse genetic approaches, no guarantee of gene function
(Junker et al., 2014). However, it also represents an easily-accessible, large dataset of potentially
uncharacterised genes (>30,000) which may have undiscovered roles in development. Given the
well-studied regionalisation of the otic placode by clearly defined domains of gene expression and
the previous di culty with identifying posterior otic markers using phenotypic means, this presents
a good system for utilising such a search (Ruzicka et al., 2015; Whitfield and Hammond, 2007;
Bang et al., 2002). This is supported by the number of known otic markers identified in the two
searches performed. However, alongside this, an unbiased transcriptomics approach focused on
characterising early otic genes di↵erentially expressed either after perturbation or across the AP
axis was also pursued, as discussed in Chapter Five.
Whilst the initial search for early otic markers with a lobed AP expression pattern gave a number
of candidates, including cdr2l, this lobed pattern did not appeared to reflect later AP localisation
of expression or identity. Llgl2, one of the markers characterised from this search, rather than
having expression restricted to the AP otic domains, did show an interesting apical localisation of
its transcript within the ear. This is the opposite to the basal localisation of the peptide, which in
zebrafish has been implicated in the formation of ciliated lumenal organs, including the otic vesicle
(Tay et al., 2013). As Llgl2 is required for formation of hemidesmosomes at the basal membrane, it
may play a role in establishing the early apical-basal polarity of cells of the otic placode (Sonawane
et al., 2009). Such early establishment of otic apical-basal polarity has been shown to be impor-
tant in determining the size of the otic lumen (Hoijman et al., 2015). It would therefore also be
interesting to study the function of Llgl2 in pillar formation and fusion, given its later expression
in the tips of the protruding luminal pillars.
In the second search for later posterior otic markers, which yielded a smaller number of candi-
dates, nav3a was identified as being expressed in the posterior otic domain from 16hpf and later
expanding anteriorly along the dorsal edge. Interestingly the anteroventral domain from which
nav3a was excluded is marked by a number of anterior otic markers, such as hmx3a, and is strongly
influenced by anterior Fgf signalling (Whitfield and Hammond, 2007; Maier and Whitfield, 2014).
This localisation of nav3a expression, may indicate a role in regulating posterior identity. However,
in the developing zebrafish liver bud expression of nav3a has been shown to be positively regulated
by Wnt signalling but una↵ected by loss of Fgf (Klein et al., 2011). Whilst Wnt signalling is not
thought to be involved in patterning the AP otic axis (see section 1.4.1), Wnt emanating from
the dorsal hindbrain in vertebrates has been implicated in otic dorsoventral (DV) patterning in
mice with a similar role postulated in zebrafish (Riccomagno et al., 2005; Lecaudey et al., 2007).
Therefore the dorsal expansion of nav3a seen after 16hpf, may be driven by dorsal sources of wnt1
or wnt3a adjacent to the developing otic placode at 16hpf(Lecaudey et al., 2007). Intriguingly,
nav3a is not thought to be a transcriptional activator, instead being implicated in axonal guidance
and cellular movement (Klein et al., 2011). For that reason, identifying whether nav3a appears
associated with posterior otic character would be a key initial question to address.
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Following on from these two ZFIN searches, cdr2l was focused on as it showed dynamic expression
across the AP otic axis during the period in which AP otic identity is thought to be assigned in
zebrafish (Hammond and Whitfield, 2011). Whilst otic expression of cdr2l persisted in the anterior
after a loss of fgf3 or inhibition of Fgf signalling with SU5402, loss of fgf8a did not appear to have
the same e↵ect. As expression of fgf3 within rhombomere 4 is still present in fgf8a mutants, this
suggests fgf3 might be the key regulator in the progressive loss of cdr2l expression from 16hpf
onwards (Léger and Brand, 2002). Despite this di↵erence, over-expression of either fgf3 or fgf8a
resulted in an obvious reduction in otic cdr2l expression by 18-19hpf. However, the loss of otic
cdr2l expression, even when persisting in the anterior after loss of fgf3, at 26hpf puts into doubt
cdr2l being involved in defining posterior identity. If this were the case, expression of cdr2l would
be expected to persist as posterior identity is established. The lack of a clear anterior duplication
of cdr2l after aberrant activation of Hh signalling, which has previously been shown to result in a
strong duplication of posterior otic character, also supports this.
I have also shown that during development cdr2l is also expressed in neuronal structures such
as the anterior forebrain, the assumed trigeminal placode, ventral hindbrain, lateral neural tube
and anterior-dorsal neurons within the trunk, from 20hpf onwards. This may indicate another role
for Cdr2l in the regulation of neuronal populations, possibly providing a link with its previously-
describe characterisation within cerebellar Purkinje cells (Schubert et al., 2014). However the
broad range of structures in which cdr2l is expressed during development also makes it di cult to
infer how Cdr2l may be regulating neuronal development.
Given the interesting expression profile of cdr2l, along with the indication it may play role in
determining posterior otic identity, this clearly asks the question - what is Cdr2l’s function during
otic development? Chapter Four begins to address this by presenting data from embryos where
cdr2l has been either knocked-down or knocked-out.
3.4 Conclusions
• During early development of the otic placode a broad range of markers with potentially
di↵erent functions are expressed, with a high proportion being linked to cilia function.
• Cdr2l and nav3a both represent novel markers of the posterior otic domain.
• Cdr2l persists until 26hpf in the anterior otic domain in loss of fgf3 mutants or after treatment
with the pan-Fgf signalling inhibitor, SU5402.
• Over-expression of either fgf3 or fgf8a leads to a down-regulation of otic cdr2l expression but
this is only clearly apparent at 18-19hpf.
• Cdr2l expression does not persist in the anterior otic domain and expression in the lateral
neural tube appears una↵ected when Hh signalling is aberrantly activated.
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Chapter 4
The role of cdr2l in otic placode development
4.1 Introduction
CDR2L is a highly coiled, cell-membrane localised member of the cerebellar degeneration-related
(CDR) family that has primarily been studied in relation to its role in Paraneoplastic Cerebellar
Degeneration (PCD) (Eichler et al., 2013). In this human pathology it is thought that an autoim-
mune response against a highly-conserved antigenic epitope in CDR2L and CDR2, which share
45% identity in humans and 41% identity in zebrafish, occurs in reaction to ectopic expression
of CDR2 within certain tumour types (Corradi et al., 1997; Sakai et al., 1990). The subsequent
inhibition of endogenous CDR2L and CDR2 within cerebellar Purkinje cells results in their loss,
possibly due to deregulation of calcium homeostasis or the cell cycle within these cells (Schubert
et al., 2014; Eichler et al., 2013). However, the expression and function of both Cdr2l or Cdr2
during development have not been reported.
In zebrafish, the dynamic expression of cdr2l across the anterior-posterior otic axis during early
development, which appears responsive to changes in Fgf signalling, suggested a possible role for
Cdr2l in otic patterning (Chapter Three). To identify any such function of Cdr2l, two approaches
to reduce the expression of the wild-type cdr2l transcript were used. Firstly a synthetic morpholino
oligo was injected into one cell embryos to block translation of Cdr2l. Translation-blocking mor-
pholinos function by binding a complementary sequence of the transcript 5’ to the translation start,
thus sterically blocking binding of the ribosome to the transcript (Summerton, 1999). In zebrafish
this has been used to produce gene-specific knock-down up to 50hpf (Nasevicius and Ekker, 2000).
However, despite morpholinos representing a quick method for knocking-down genes of interest,
their ability to recapitulate phenotypes observed in the corresponding mutant has recently been
questioned (Kok et al., 2015). The use of morpholinos is also associated with o↵-target e↵ects
such as general craniofacial defects, trunk abnormalities and heart oedema (Robu et al., 2007;
Bedell et al., 2011). These are estimated to occur in around 15-20% of morphants and despite the
specificity of the morpholino function being controlled for, such artefacts can be misleading (Bedell
et al., 2011).
Advances in generating targeted mutations, in particular CRISPRs, have presented reverse genet-
ics as an alternative to transient knock-down approaches such as morpholinos. Such approaches
now have high mutagenesis e ciencies and germline transmission rates along with low associated
costs compared to previous reverse genetic techniques such as TILLING (Targeting Induced Local
Lesions in Genomes) (Schulte-Merker and Stainier, 2014). Whilst the potential for mutation at
o↵-target sites is still a consideration in CRISPR-generated mutants, this is only thought to occur
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in around 1.1-2.5% of injected embryos (Hruscha et al., 2013). Therefore the second approach
was to knock-out the wild-type zebrafish cdr2l gene by generating stable lines carrying targeted
non-sense mutations in cdr2l utilising CRISPRs.
Recently, it has been suggested that in deleterious mutants a compensatory network of gene
regulation may bu↵er against the e↵ects of the deletion, which is not seen in morpholino-based
knock-down approaches (Rossi et al., 2015). In light of this, comparing the phenotypes observed
when cdr2l was either knocked-down or knocked-out allowed validation of the phenotypes seen.
Given the drawbacks of each approach mentioned above, this therefore represents a comprehensive
approach beginning to identify the function of Cdr2l during development.
4.2 Results
4.2.1 cdr2l morphant morphology
To knock-down expression of cdr2l during otic development, a morpholino (MO) was designed
against the sequence upstream of the translation initiation site (+1, Figure 4.1A). Initially 1, 2
and 3nL of this MO at a concentration of 0.9mM (7.6ng/nl) were injected with a Ringer’s solution
control alongside into wild-type embryos. These were then characterised over five days for their
survival and any otic phenotypes. At 2dpf a number of MO-injected embryos across all three
injected volumes were observed to have either a single or no otolith phenotype, whereas the ma-
jority of the Ringer’s injected controls (99%) had two normally-positioned otoliths. Interestingly
though, the percentage of embryos having a single otolith at 2dpf appeared consistent across all
three injection volumes at 1nl; 34%, 2nl; 40% and 3nl; 32% (Figure 4.1F) which could suggest a
general developmental delay rather than a specific response to knock-down of cdr2l. However, at
3dpf the single otolith phenotype persisted, with the 1nl-injected batch having a slightly higher
percentage, 37% (37/101) with one otolith and the 2nL-injected batch still having 40% (32/80)
with one otolith compared to the Ringer’s-injected controls, where all embryos (100%) had two
otoliths (Figure 4.1A-E’).
Despite the persistence of this phenotype at 3dpf, the otic morphology in the morphants with
a single otolith generally appeared perturbed showing a lack of pillar formation and/or fusion
(Figure 4.2D’), which was also observed to a lesser extent in the 2nL-injected embryos with two
otoliths. Given this, along with other non-specific e↵ects such as a smaller head and eyes as well
as oedema seen, this perturbation of the pillars could reflect o↵-target e↵ects commonly reported
in morphants (see introduction 4.1). It was also observed that the otic vesicles generally appeared
smaller in the morphants, although this may be due these embryos having an overall smaller head
when compared to the controls. In embryos injected with a lower volume (0.5nl) of the same con-
centration (0.9mM) MO, only 9% of embryos had a single otolith phenotype in both ears; however,
these embryos also displayed the most severe overall morphological defects (Supplementary Figure
4).
The survival of embryos over the first five days was also recorded (Figure 4.1G) and showed
that all three MO injection volumes show a drop in survival at 4dpf, which was not observed in
the Ringer’s injected controls but the 1nL injection volume have the lowest drop in survival. Inter-
estingly the batch of embryos injected with 2nL of MO showed a greater drop in survival at 4dpf
than those injected with 3nL (28% vs 56% at 4dpf, respectively). As the 1nL injection volume
gave the highest survival along with a possible otic phenotype this injection volume of the 0.9mM
ATG MO was used in all subsequent experiments.
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Figure 4.1: Characterisation of cdr2l morphant survival and gross morphology
(A) Schematic of the cdr2l morpholino binding site, 28bp upstream of the cdr2l translation start site
(+1). (B–E’) Images of live embryos at 3dpf. (B–B’) AB embryos injected with 2nl of Ringer’s solution
appear to have no obvious defects. ( C–D’) Embryos injected with 1nl of 0.9mM cdr2l ATG MO
appeared to either have a normal otic morphology i.e two otoliths (64/101) or a single otolith
morphology (37/101). Both groups displayed a variable heart oedema phenotype. (E-E’) Embryos
injected with 2nl of 0.9mM MO displayed a similar split in otolith number but with a more abnormal
overall morphology i.e curved trunk, smaller eyes and larger oedema. (F) Otolith phenotypes for
injection of 1-3nl 0.9mM at 2dpf (G) Survival curves for 1–3nl of 0.9mM MO over 5dpf. N= number of
individual embryos observed. B–E were taken using bright field with a 4x objective and B’–E’ using DIC
with a 40x objective. Scale bars B–E: 250µM and B’: 50µM.
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4.2.2 Cd2rl morphants show largely una↵ected patterning of the anterior-
posterior otic axis but a possible reduction in overall length
As otic expression of cdr2l appears negatively regulated by Fgf (Chapter 3), a key determinant of
anterior otic identity in zebrafish (Hammond and Whitfield, 2011), and cdr2l the morphants show
a partially penetrant loss of an otolith which could reflect altered otic patterning, markers of the
otic anterior-posterior (AP) axis in cdr2l morphants were studied. Embryos were injected with
either 1nL of a non-specific control MO at 0.9mM or 1nL of the cdr2l ATG MO at 0.9mM alongside
an uninjected control and raised to either the 18-20ss (approximately 18-19hpf) or Prim-7 ( 26hpf)
stage before being fixed.
18-20ss embryos were assayed for expression of the anteromedial marker, hmx2 by in situ hy-
bridisation. The cdr2l morphants showed no obvious di↵erences in otic hmx2, either in strength
or localisation, in staining when compared to the uninjected and control MO (Figure 4.2A-C).
To confirm this the overall anterior-posterior length of the hmx2 expression domain for all three
conditions was measured from the lateral-most point of expression along the outer otic edge to the
most posterior point. This showed no significant di↵erence in the length of the hmx2 expression
domain, as would be expected if the domain was expanded or reduced either laterally or posteriorly,
when either the non-specific control or cdr2l morphants were compared to the uninjected controls
(Supplementary Figure 5).
Similar to hmx2 the expression domain of the otic non-neural ventrolateral marker, otx1b, in Prim-
7 staged cdr2l morphants did not appear drastically reduced in size or staining intensity relative
to the uninjected and non-specific MO controls (Figure 4.2D-F). However, as the otx1b staining
appeared irregular in shape in a number of embryos, for all injection conditions the percentage
length of the expression domain relative to the overall anterior-posterior length was measured.
To do this an ROI was bounded to the laterally imaged otic vesicles and the distance from the
anterior edge to the posterior edge measured. Then the domain of otx1b staining was measured
from the anterior-most to the posterior-most point and this value was then normalised against the
total anterior to posterior length. This confirmed that the normalised anterior to posterior length
of otic otx1b staining in the cdr2l morphants was not significantly di↵erent from the uninjected
controls, with the non-specific controls also not di↵ering significantly when compared to the unin-
jected (Supplementary Figure 6).
Few markers of posterior otic character have been identified but of these fsta has been previ-
ously shown to be associated with posterior otic character (Hammond and Whitfield, 2011). In the
Prim-7 staged cdr2l morphants staining for fsta in 55% (6/11) appeared strikingly stronger within
the medial hindbrain compared to the uninjected and non-specific controls (Figure 4.2G compared
to I). Whilst staining in the posterior otic vesicle was present in all cdr2l morphants, the strength
of staining appeared reduced, although possibly stronger within the mesenchyme just posterior to
this (Figure 4.2I compared to G and H). Staining in the remaining 45% (5/11) of morphants showed
staining within the hindbrain similar to that seen in the uninjected and non-specific controls and
again, whilst staining was present within the posterior otic vesicle, it appear reduced in strength
(Figure 4.2J).
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Figure 4.2: cdr2l morphants show no abnormal patterning of the anterior otic marker,
hmx2 or the ventrolateral otic marker, otx1b but the posterior otic marker, fsta, appears
abnormal
(A–C) hmx2 expression in cdr2l morphants at 18–20ss does not appear obviously expanded in the cdr2l
morphants. (D–F) The domain of otx1b expression also does not appear strikingly di↵erent or expanded
in the prim-7 staged morphants. (G–J) fsta staining in 6/11 morphants (I) appeared up-regulated within
the medial hindbrain compared to both controls with expression within the posterior otic vesicle
appearing reduced. Staining in the remaining 5/11 morphants (J) showed staining within the hindbrain
similar to that seen in both controls with staining in the posterior otic vesicle again appearing slightly
reduced. (K) Measurement of the anterior to posterior otic length for both ears from dorsal imaged
18–20ss embryos. This shows a significant di↵erence in the mean AP length although post-hoc testing for
multiple comparison to the uninjected control shows no significance (one-way ANOVA p=0.0388,
Holm-Sidak adjusted p=0.3182 and 0.3182). (L) Measurement of the anterior to posterior otic length for
Prim-7 (26hpf) embryos. This shows a significant di↵erence between the mean AP length of the
uninjected and cdr2l MO injected embryos (one-way ANOVA adjusted p=0.0280 with Dunnett’s multiple
comparison). N= number of individual embryos measured. In K, both ears were measured from 6 dorsal
images for each condition (a total of 12 data points), whereas in L only the left ears could be measured
due to the lateral perspective. A–C are dorsal views with all other images being lateral views. All images
were taken using DIC with a 40x objective. Scale bars in A, D and G: 50µM.
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The anterior to posterior length of the otic vesicle was also measured for all three injection
conditions by bounding imaged otic vesicles with a Region Of Interest (ROI) within ImageJ and
measuring from the anterior to posterior edges of this. For 18-20ss staged embryos, a significant
di↵erence in length between the conditions was found with the morphants having a smaller mean
than either the uninjected and non-specific controls. However a multiple comparison test showed no
significant di↵erence between either the cdr2l morphants or non-specific controls when compared to
the uninjected (Figure 4.2K). There was a significant di↵erence in the variation between the groups
(Brown-Forsythe p=0.0222 ** and Bartlett’s p= 0.0072 *); the standard deviation (SD) for the
cdr2l morphants (9.648µm) was more than double that of the non-specific (4.142µm) and uninjected
(4.503µm) controls (Figure 4.2L). The Prim-7 ( 26hpf) staged embryos also showed a significant
di↵erence in length between conditions, with the morphants again having a smaller mean AP length
than both the control conditions. A multiple comparison test also identified a significant di↵erence
between the uninjected and cdr2l morphants but not the non-specific MO control. Interestingly,
unlike the 18-20ss embryos, the di↵erence in variance was not significant (Brown-Forsythe p=0.4175
and Bartlett’s p=0.4118) although the cdr2l morphants did show a greater SD (10.66µm) when
compared to the non-specific (6.774µm) and uninjected controls (7.281µm).
4.2.3 Markers of the delaminating otic neuroblasts and their subsequent
di↵erentiation display a modest reduction in expression in the
cdr2l morphants
Alongside its role in determining and maintaining anterior identity, Fgf signalling, which appears
to negatively regulate cdr2l, is also thought to positively regulate the number of neuroblasts that
delaminate from a anteroventral otic domain (Maier and Whitfield, 2014). Given this, the expres-
sion of neurog1, a marker of delaminating otic cells destined to form the statoacoustic ganglion
and neurod1, a marker of cells subsequently completing neuronal di↵erentiation within the neu-
rog1 -expressing population (Andermann et al., 2002; Korzh et al., 1998) were assayed by in situ
hybridisation in cdr2l morphants. In cdr2l morphants staged at 20-21ss (approximately 19-20hpf),
neurog1 staining is still observed within a similar anterior otic domain to the uninjected and
non-specific controls (Figure 4.3A-C’) and expression in the head and trunk also appears rela-
tively consistent between all conditions (not shown). However, in the majority (70%, 33/47) of
cdr2l morphants otic neurog1 staining appeared slightly weaker and patchy when compared to
the uninjected and non-specific controls (Figure 4.3C compared to A and B). Neurod1 staining in
high-pec staged (approximately 42hpf) cdr2l morphants in the domain anterior to the otic vesicle,
appeared grossly similar in position as did staining posterior to the otic vesicle when compared
to the uninjected and non-specific controls (Figure 4.3D-F). Interestingly, the domain of neurod1
staining that extends anteriorly to the otic vesicle, likely comprised of the statoacoustic ganglion,
the anterior lateral line ganglia and facial ganglion, does appear slightly reduced in overall size in
the morphants compared to the controls, although this could reflect the morphants being smaller
overall (Andermann et al., 2002).
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Figure 4.3: Cdr2l morphants show weakened neurog1 staining with a possible reduction in
the anterior otic domain of neurod1 expression
(A–C’) Expression of neurog1, a marker for delaminating otic neuroblasts, in uninjected (A), non-specific
MO injected (B) and 0.9mM cdr2l MO injected (C & C’) embryos at 20–21ss (approximately 19hpf).
(D–F) Expression of neurod1, a marker of neuronal di↵erentiation, neuroblasts in uninjected (D),
non-specific MO injected (E) and 0.9mM cdr2l MO injected (F & F) embryos at the high-pec stage
(approximately 42hpf). A-C’ were taken using DIC microscopy with a 40x objective and D-F using DIC
microscopy with a 10x (1.6 mag) objective. Scale bars: A; 50µM
and D; 100µM.
4.2.4 Cdr2l morphants have no apparent vestibular defects but a pos-
sible swim-bladder inflation phenotype by 5dpf
The zebrafish sensory maculae, in particular the utricle, are known to be required for detection
of vestibular stimuli (Riley and Moorman, 2000). Defects either in the sensory epithelium itself
or through their disrupted innervation result in a clear dysfunction in detecting vestibular stimuli
(Kwak et al., 2006; Whitfield et al., 2002). Therefore if cdr2l plays a role in the development
of either the sensory domains themselves or the neurogenic otic domain, the loss of Cdr2l in the
morphants should dampen their response to vestibular stimuli.
Using a protocol previously published by Kwak et al, 2006 to test the vestibular response of
larvae, cdr2l morphants injected with 1nL of 0.9mM MO were tested for their ability to respond
to tap stimuli from a seeker handle (motor coordination test) and whether they were capable of
balancing dorsal side up, one minute after this stimulus (balance test). All embryos were tested
three times and were only scored as a fail if they did not respond or subsequently stay upright
for two or more of the three tests (Figure 4.4A and B). In the motor coordination test, a subset
of the cdr2l morphants tested failed to either respond or do so in a stereotypical manner (10%,
1/10) but this was not significantly di↵erent when compared to the number of non-specific control
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MO-injected embryos that failed (7%, 1/15), with none of the uninjected controls failing (0/15)
(Figure 4.4A). In the balance test, cdr2l morphants did show a higher number of embryos that
were unable to balance after one minute, instead resting on their sides (40%, 4/10). Yet when
compared to the control MO (13%, 2/15 failed) this higher percentage in the cdr2l morphants was
not significantly di↵erent (Figure 4.4B).
Another suggested indicator of impaired motor function, although not necessarily Impaired otic
function, is a lack of swim bladder inflation due to the larvae being unable to reach the air-water
interface (Riley and Moorman, 2000). In larvae injected with 1nL of 0.9mM cdr2l MO there was a
significant association with a non-inflated swim bladder when compared to the uninjected controls
(55% (6/11) vs 6% (1/17), p=0.0069, odds ratio=19.20) (Figure 4.4C). There was no such asso-
ciation seen when the non-specific control was compared to the uninjected controls (6% (1/16) vs
6% (1/17), p=1.0000), suggesting that the cdr2l morphants may have a reduced ability to inflate
their swim bladders.
Figure 4.4: cdr2l morphants at 5dpf show no significant vestibular defects but reduced
swim bladder inflation. Assessment of (A) motor coordination, (B) balance and (C) swim bladder
inflation at 5dpf in uninjected embryos, non-specific control MO and 0.9mM cdr2l morphants. A
two-tailed Fisher’s exact test was used to separately compare the outcome count data from the
uninjected controls to the control MO and 0.9mM cdr2l injected embryos for all tests.
N= number of individual larvae tested.
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4.2.5 The cdr2l ATG morpholino inhibits translation of the cdr2l CDS
in vivo
Figure 4.5: Co-injection of the cdr2l MO inhibits translation of a CDR2L-eGFP fusion
construct
In vivo e cacy assay for cdr2l ATG morpholino binding and blocking. (A) Schematic of the
CDR2L-eGFP fusion construct with the 5’ morpholino binding sequence. (B) Graph of fluorescence
phenotypes in construct–injected embryos after injection with either the non-specific control morpholino
or the cdr2l morpholino. Embryos were grouped according to fluorescence, with (C, C’) representing
embryos grouped with no observable fluorescence, (D, D’) having mid-strength fluorescence and (E, E’)
having strong fluorescence. Insets for C, D and E show bright-field images of the main panels with
dotted-ROIs corresponding to magnified images C’, D’ and D’, respectively. C-E were taken using 9x
magnification. N= number of individual embryos.
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As the cdr2l morpholino phenotype appeared subtle with no striking e↵ect on otic development
despite its strong expression during early otic development (Chapter three), I wanted to confirm
that the morpholino, at the concentration being injected, did inhibit cdr2l translation in vivo.
To test this, a construct was synthesised which contained the coding sequence (CDS) for cdr2l,
including the 5’ morpholino binding site, fused to the coding sequence for eGFP, and driven by
a CMV promoter to allow constitutive expression of the fusion construct when injected at the
one-cell stage (Figure 4.5A). 150pg of this construct were then injected either alone or alongside
the non-specific control or the cdr2l morpholino and the embryos assessed for eGFP fluorescence
at the 90% epiboly/bud stage (approximately 9-10 hours after injection) (Figure 4.5B).
In embryos injected with 150pg of construct and 1nL of 0.9mM cdr2l morpholino, strong or mid-
strength eGFP fluorescence was not seen (0%, 0/56) whereas a high percentage of embryos showed
this degree of fluorescence in both the construct-injected (89%, 32/36) along with the construct
and non-specific MO-injected (75%, 36/48) embryos (Figure 4.5C compared to D and E). This con-
firms that the cdr2l morpholino is capable of inhibiting translation of the cdr2l CDS-containing
construct in vivo and therefore is also likely functioning to knock down endogenous cdr2l transla-
tion.
4.2.6 Generation of cdr2l CRISPR mutants
Due to this being the first reported knock-down of cdr2l in zebrafish and the issues associated
with the use of morpholinos, in particular o↵-target e↵ects and a lack of correlation with the
corresponding mutant in the phenotypes reported, a cdr2l mutant was generated using CRISPR
mutagenesis to confirm the subtle phenotypes in the variation of AP otic length and swim bladder
inflation observed (Kok et al., 2015). The CRISPR system uses a guide RNA designed to a 20bp
genomic target sequence adjacent to a protospacer adjacent motif (PAM) trinucleotide which when
present with the protein Cas9 in vivo forms a complex around the genomic DNA, complementary
to the target sequence and produces double stranded breaks. When these are repaired through
non-homologous end joining there is a likelihood of insertions or deletions occurring (Hruscha et al.,
2013).
For cdr2l, a guide RNA was designed to target exon 2 of the cdr2l genomic sequence (Figure
4.6A) and within the F1 generation generated using this guide RNA two mutations, a 4bp deletion
and a five bp insertion along with a single bp deletion 5’ to this (referred to as 5/1 InDel), were
identified. Both of these mutations were predicted to produce frameshifts in the coding sequence
resulting in a premature stop codon (Figure 4.6B). F1 fish carrying these mutations were used
as founders to generate a stable heterozygous F2 line for each allele and when incrossed it was
expected that 25% of the embryos would be homozygous for the mutations based on Mendelian
inheritance.
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Figure 4.6: cdr2l exon 2 CRISPR design and identified alleles (A) Schematic of cdr2l exon
structure and the 20bp guide sequence designed to recognise base pairs 34-54 of exon 2 (in blue) when
transcribe as a single guide RNA (sgRNA, in green) with the sca↵old sequence. In the presence of Cas9,
this sgRNA should induce a double strand break approximately 3bp (black arrow) up-stream of the
protospacer adjacent motif (PAM, grey box). (B) From the F1 population two mutant alleles were
identified for carrying forward. A 4bp deletion (red box), 3bp upstream of the PAM (grey box), which is
predicted to produce a frameshift within exon 2 and a premature stop codon at the start of exon 3,
residue 66. Also a 5/1bp insertion/deletion (red box) within and upstream of the PAM (grey box), which
is predicted to produce a frameshift within exon 2 and a premature stop codon at the end of exon 2,
residue 47. Peptide sequence predicted with ExPASy (SIB) and aligned in MUSCLE (EBI).
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4.2.7 Cdr2l mutants do not show any otolith, vestibular or swim bladder
defects but do have a reduced anterior-posterior otic vesicle length
Figure 4.7: Neither the cdr2l 4bp deletion or the 5/1bp InDel mutant alleles show obvious
otic morphological defects but may show a reduction in anterior to posterior length at 1dpf
(A–D’) Live images of 3dpf embryos. 4bp Deletion +/- incross sibling (A) and mutants (B–B’) and
5/1bp InDel +/- incross sibling (C) and mutants (D–D). (E) Otolith phenotypes at 2dpf in wild-type,
4bp Deletion incross and 5/1bp InDel incross progeny. There is no obvious change in otolith number in
either allele, with neither the 1 otolith or no otolith phenotypes reaching 25% (red dotted line) as would
be expected if a fully penetrant mutant phenotype. (F) Measurement of the anterior to posterior length
of live, laterally-imaged; AB wild-types, 4bp deletion incross and 5/1bp InDel incross progeny at 1dpf.
4bp deletion progeny have a significantly shorter AP length than their wild-type counterparts (t test
p=0.0139, t=3.141 df=7.927), whereas the 5/1bp InDel progeny have a shorter mean than their
wild-type counterparts but this is not significant (t test p=0.2742 , t=1.121 df=22.55). All images are
lateral views taken with a 4x (2x mag) objective using DIC microscopy. Scale bars: A; 150µM. N=
number of individual embryos.
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Progeny from heterozygous incrosses of both alleles showed no increase in mortality at 0dpf com-
pared to wild-types or by 3dpf (Supplementary Figure 7). This suggests that homozygous cdr2l
mutants for both alleles are likely viable. No obvious morphological abnormalities either within
the ear or in general were observed in either allele by 3dpf (Figure 4.7A-D). When assessed for
otolith number at 2dpf, following the observation that a number of cdr2l morphants had either
single or no otoliths at a similar time point, both alleles showed the majority of embryos (4bp Del;
100%, 31/31 and 5/1bp InDel; 98%, 47/48) to have the expected number of otoliths with a similar
distribution of phenotypes to the AB wild-type controls (100%, 29/29) and well below the 25%
expected for any fully penetrant mutation (Figure 4.7E).
As cdr2l morphants also showed either a reduced anterior to posterior (AP) otic length or greater
variation in this length (Chapter 3), twenty progeny from a heterozygous incross for both alleles
were imaged at 1dpf and their otic AP length measured (Figure 4.7F). Wild-type embryos were
imaged for comparison less than an hour before for 5/1bp InDel progeny and less than an hour
after for 4bp deletion progeny. Interestingly, the embryos from the 4bp deletion incross showed a
significantly smaller AP length when compared to the AB wild-type embryos (119.8µm ± 1.656 vs
131.0µm ± 3.179), although there was no significant di↵erence in variation (F test p=0.7799). For
the 5/1bp InDel incross, embryos also had a smaller mean AP length than their AB counterparts
(118.5µm ± 1.375 vs 120.9µm ± 1.681). However, this reduction was not significant, with the
di↵erence in variation also being non-significant (F test p=0.7742).
To test whether cdr2l mutants displayed any abnormal vestibular response, given the slightly
increased failure rate in the morphants, embryos at 5dpf from a 4bp deletion heterozygote incross
were observed for their response and subsequent ability to balance after tap stimuli. For both the
motor coordination and balance tests the majority of the incross embryos passed, with only 2%
(1/48) failing the motor coordination test and none failing the balance test (Figure 4.8A and B). As
25% of the incross embryos are expected to be homozygous mutants, the low fail rate suggests that
there are no strong vestibular defects in the homozygous mutants. A negative control, where 4bp
deletion incross embryos were anaesthetised in a 1:25 dilution of tricaine was also run alongside.
Within this group, 0% (0/12) passed the motor coordination test and only 25% (4/12) passed the
balance test (data not shown).
cdr2l morphants were also observed to have a significantly higher percentage of non-inflated swim
bladders at 5dpf when compared to the uninjected AB controls. However, in 5dpf larvae from both
a 4bp deletion +/- incross and a 5/1bp InDel +/- incross, the number of larvae with non-inflated
swim bladders (4%, 1/26 and 7%, 6/85 respectively) was not significantly di↵erent to the AB
wild-type controls (11%, 3/28).
74
Figure 4.8: cdr2l 4bp deletion mutants at 5dpf show no obvious vestibular defects and
neither the 4bp deletion or 5/1bp InDel alleles show a significant reduction in swim
bladder inflation
Assessment of (A) motor coordination, (B) balance at 5dpf in progeny from a heterozygous cdr2l 4bp
deletion incross suggest no obvious vestibular defects in the mutants, as less than 25% (expected number
of mutants based on Mendelian inheritance, red dotted line) of embryos failed. Embryos were scored after
observation of response to three, separate tap tests. (C) Swim bladder inflation in progeny from a
heterozygous incross for both cdr2l mutant alleles compared against AB wild-type larvae shows no
significant association between genotype and swim bladder inflation. A two-tailed Fisher’s exact test was
used to separately compare the outcome count data from the wild-types to the 4bp deletion and 5/1bp
indel progeny. N = number of individual larvae tested.
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4.2.8 Cdr2l 4bp deletion mutants show a loss of cdr2l full-length wild-
type transcript by 14-16ss but no up-regulation of the potential
paralogue cdr2a
The homozygous subset of embryos from the 4bp deletion heterozygous incross should have reduced
or no transcription of the full-length wild-type cdr2l transcript due to the presence of the mutant
sequence predicted to encode an early stop in exon 2, which should be lead to the mutant transcript
being degraded via non-sense mediated decay (Jopling, 2014). To determine whether this is the
case, 14-16ss (approximately 16-17hpf) embryos from a 4bp deletion incross were assessed by in
situ hybridisation for expression of the entire 1.39kb wild-type cdr2l transcript. In 38% (23/60)
of embryos, staining for cdr2l was dramatically reduced in all regions in which it is normally ex-
pressed (Figure 4.9B compared to A) and this loss was consistently seen across two independent
experiments. This suggests that in a subset of embryos, likely to be homozygous mutants, the
full-length cdr2l transcript is not present. Based on this, the anterior to posterior (AP) otic length
in nine embryos where cdr2l staining was lost was measured using an ROI bounded to the dorsally
imaged otic vesicle. This was to observe whether in these embryos where expression of the cdr2l
transcript is lost, if there is a reduction in otic AP length consistent with that previously observed
in both the morphants and heterozygous mutant incrosses (Figure 4.9C). The cdr2l 4bp deletion
(presumed homozygous) mutants showed a smaller mean length although this was not significantly
di↵erent when compared to the siblings with strong wild-type cdr2l staining (97.48µm ± 2.522 vs
98.95µm ± 1.297). However, there was a significant di↵erence in the compared variances (F test
p=0.0090, SD = 5.505µm vs 10.70µm). Interestingly, this slight reduction in AP length with a sig-
nificantly higher variation in length is similar to that observed in the cdr2l morphants (Figure 4.2).
A predicted paralogue of Cdr2l is Cdr2a (Ensembl), which shares 75% transcript identity over
26% of the cdr2l transcript with 75% identity over a region spanning exons 1 to 4 (out of 5) (Fig-
ure 4.9D). As it has been suggested that in deletion mutations, functional compensation is more
likely than in knockdowns, such as morphants (Rossi et al., 2015), I wanted to confirm whether ex-
pression of cdr2a, as a potential paralogue of Cdr2l, was up-regulated in the 4bp deletion mutants.
To confirm this an in situ hybridisation for cdr2a was carried out with 16hpf (14ss) progeny from a
4bp deletion heterozygous incross, which showed that cdr2a does not appear to be up-regulated in
the mutant otic vesicle or expressed in the wild-type siblings, as none of the embryos showed any
staining (Figure 4.9E). This is consistent with previous in situ hybridisation results using di↵erent
cdr2a probes, which have shown that cdr2a does not obviously show any strong localised expression
the developing zebrafish.
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Figure 4.9: cdr2l 4bp deletion mutants show a reduction in cdr2l staining, which does not
correlate with a significant di↵erence in otic length or up-regulation of the possible
paralogue, cdr2a
(A-B) Staining for cdr2l in 14-16ss (16–17hpf) embryos from a cdr2l 4bp deletion +/- incross, where 38%
of embryos show a striking reduction in cdr2l staining (B). (C) The otic anterior to posterior length does
not di↵er significantly between embryos showing staining (siblings) and those not (mutants) (t-test
p=0.6100, t=0.5165 df=25.41), although there was a significant di↵erence in variance (F test p=0.0090).
(D) mRNA nucleotide BLAST alignment of the possible paralogue, cdr2a to cdr2l. (E) Staining for cdr2a
in 14ss (16hpf) embryos from a cdr2l 4bp deletion +/- incross where all embryos showed no obvious otic
staining or strengthening of staining. A and B were taken with a 4x (2x mag) objective and E with a 40x
objective using DIC microscopy. Scale bars: A; 200µM and E; 50µM. N= number of individual embryos.
For C, both ears were measured from dorsal images (a total of 18 datapoints).
4.2.9 Otic expression of the positive cell cycle regulator mycb was not
clearly altered in cdr2l mutants
The human protein, Cerebellar Degeneration Related protein 2 (CDR2), has previously been shown
to directly interact with the cell cycle regulator C-MYC through a helix-leucine zipper motif, which
leads to a reduction in C-MYC activity (Bretones et al., 2015; Okano et al., 1999; Fathallah-Shaykh
et al., 1991). Alignment of the human CDR2 (NP 1793.1) peptide sequence to the zebrafish Cdr2
(XP 5169488.1) and Cdr2l (NP 1303823.1) sequences shows that all the leucine residues that form
the helix-leucine zipper motif suggested to interact with c-Myc are conserved in the same position
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in the zebrafish Cdr2l peptide sequence but only the first three are present in the zebrafish Cdr2
sequence (Figure 4.10A). Therefore, as this suggests that zebrafish Cdr2l may be able to interact
with c-Myc, the expression of one of two fish c-Myc paralogues, mycb, was assayed by in situ
hybridisation in 14, 18 and 26hpf wild-type embryos to observe whether mycb is expressed in the
otic tissue at a similar time to cdr2l (Figure 4.10B-D) (Kotkamp et al., 2014).
Figure 4.10: mycb expression does not appear altered by the loss of cdr2l
(A) Alignment of the human CDR2 (residues 109-139) peptide sequence to the zebrafish Cdr2 (residues
109–139) and zebrafish Cdr2l (residues 109–139) peptide sequences shows conservation of a possible helix
leucine zipper motif (in blue) proposed to bind to C–MYC. (B-D) ISH staining for mycb at 14, 18 and
26hpf in wild-type embryos. (E-G) ISH staining for mycb in 19hpf (19–20ss) cdr2l 4bp deletion mutants
(F and G) and their wild-type sibling (E).B was taken with a 4x (2x mag) objective and all other images
with a 40x objective using DIC microscopy. Scale bars: A; 200µM and C/E; 50µM.
Otic expression of mycb RNA appeared strikingly similar to that of cdr2l, appearing broadly
expressed across the otic placode at the early 10ss (14hpf) before being lost in the anterior otic
domain by 18hpf and showing only weak expression within the presumed otic sensory patches by
26hpf (Figure 4.10B-D). Based on this and the conserved helix-leucine zipper motif residues, the
expression of mycb was studied in the 19-20ss (19hpf) o↵spring from a cdr2l 4bp deletion incross
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(Figure 4.10E-G). Within these mycb-stained embryos, 69% (25/36) showed weak otic staining
with the remaining 31% (11/36) showing strong staining within the posterior otic domain similar
to that observed in the AB wild-types. However, when a subset of these embryos were genotyped,
nine from each group, two homozygous mutants were identified in those embryos showing strong
posterior otic staining (11/36) and one identified in the weak group (25/36) (Figure 4.10F and G).
Wild-type siblings also found in both groups, although a higher number showed strong posterior
otic staining (11/36)(Figure 4.10E). This suggests that loss of cdr2l in the 4bp deletion mutants
does not have a clear e↵ect on expression of mycb RNA at this time point.
4.2.10 Expression of neurog1, neurod1 and fsta in the cdr2l mutants
It was also planned to observe expression of neurog1, neurod1 and fsta in the mutants to confirm
the phenotypes previously observed in the morphants. Unfortunately, due to time constraints
this data could not be included within this thesis. However, preliminary data for fsta expression
in embryos from a 4bp deletion +/- incross, suggests the strong up-regulation of fsta within the
medial hindbrain seen in a subset of the morphants is not recapitulated in the mutants. Given
the cdr2l mutants appear homozygous viable, adult homozygous mutants are being identified to
generate greater numbers of homozygous embryos for future work, including conformation of the
previous morphant phenotypes.
4.3 Discussion
This chapter has focused on data investigating the function of Cdr2l during otic development us-
ing two di↵erent approaches, morpholino-mediated knock-down and generation of cdr2l knock-out
mutants using targeted CRISPR mutagenesis.
In cdr2l morphants the expression of markers associated with specifying the anterior and the
ventral otic domains do not appear expanded or altered. However, otic expression of fsta, a BMP
antagonist previously reported as a posterior otic marker, appeared reduced within the morphants
vesicles (Figure 4.2J) (Erickson et al., 2010; Hammond and Whitfield, 2011). Whilst 55% of
morphants also appeared to show an up-regulation of fsta within the hindbrain and mesenchyme
abutting the posterior of the vesicle, a similar striking up-regulation was not observed in the 4bp
deletion mutants (data not shown). Interestingly, such strong expression of fsta within the hind-
brain was not reported in 19 or 30hpf embryos, making it unlikely this is reflecting a developmental
delay in the morphants (Erickson et al., 2010; Hammond and Whitfield, 2011). The role of fsta
within the posterior otic domain is unknown but is likely linked to the expression of bmp7 within
a similar domain at this time (Mowbray et al., 2001). In zebrafish, otic Bmp7a has been suggested
to mediate the positive regulatory e↵ect of Tfap2a on neuronal di↵erentiation within the ventral
domain (Kantarci et al., 2015). Interestingly, a gradient of Bmp7 has also been reported to be
involved in defining the tonotopic axis in the chick basilar papilla in response to Hh signalling,
although this does not appear to be conserved in mice (Mann et al., 2014; Son et al., 2015). There-
fore the slight down-regulation of otic fsta seen in the morphants may reflect a requirement for
Cdr2l in maturation or maintenance of the posterior otic domain rather than its specification. This
is supported by the lack of posterior expansion seen in the expression of hmx2 and otx1b in the
morphants. Given the low numbers and di↵ering phenotypes in the morphants, repeats of this
experiment to gain higher numbers would be ideal both in the morphants and mutants. In the
morphants, observing expression at later time points would also help confirm, in conjunction with
the mutants, whether the up-regulation within the hindbrain is due to developmental delay.
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In the cdr2l morphants I have also identified a possible reduction in the expression of neurog1,
a marker of delaminating otic neuroblasts and neurod1, a marker of subsequent neuronal di↵er-
entiation. These markers were examined at as Fgf signalling has been suggested to positively
regulate the number of emerging otic neuroblasts but negatively regulate otic expression of cdr2l.
Therefore it was hypothesised that loss of cdr2l transcription might lead to changes, possibly an
up-regulation, of the number of delaminating neuroblasts, which should be reflected in the expres-
sion of both markers (Maier and Whitfield, 2014). While the weaker expression of otic neurog1
could reflect a depletion of delaminating neurog1 -positive cells, neurod1 staining appeared reduced
in area and remained grossly normally patterned around the otic vesicle. This reduction in neu-
rod1 staining is contrary to what would be expected if the number of delaminating neuroblasts
had increased in response to a loss of cdr2l. This suggests that Cdr2l and Fgf are unlikely to be
regulating otic neurogenesis in an opposing manner as hypothesised. Another possible explanation
is that Cdr2l may influence this neural otic population by negatively regulating early maturation
of otic cells destined to delaminate. This is supported by the loss of otic cdr2l expression in the an-
terior at 16hpf when neuroblast delamination begins and the lack of co-expression in the extra-otic
domains of neurod1 (Andermann et al., 2002). Whilst the morphants appeared to show altered
expression of fsta and the neurogenic markers, no significant loss of motor coordination or ability
to balance using a well established tap test was observed (Kwak et al., 2006). This was surprising,
especially when considering a proportion of 1nL injected morphants were also observed to have a
reduction in otolith number and indicates that loss of cdr2l likely has no significant impact on the
the vestibular otic response.
Given the possible reduction in posterior otic fsta expression in the morphants, loss of cdr2l may
be a↵ecting the detection of auditory stimuli, thought to be primarily detected by the posterior,
saccular macula (Bang et al., 2002). Therefore it would be interesting to carry out auditory test-
ing on the morphants using a pre-pulse inhibition assay. However, the significant non-inflated
swim bladder phenotype in the cdr2l morphants may confound any testing, as the swim bladder
is thought to play a role in conducting auditory stimuli in otophysi (Popper and Fay, 1973).
Whilst observation of the cdr2l CRISPR mutants confirmed that loss of cdr2l transcription does
not a↵ect motor coordination and balance in larval zebrafish, the reduction in otolith number and
non-inflated swim bladder phenotypes observed was not reproduced. As this did not appear to be
due to the cdr2l paralogue, cdr2a, acting redundantly in this knock-out, it suggests these are likely
to be non-specific consequences of the morpholino injection. Therefore further work to confirm
the neurod1 and fsta morphant phenotypes in the mutants would also be beneficial. Interestingly,
the cdr2l CRISPR mutants do appear to recapitulate the slight reduction in mean AP length and
increased length variability noted in the morphants, which could point towards a role in regulat-
ing proliferation or apoptosis during early otic development as previously mentioned. Expression
of mycb, which has been linked to proliferation in zebrafish, does not appear consistently up or
down-regulated in response to knock-out of cdr2l, despite their possible interaction at the protein
level (Lee et al., 2016). Therefore directly observing the levels of proliferation and apoptosis in
developing otic placode of cdr2l mutants presents a better approach to confirm any changes which
might influence otic AP length. A model with Cdr2l maintaining or reflecting otic proliferation
would also fit with its down-regulation in response to Fgf manipulation, given that Fgf signalling
can drive otic maturation (Hammond and Whitfield, 2011; Maier and Whitfield, 2014).
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4.4 Conclusions
• Cdr2l expression is lost progressively across the otic AP axis during early otic development
in zebrafish.
• Loss of cdr2l function does not appear to result in any consistent otic morphological defects
or inability to detect vestibular stimuli.
• Cdr2l does not appear to regulate anterior otic patterning but may reduce otic expression of
the posterior marker, fsta.
• Loss of cdr2l in morphants results in a reduction in the strength of neurog1 and area of
neurod1 expression. This has yet to be confirmed in cdr2l mutants.
• Mycb is initially broadly expressed across otic AP axis during early otic development but
this is progressively lost from the anterior otic domain and is ultimately lost in the majority
of the otic epithelium by 26hpf.
• The general reduction and variation in otic AP length in both cdr2l morphants and mutants
may indicate a role regulating proliferation within the developing otic placode, despite not
having a clear influence on the expression of the positive cell-cycle regulator mycb.
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Chapter 5
Development of a transcriptomics approach to
identifying di↵erential gene expression associated
with posterior otic identity
5.1 Introduction
The functional and morphological asymmetry of the inner ear is the result of the spatially and tem-
porally dynamic transcription of a myriad of genes during its development (reviewed in (Whitfield
and Hammond, 2007; Bok et al., 2007a)). Identification of these regulators in otic development has
primarily been through reverse-genetic screens or analysis of genes with previously known functions
in development or that are regulated by pathways acting during otic development (Whitfield et al.,
1996a). However over the past decade, a rapid improvement in genome annotation and sequenc-
ing technologies have made it easier and cheaper to identify the majority of the transcriptome.
Such transcriptomic approaches have continued to progress with improvement in next-generation
sequencing techniques such as RNA-Seq seeing their increased use over hybridisation-dependent
microarrays. Whilst currently requiring more intensive analysis, such next-generation techniques
are being increasingly used as they have greater versatility, are not limited by prior annotation and
provide better quantitation of transcript levels (reviewed in (Martin and Wang, 2011)). However,
microarray-based systems are still a well-established tool for comparing di↵erential expression and
have been used to study transcriptional di↵erence in otic tissue to changes in Fgf signalling in chick
and mouse (Oshlack et al., 2010; Yang et al., 2013; Urness et al., 2010).
Whilst in zebrafish the anterior otic expression of a number of genes has been linked with es-
tablishing anterior otic character, an early transcriptional network defining the posterior has not
been identified. Evidence for posterior-specific expression within the early otic placode has been
presented previously in chapters Three and Four, where I described the expression of two novel
markers expressed in the posterior domain during the time period over which AP patterning is
thought to be occurring. The progressive reduction in the propensity of the posterior domain
to adopt an anterior duplicated fate in response to over-expression of fgf3 (discussed in Chapter
Six) also supports a change in the posterior otic tissue. Therefore, using the well-characterised
equipotent nature of the poles of the zebrafish otic placode to adopt either anterior or poste-
rior character, a transcriptomics approach to study di↵erential gene expression in otic tissue after
posterior duplication was investigated, as described in this chapter.
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5.2 Results
For utilising a transcriptomics approach, the first step is to isolate the tissue of interest, in this
case the otic placode. This is of particular importance for the proposed isolation of duplicated otic
tissue after signalling pathway manipulation, given that most tissues surrounding the otic placode
will likely respond to manipulations of Fgf or Hh signalling.
Initially a transgenic cldnb:lynGFP line, which expresses GFP within the ear along with other
sensory placodes, was identified as a potential marker of the otic tissue (Haas and Gilmour, 2006).
It was planned that by GFP labelling the otic tissue in this way, after treatment to induce an
AP duplication the otic cells could be isolated from a dissected tissue sample using fluorescence-
activated cell sorting (FACS) before subsequently being processed for a transcriptomic approach.
Proof-of- principle has already been demonstrated using this transgenic line, for isolating and pro-
filing neuromasts of the posterior lateral line (Gallardo and Behra, 2013).
To test the feasibility of this approach for isolating otic cells,, Tg(cldnb:lynGFP embryos between
14hpf and 16hpf were dissected in Ringer’s solution using transverse cuts to isolate either, the otic
tissue, along with the adjacent hindbrain, the trunk as a negative control, or the head as a positive
control (Figure 5.1A-C, white-dotted outlines). These tissue sections were then dissociated in a
sterile solution of 0.25% porcine trypsin, 1mM EDTA and 10mg/mL proteinase K in PBS with
gentle agitation for 20 minutes before being stopped and washed. After being spun-down follow-
ing the final wash, cells were resuspended in PBS and the number of GFP-positive cells counted
using flow cytometry. This confirmed that it was possible to identify a GFP-positive population
of cells (6%, 759/12552), likely reflecting the otic placodal cells, from the section isolated con-
taining hindbrain and otic vesicle tissue (Figure 5.1C’). This was done using negative and positive
controls to set the gate threshold at which cells are considered GFP-positive (Figure 5.1A’ and B’).
However, expression of otic GFP within the cldnb:lynGFP line is only weakly observable at 14-
16hpf, making it less ideal for isolating otic early during its development. Also, as mentioned
previously, the cldnb:lynGFP line also marks other sensory placodes including the anterior and
lateral line which arise adjacently to the otic placode within the posterior placodal area (PPA)
(Ladher et al., 2010). Therefore it is likely that the GFP cells from the hindbrain sections isolated
would represent a heterogeneous population of placodal fates.
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Figure 5.1: Isolation and counting of GFP positive otic cells from Tg(cldnb:lynGFP)
embryos
(A–A’) Sections of mostly GFP negative trunk tissue were used as a negative control. Flow cytometry
confirmed a low count of GFP+ cells (R2 1.8%, 63/3507). (B–B’) Head sections containing a large GFP
positive population within the optic placode were used as a positive control. This was reflected in a high
count of GFP+ cells (R2 26%, 822/3174). (C–C’) The otic tissue was isolated as a section of hindbrain
and a small population of GFP+ cells were identified based on thresholds set by the negative and
positive controls (R2 6%, 759/12552). For the count plots; x axis = FITC intensity and y axis = cell
count. White-dotted outline represent sections used. A–C were taken at a 30x zoom using epifluorescent
imaging. N= number of pooled embryos used for each count.
To address the issue of otic specificity, other promoters with strong, early otic expression were
examined. DeLaurier et al, 2010 utilised a BAC (CH73-243G6) containing the genomic sp7 se-
quence to drive eGFP expression within the otic placode from 6ss (12hpf) onwards with no other
obvious expression in other tissues, even by 24hpf (Figure 5.2B) (DeLaurier et al., 2010). Whilst
duplicating the AP axis by perturbing Fgf and Hh signalling may identify responses to these treat-
ments, some transcriptional di↵erences present along the AP axis during normal development may
be lost. Therefore, by using the otic specific sp7 promoter to drive the photo-convertible protein,
Kaede, it was hoped that the posteromedial otic cells from untreated embryos could be labelled
in this way and isolated using FACS, an approach previously used (Figure 5.2A) (Brown et al.,
2008). These isolated cells could then be used to characterise the early transcriptional state that
under wild-type conditions results in posterior otic identity.
A construct with Kaede being driven by the sp7 promoter, flanked by Tol2 insertion sites was gen-
erated through recombineering, with the kaede coding sequence inserted into the sp7 -containing
BAC at the same location used by DeLaurier et al, 2010 to ensure a similar expression profile.
This construct was then injected into AB wild-type embryos with transposase, which facilitates
genomic insertion (Suster et al., 2009). A stable F1 Tg(sp7:kaede) line was raised, which dis-
played the expected otic specific expression of Kaede and this was confirmed to be responsive to
photo-conversion (Figure 5.2C).
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Figure 5.2: Targeted isolation of cells from the posterior otic domain using
photo-conversion
(A) Schematic outline of the proposed approach for labelling and isolating cells from the posterior otic
domain. (B) In situ staining for sp7 shows otic specific expression at 16 and 19hpf. (C) The F1
generation of Tg(sp7:kaede) showed strong expression of kaede within the otic vesicle at 24hpf, which also
appeared photoconvertible (red). Expression of the crya:venus selection marker can also be seen in the
lens (blue). (D) Trial photo-conversion of the anterior otic domain at >18hpf using 39 seconds of
exposure with a 403nm   laser at 50.69%. Images in B were taken using 7x magnification and brightfield.
To test whether specific regions of the otic vesicle could be photo-converted, Tg(sp7:kaede)
embryos were mounted, dorsal side down, in 1% low-melting point agarose before being photo-
converted. Given the small size of the domain to be photo-converted, photoconversion was per-
formed on a confocal microscope with a 40x objective. Photo-conversion of the anterior otic
domain in 18hpf embryos was successfully achieved using three pulses of 403 nm laser for 13 sec-
onds (Figure 5.2D). Therefore using the same method, the anterior halves of both otic placodes
were photo-converted in 15hpf Tg(sp7:kaede) embryos.
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After photo-conversion, these Tg(sp7:kaede) embryos were dissociated as previously described and
analysed by flow cytometry, with a non-transgenic negative control and unconverted sample run
alongside (Figure 5.3).
In both the unconverted and anterior photo-converted samples, no clear green (y-axis) or red
(x-axis) population of cells were present but a population of cells between the two was apparent
(Figure 5.3B and C). In the photo-converted sample the proportion of this population of cells was
greater at 0.08% compared to 0.03% in the unconverted. As Kaede is still being produced within
the otic placode of these embryos, even after photo-conversion this might represent a mixture of
both unconverted and converted Kaede.
Figure 5.3: Isolation and counting of photo-converted Kaede positive otic cells from
Tg(sp7:kaede) embryos
(A) Cells from dissociated wild-type embryos were used as a negative control. Flow cytometry confirmed
a low count of kaede+ cells (R3 1x10-4%). (B) Plot of cells from dissociated, unconverted Tg(sp7:kaede)
embryos show a population of positive cells both green and red (R3 3x10-4%). (C) Plot of cells from
dissociated Tg(sp7:kaede) embryos where the anterior otic domain has been photo-converted. These show
an increase in the population of positive cells both green and red (R3 8x10-4%). Black dotted box outline
a zoom of the corresponding R3 region. For the plots; x axis = red (PE) (converted) intensity and y axis
= green (FITC) (unconverted) intensity. N= number of pooled embryos used for each count.
The next stage was to test whether this transgenic line could be used to isolate otic cells using
FACS with the view of confirming that the Kaede-positive cells isolated expressed otic markers.
This test would also give an indication of the potential yield of positive cells after sorting. For
this, 18hpf unconverted Tg(sp7:kaede) embryos were used with Kaede RNA-injected embryos and
uninjected embryos run as positive and negative controls respectively (Figure 5.4).
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A di↵erent protocol from before was used to dissociate the embryos in an attempt to reduce the
time taken to dissociate the cells and improve the purity of the collected cells, based on previously
published protocols and personal discussion with Dr S Baxendale. Briefly, after removing the ma-
jority of the yolk in sterile ca2+-free Ringer’s solution, embryos were dissociated in a 1.75mg/ml
solution of collagenase/dispase (Roche), which has been suggested to be quicker and less damaging
than trypsin, with gentle agitation (Lawson Lab (http://lawsonlab.umassmed.edu) and personal
discussion with Dr S Baxendale). This dissociation generally took around 40 minutes with the cells
then being washed in room temperature, sterile PBS. After being spun-down following the final
wash, cells were resuspended in Hank’s Bu↵ered Saline Solution (HBSS - a pH and osmotically
balanced solution) to increase their chances of survival.
The negative and positive control suspensions were used to set the gate intensity thresholds for
unconverted Kaede-positive cells prior to sorting. Using this threshold a much smaller population
of unconverted Tg(sp7:kaede) cells (4.2x10-4%, 90/211,723) (Figure 5.4C and C’) were identified
compared to the Kaede RNA injected positive control population (34%, 8,854/25,602) (Figure 5.4B
and B’).
This smaller population might be due to the fluorescent signal in the Tg(sp7:kaede) sample being
weaker, as the population of cells just below the threshold (bracket population) appears larger than
in the wild-type negative control (Figure 5.4A’ compared to C’). However, given that there is over-
lap, lowering the selection gate to collect these cells would also potentially collect non-labelled cells.
The Tg(sp7:kaede) photo-conversion approach was initially followed due to the greater specificity
of the promoter and the ability to target regions of the otic placode. However, given the small
population of positive cells collected, possibly resulting from weak fluorescence, it was decided that
this approach was not viable to produce the yield of cells needed for the required amount of RNA.
Due to time constraints and other lines of experimental work, the planned transcriptomics assay

















































































































































































































































































































































































































































In this chapter, I have explored approaches for isolating early otic tissue by FACS. This aim of
this was to ultimately identify di↵erential gene expression that may reflect regulation of anterior or
posterior otic identity using transcriptomics. One of the key issues encountered was that of speci-
ficity, both in isolating just the otic tissue and going one step further, potentially isolating only the
posterior otic tissue. In regards to the first of these, the sp7 promoter certainly appeared to give
better and earlier otic-specific expression than seen with the Tg(cldnb:lynGFP) line. Therefore the
sp7 promoter could be used to drive expression of a brighter fluorescent protein such as eGFP or
mCitrine (Shaner et al., 2005). Whilst this would help isolate the early otic tissue, it would rely
on perturbing the tissue with modulators of Hh or Fgf signalling to duplicate the otic tissue. This
might be informative as ultimately this can give rise to ears with duplication across the AP axis
in zebrafish. However, it may also be a less accurate representation of the patterning events that
occur during normal otic development, discussed further in Chapter 7. Another issue with this
approach is it still relies on FACS and the necessary dissociation step prior to this. Although the
trialled approach did not appear to result in any high levels of cell death (Supplementary Figure
8.), it is conceivable that in the time between the initial dissociation and collecting the cells that
transcriptional changes may have occurred.
The second issue was that of isolating tissue with regional specificity across the otic AP axis.
As the otic placode is highly segregated into domains of varying gene expression, morphology and
function an approach where the region of otic tissue could be decided seemed ideal. This would
also allow isolation of the anterior and posterior medial otic domains under normal developmental
conditions, which could then be compared. Unfortunately using the sp7 promoter to drive otic
expression of the photo-convertible protein Kaede did not work. This was due to the endogenous
Kaede signal being too weak to identify the otic population clearly, let alone a smaller posterior
subset. The use of Kaede RNA injection may be an alternative to this, as despite not being lo-
calised to the otic epithelium it is stronger in intensity and gives a clear population as shown in
Figure 5.4 and previously reported (Brown et al., 2008). It would also ensure that labelled cells
do not continue to produce new, unconverted Kaede, which may dilute the converted signal.
Another approach to gain information about spatial resolution of transcripts across the AP axis
from whole otic isolates would be to screen any di↵erentially expressed genes by in situ hybridisa-
tion. This would constitute a validation following any transcriptomics assay and could be done in
a relatively high-throughput method. Another, more elegant approach to this would also be to use
RNA tomography. This uses RNA isolated from serial sections of tissue, which is then uniquely
labelled and subsequently analysed by RNA-seq. This allows a map of the transcriptome across
the sections and ultimately the tissue to be built up (Junker et al., 2014).
An issue not addressed in this chapter is that of the time point at which the otic tissue would
be isolated. The spatial localisation of expression across the AP otic axis is crucial in assigning
anterior and most likely posterior identity to the otic placode. However, this dynamic localisation
of otic expression occurs over a time period, reflecting di↵ering interactions and regulatory rela-
tionships. Therefore the characterisation of these as presented in the next chapter (Chapter Six)




Integration of Fgf and Hh signalling across the
early otic placode
6.1 Introduction
The patterning and development of the vertebrate inner ear is known to be dependent on a num-
ber of signalling pathways, including those of BMP, Wnt, Retinoic Acid (RA), Hedgehog (Hh) and
Fibroblast growth factor (Fgf) signalling (reviewed by (Bok et al., 2007a; Whitfield, 2015)). The
integration of these signals, both directly and indirectly, regulates expression of otic genes with
di↵ering temporal and spatial dynamics producing a structure with asymmetry around all three
axes. Whilst di↵erences in the otic morphology are seen between vertebrate models, particularly
in the auditory sensory organs, the overall structure of the inner ear is remarkably conserved.
Similarly, despite the regulatory activity and function of a number of signalling ligands and otic
genes di↵ering between vertebrates during early otic morphogenesis, a number show conservation
in their function and localisation. The Shh and Fgf signalling pathways exemplify this, as during
otic development in zebrafish they are crucial for defining anterior-posterior otic identity, with Hh
also being required for dorsoventral patterning. However, in chick and mouse otic development,
Shh and Fgf signalling are primarily thought to pattern the early dorsoventral axis with RA being
responsible for regulating the anterior-posterior axis (Bok et al., 2005; Brown and Epstein, 2011;
Hatch et al., 2007; Hammond et al., 2010; Hammond and Whitfield, 2011; Freter et al., 2008; Ohta
et al., 2016; Bok et al., 2011; Cadot et al., 2012). However, despite this di↵erence, regulation by
Hh and Fgf signalling of a number of genes required for patterning the otic tissue, albeit with
di↵erences in their function, do show some comparability between these vertebrate models (see
Sections 1.4 and 1.5) .
The importance of the interaction between such extra-otic signals and the otic tissue during de-
velopment is highlighted by the ability of the otic tissue in zebrafish, amphibians and chick to
duplicate either the anterior or posterior otic structures in response to alterations in the signalling
environment (Bok et al., 2011; Hammond and Whitfield, 2011; Waldman et al., 2007). In zebrafish,
duplications of the anterior or posterior otic domains are easily achieved through perturbation of
Hh or Fgf signalling, respectively and as such makes this an ideal system for understanding the
regulatory dynamics occurring with the zebrafish otic placode that ultimately lead to asymmetry
along the anterior-posterior axis. Whilst a number of genes that show di↵erential expression after
changes in Hh or Fgf signalling have been identified and their requirement in patterning of the
otic tissue studied, the way in which these are regulated both in time and by both Hh and Fgf
signalling, acting independently of each other is not clearly understood (Hammond and Whitfield,
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2011). Another important feature identified for defining the response of the otic tissue to the sig-
nalling environment acting on the developing otic tissue is the competence of the tissue to respond.
In zebrafish and chick, a time-window over which the anterior-posterior axis in particular is sensi-
tive to perturbations in signalling has been reported and the role of Fgf, Hh and RA signalling in
the induction, specification and maturation of the otic tissue in all three of these model organisms
emphasises the need for such regionalised changes in response (Bok et al., 2011; Hammond and
Whitfield, 2011; Whitfield, 2015).
In this chapter, I firstly discuss the di↵ering timings seen in the onset of expression in the posterior
otic domain of genes associated with anterior identity in response to two approaches, loss of Hh
signalling and over-expression of fgf3, known to duplicate anterior otic morphology as I look to
identify the earliest otic determinant of anterior identity and how Fgf and Hh signalling integrate
to regulate this. Secondly, I ask how certain otic regions display competence to initiate but not
maintain expression of anterior otic genes in response to over-expression of fgf3 and how this itself
appears to be transient. Finally, given the role of RA in patterning the anterior-posterior axis
of sensory otic tissue in amniotes, I present preliminary data suggesting that any e↵ect on the
anterior-posterior identity of sensory tissue in zebrafish is limited, both in conjunction with Hh
signalling and alone.
6.2 Results
6.2.1 Posterior otic morphology is lost in embryos treated with 100µM
cyclopamine (CyA) between 14-15 and 22.5hpf
Treatment of embryos with 50 and 90µM of the Hh signalling inhibitor, CyA, prior to 15ss have been
shown by separate groups to phenocopy the duplication of anterior otic identity seen in the severe
Hh loss-of-function mutations in dispatched1 (previously chameleon, disp1tf18b) and smoothened
(smob641) (Hammond et al., 2003, 2010; Sapède and Pujades, 2010). Given Hh’s requirement for
a number of developmental processes, inhibition of Hh signalling with CyA within a treatment
time-window provides the advantage of reducing non-otic developmental e↵ects.
Embryos treated with 50µM of CyA as previously used by Hammond et al, 2010, maintained
expression of the Hh signalling readout marker ptch2 albeit at a lower level (data not shown).
Therefore, to ensure a strong response, embryos were treated with a higher dose at 100µM from
14-15hpf to 22.5hpf with embryos being washed, twice, following treatment and allowed to develop
onwards to 3dpf (75hpf) (Figure 6.1G). This treatment consistently resulted (42/47 of treated
embryos, 89%) in a lateral positioning of the posterior macula, as seen in the live images from
the positioning of the posterior otolith (Figures 6.1C and C’), relative to that in the untreated
and vehicle controls (Figures 6.1A and B, respectively). However, this lateral positioning of the
posterior macula occurred with varying distance between the anterior and posterior otoliths, as
shown by Figures 6.1C and C’.
To visualise the actin-rich stereociliary bundles of the otic sensory patches, including the mac-
ula underlying the otoliths, embryos were stained within FITC-conjugated phalloidin (Figures
6.1D-F’). In the CyA-treated embryos this clearly shows a loss of the stereotypical shape of the
posterior macula sterociliary bundles (Figures 6.1F) when compared to the untreated (Figures
6.1A, D) and vehicle controls (Figures 6.1B). In the CyA-treated, phalloidin-stained embryos a
supernumerary crista was also observed adjacent to the lateral crista in 3/6 (50%) of the embryos
imaged (Figure 6.1F’), which has previously been reported in severe Hh loss-of-function mutants
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but not in CyA-treated embryos (Hammond et al., 2003). In the untreated and vehicle controls,
such supernumerary cristae were not seen.
This phenotype seen in the 100µM CyA-treated embryos, alongside the altered position and shape
of the posterior macula, suggests this treatment between 14-15hpf to 22.5hpf is su cient to re-
sult in a loss of posterior otic identity with the posterior macula resembling a duplicated anterior
macula. This treatment appears have little impact on the other structures of the ear, as shown by
the largely correct positioning and formation of the semicircular canals. However, treatment with
90µM CyA over a longer time period has been reported in zebrafish to lead to a reduction of hair
cells within the posterior macula but this was not looked at in this study (Sapède and Pujades,
2010).
Figure 6.1: Inhibition of Hh signalling between 14/15 and 22/23 hpf results in a
duplication of anterior otic morphology
(A–C’) Images of live embryos at 3dpf. Treatment with cyclopamine (CyA) between 14/15 and 22/23hpf
results in a laterally positioned, smaller posterior otolith resembling the anterior otolith (C–C’) compared
to the untreated (A) and vehicle controls (B). (D–F) Actin staining of the stereociliary bundles of the otic
sensory patches highlights the lateral position of the posterior macula underlying the posterior otolith in
CyA-treated embryos and the similarity in gross morphology to the anterior macula. (D’–F’) Imaging of
the cristae highlights that in 3/6 imaged embryos there is a supernumerary crista (yellow asterisks). (G)
Schematic of CyA treatment. All images are lateral views. A-C’ were taken using bright field with a 20x
objective. D-F’ were taken using confocal microscopy with a 40x oil objective. Scale bars: 50µM.
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6.2.2 Inhibition of Hh signalling between 14-15 and 22.5hpf leads to de-
layed ectopic posterior otic expression of the anterior otic factors
fgf3, fgf8a and pax5
As the treatment of embryos with 100µM from 14-15hpf to 22.5hpf appears su cient to result
in a loss of posterior otic identity and duplication of anterior macula morphology (Figure 6.1), I
wanted to ask whether this resulted in a concomitant duplication of genes associated with anterior
otic identity immediately after treatment, at 22.5hpf. While it has previously been shown that in
the severe Hh loss-of-function mutants, disp1tf18b and smob641 at 24hpf, the anterior factors fgf8a
and pax5 do not show ectopic posterior otic expression (Hammond et al., 2003), the expression of
anterior otic factors has not been studied after transient loss of Hh signalling.
Wild-type embryos were treated under the same conditions as used in section 6.1, to produce
a loss of posterior and duplication of anterior otic identity with 100µM of CyA applied between
14-15hpf to 22.5hpf, before embryos were fixed and assayed by in-situ hybridisation (Figure 6.2K).
After treatment with CyA the anterior markers fgf3, fgf8a and pax5 (Figure 6.2B, D and H, re-
spectively) show no ectopic posterior otic expression or expansion of their anterior otic expression
domains at 22.5hpf,. Interestingly, fgf10a staining was observed to be slightly strengthened in
the anterior of the otic vesicle and also along the medial edge (Figure 6.2F). To confirm that the
100µM CyA treatment was reducing Hh signalling, in-situ hybridisation for ptch2 was used. As a
downstream negative regulator of Hh signalling, ptch2 expression is dependent on levels Hh sig-
nalling (Lewis et al., 1999) and in treated embryos, ptch2 staining is clearly reduced, although not
lost completely (Figure 5.2J) when compared to the vehicle control (Figure 6.2I).
When fgf3 is over-expressed under a heat-shock promoter, this results in a loss of of posterior
otic identity and duplication of anterior identity similar to that seen under loss of Hh conditions
(Hammond et al., 2010; Hammond and Whitfield, 2011). Under these conditions, the anterior
markers pax5 and hmx2 show expanded expression across the medial otic edge and into the poste-
rior otic domain by 24hpf (Hammond and Whitfield, 2011). This suggests expanded or duplicated
expression of anterior factors is likely required for the duplication of the anterior otic morphology
seen and is further supported by the requirement of these factors for normal anterior otic identity
both in zebrafish and other vertebrates (Feng and Xu, 2010; Kwak et al., 2006; Léger and Brand,
2002). Whilst no posterior duplicated expression of these anterior factors was observed either after
transient inhibition of Hh signalling (Figure 6.2) or in the Hh loss-of-function mutants (Hammond
et al., 2003), it had not been confirmed whether this represents a lack of a similar duplication of
anterior factors in the posterior otic domain or a delayed onset of expression after 24hpf. There-
fore treatment with 100µM of CyA, as used previously, was repeated but with the embryos being
washed following treatment and then allowed to develop on until either 36 or 48hpf (Figure 6.3O).
In treated embryos fixed at 36hpf, expression of the strong otic anteriorising signalling factors,
fgf3 (Figure 6.3C-D’, white asterisk in C’ and D’). and fgf8a (Figure 6.3H and I), show expression
within the posterior otic domain, not seen in the vehicle controls (Figure 6.3A-B’ and E-F, respec-
tively). These posterior domains of expression appear smaller in area than the domains of anterior
otic expression, with fgf3 staining appearing weaker than that of fgf8a. This could suggest fgf8a
is more readily expressed within the posterior otic domain as fgf8a is also transiently expressed
within the posterior otic domain at around 24hpf under normal development (Figure 6.2), also
(Léger and Brand, 2002).
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Expression of pax5, which is required for maintenance of anterior otic identity in zebrafish
(Kwak et al., 2006), also appears to be duplicated within the posterior otic domain by 36hpf in
9/15 (60%) treated embryos (Figure 6.3M and N).
By 48hpf, under DIC microscopy it is also observable that the medial pseudo-stratified, thick-
ened epithelium of the saccular (posterior) macula seen in the vehicle controls (Figure 6.3G, white
arrow) is lost in 100µM CyA-treated embryos (Figure 6.3J, white arrow).
Figure 6.2: Inhibition of Hh signalling between 14/15 and 22/23 hpf does not lead to
immediate expression of anterior factors within the posterior domain
(A–D”) Expression of the anteriorising factors, fgf3 and fgf8a is neither duplicated or strengthened in the
posterior domain at 22/23hpf after treatment with 100µM CyA. (E–F’) Expression of fgf10a appears
slightly stronger along the medial edge and in the posterior otic domain in 17/29 embryos treated with
CyA. (G–H’) Expression of pax5 does not show any clear posterior expansion along the medial edge or
expression within the posterior otic domain. (I-J) Treatment with 100µM CyA shows a clear reduction in
ptch2, a downstream target and negative regulator of Hh, in all treated embryos (J, 29/29). (K)
Schematic of CyA treatment. A-J are lateral views and A’–H’ are dorsal views with the anterior to the
left in all images. A-H’ were taken using DIC microscopy with a 40x objective. Scale bars: 50µM.
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Figure 6.3: Inhibition of Hh signalling between 14/15 and 22/23 hpf does lead to
expression of anterior factors within the posterior domain by 36hpf
(A–D’) Expression of fgf3 in vehicle control and treated embryos at 36hpf as shown by in-situ, imaged
using both DIC (A–D) and fluorescent imaging (A’–D’) to emphasise posterior staining in treated
embryos (white asterisks). (E–J) Fgf8a expression is strongly duplicated by 36hpf in treated embryos
(H–J) and at 48hpf treated embryos show a clear loss of the normal posterior macula morphology seen in
the vehicle controls (white arrows). (K–N) Expression of pax5 was also duplicated in the majority of
treated embryos by 36hpf. (O) Schematic of CyA treatment. B/B’, D/D’, F, I, L N are lateral views
with all others being dorsal. Anterior is to the left in all images. A’–D’ were taken using epifluorescence
microscopy with a 40x objective with the remain images being taken using DIC microscopy with a 40x
objective. All scale bars except G: 50µM, G: 20µM.
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These results suggest that the changes occurring prior to 22.5hpf in CyA-treated embryos, are
su cient to lead to the loss of posterior otic identity with a delayed duplication of fgf3, fgf8a and
pax5 and morphological changes observable by 48hpf.
6.2.3 Inhibition of Hh signalling between 14-15 and 22.5hpf directly
results in a medial expansion of the early anterior otic factors
hmx2 and hmx3a by 22.5hpf
Despite loss of Hh signalling between 14 and 22.5hpf not resulting in the immediate induction of ec-
topic posterior expression of a number of anterior otic factors (section 6.2), in Hh loss-of-signalling
mutants hmx3a (previously nkx5.1 ) has been previously shown to have a ventral expansion of
expression into the posterior otic domain by 30hpf (Hammond et al., 2003). Given this and that
hmx3a is the earliest know marker of the anterior otic domain in zebrafish, embryos were again
treated with 100µM CyA from 14hpf to 22.5hpf, being immediately fixed after treatment to assess
whether, unlike the other anterior otic markers, hmx2 and hmx3a would show ectopic posterior otic
expression by this time point (Feng and Xu, 2010). In the treated embryos, in-situ hybridisation
for both hmx2 (25/28) and hmx3a (25/25) showed expanded staining along the ventral edge of the
otic vesicle (Figure 6.4B, B’ and D, D’) relative to the vehicle controls (Figure 6.4A, A’ and C,
C’). This expansion appeared stronger in 13/25 embryos for hmx2 and 17/25 for hmx3a.
To confirm whether this expansion was significant over multiple treated embryos the length of
staining along the medial otic edge was measured for both hmx2 and hmx3a stained embryos. The
medial edge was defined by placing a line at 66% of the overall width of a Region Of Interest
(ROI) that bounded dorsally imaged otic vesicles. The length of staining was then measured from
the anterior-most point of this line, along the medial edge, to the posterior-most point of stain-
ing. This measure was then continued to the posterior-most point along the medial line and the
staining length was then reported as a percentage of this overall medial length (Figure 6.4G) to
account for any di↵erences in otic size and was repeated for both ears. Over the embryos imaged
(n=8 vehicle controls; 10 treated for hmx2 and n=8 vehicle controls; 9 treated for hmx3a), both
hmx2 and hmx3a show a highly significant increase in the percentage length of staining in the
100µM CyA-treated embryos compared to the vehicle controls (Figure 6.4C and F, respectively).
Although hmx3a showed a greater di↵erence in the mean percentage length between the treated
and vehicle controls with a di↵erence of 18.94% vs 9.87% for hmx2.
As expression of hmx2 and hmx3a has been show to be dependent on FGF signalling in ze-
brafish (Feng and Xu, 2010; Hammond and Whitfield, 2011) the expression of etv4 (previously,
pea3 ), a well established transcriptional readout of FGF-signalling (Raible and Brand, 2001) was
assayed by in-situ hybridisation in embryos treated with 100µM CyA and vehicle controls. No
obvious di↵erence in etv4 staining was observed in the treated embryos (Figure 6.4I and I’), either
across the whole otic vesicle or the medial edge where hmx2 and 3a show expansion under these
conditions when compared to the vehicle controls (Figure 5.4H and H’). This suggests that the
expanded staining seen for hmx2 and hmx3a in 100µM CyA-treated embryos is unlikely due to an
up-regulation of FGF signalling in response to reduced Hh signalling. This is supported by data
from (Hammond and Whitfield, 2011), where in-situ staining for etv4 showed no change in either
loss of Hh (smob577–/–) or aberrant Hh signalling (ptc1–/–; ptc2–/–) transgenic backgrounds.
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Figure 6.4: Inhibition of Hh signalling between 14/15 and 22/23 hpf leads to a posterior
expansion of hmx2 and hmx3a expression
Expression in vehicle control and 100µM CyA-treated embryos at 22.5hpf as shown by in-situ
hybridisation. (A–B’) Expression of hmx2 is expanded medially in treated embryos (C) Quantification of
hmx2 medial expression as a percentage of the overall medial anterior-posterior otic length shows a
significant increase in the length of medial staining in treated embryos versus the vehicle controls (t-test
on log-transformed data p=0.0001, t=4.360 df=30.69). (D–E’) Expression of hmx3a in treated embryos
shows a more dramatic expansion along the medial otic domain. (F) Quantification of hmx3a medial
expression shows a significant increase in the length of medial staining in treated embryos versus the
vehicle controls (t-test p=<0.0001, t=5.504 df=31.98). (H–I’) Expression of the Fgf transcriptional
target, etv4, within the otic vesicle is unaltered in treated embryos. (G) Diagram of method used for
quantification of staining. N= number of individual embryos. For C and F, both ears were measured
from dorsal images. A–I are dorsal views with A’–I’ being lateral views focused on the medial otic wall.
Anterior is to the left in all images. All images were taken using DIC microscopy with a 40x objective.
Scale bars: 50µM. N= number of individual embryos.
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In the 100µM CyA-treated embryos it was observed that when the anterior to posterior length
of the otic vesicle was measured using a bounding ROI the means of treated embryos for both
hmx2 and hmx3a in-situ hybridisations were smaller, although only significantly for those stained
for hmx2, than the vehicle controls. Therefore to ensure the changes in otic expression of both
hmx2 and hmx3a were a consequence of altered Hh signalling rather than the otic tissue being
smaller, the expression of hmx2 and hmx3a was also studied in the strong Hh loss-of-signalling
mutants, smohi1640–/–. Rather than being a point mutation such as the smob641 and smob577
alleles previously used in our lab (Hammond et al., 2003; Hammond and Whitfield, 2011), the
smohi1640 allele has a 6 kb proviral insertion within the first exon (Chen et al., 2001) and has been
suggested to be a stronger loss-of-function smoothened mutation (personal communication with
Drs S Elsworthy and R Wilkinson). As the otic phenotype in smohi1640–/– mutants has not been
described, homozygous mutants were morphologically identified and grown up alongside siblings
to 3dpf at which point they were imaged (Figure 6.5A-B’).
In the identified smohi1640–/– embryos, the predominant (61%, 17/28) otic phenotype was that
of a smaller ear with two otoliths positioned next to one another on the ventral otic surface (Fig-
ure 6.5B’) with the pillars either forming incorrectly or not at all, which resembles the phenotype
seen in smob641 mutants (Hammond et al., 2003). The other 39% of identified smohi1640–/– ap-
peared to have a slightly milder phenotype with the otoliths still being positioned ventrally but
spaced further apart and the ventral pillar also appearing more developed (Figure 6.5B), similar
to the phenotypes reported for disp1tf18b mutants and previously seen in 100µM CyA-treated em-
bryos (Figure 6.1) (Hammond et al., 2003).
In the identified smohi1640–/– embryos fixed and stained with phalloidin (Figure 6.5C-D’), the sac-
cular macula is clearly ventrally positioned abutting the anterior utricular macula (Figure 6.5D)
unlike in the siblings (Figure 6.5C). In the phalloidin-stained smohi1640–/– embryos, we also ob-
served a supernumerary lateral crista (Figure 6.5D’, white asterisks) in 100% (8/8) of those imaged
whereas this phenotype was not observed in any of the siblings imaged (6/6). Interestingly, despite
showing phenotypic similarities to both disp1tf18b and smob641 mutants, the penetrance of this phe-
notype appears much higher in smohi1640–/– embryos than previously observed in the disp1tf18b and
smob641 mutants (reported at 31% and 51%, respectively) (Hammond et al., 2003).
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Figure 6.5: smuhi1640 homozygous embryos show a strong duplication of anterior
morphology at 3dpf
(A–B’) Live images of siblings and smuhi1640 mutants at 3dpf, showing a strong anterior duplication
phenotype in the mutants (B–B’). (C–D’) Phalloidin staining of the actin-rich stereociliary hair cells of
the otic sensory patches. The posterior macula in the mutants (D) clearly shows a loss of the
medially-located stereotypical fan morphology associated with posterior identity when compared to the
siblings (C). Lateral views focusing on the cristae (C’–D’) show a highly-penetrant supernumerary lateral
crista phenotype. All images are lateral views with anterior to the left. A-B’ were taken using brightfield
microscopy with a 20x objective. C-D’ were taken using confocal microscopy with a 40x oil objective.
Scale bars: A; 50µM, C&C’; 25µM.
In smohi1640–/– mutants and their siblings at 22.5hpf the expression of hmx2 and hmx3a was
then assayed using in-situ hybridisation. As seen in the 100µM CyA-treated embryos, staining
for both hmx2 and hmx3a appeared expanded along the ventromedial otic edge compared to the
siblings (Figure 6.6B, B’ and E, E’, respectively). This was quantified using the same methodology
as used in Figure 6.4 and confirmed the expansion in staining between the identified mutants and
their respective siblings to be highly significant (Figure 6.6C and F), with a di↵erence in mean
percentage anterior-posterior length of 28% for hmx2 and 22% for hmx3a.
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Figure 6.6: smuhi1640 homozygous embryos show a posterior expansion of hmx2 and hmx3a
at 22/23hpf
Expression in smuhi1640 mutants and their wild-type siblings at 22.5hpf as shown by in-situ. (A–B’)
Expression of hmx2 is expanded medially in smuhi1640 mutants when compared to the siblings. (C) The
expansion of hmx2 staining in smuhi1640 mutants is a significant increase in the length of medial staining
when compared to the siblings (t-test p=< 0.0001, t=5.504 df=31.98). (D–E’) Expression of hmx3a is
also expanded medially in mutant embryos relative to the siblings. (F) This expansion of hmx3a staining
in the mutants is significant when compared to the length of medial hmx3a staining in the siblings (t-test
p=<0.0001, t=6.069 df=20.25). N= number of individual embryos. For C and F, both ears were
measured from dorsal images (a total of 16 datapoints). A–E are dorsal views with A’–E’ being lateral
views focused on the medial otic wall. Anterior is to the left in all images. All images were taken using
DIC microscopy with a 40x objective. Scale bars: 50µM. N= number of individual embryos.
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6.2.4 The ventromedial expansion of hmx2 and hmx3a expression after
inhibition of Hh signalling between 14-15 and 22.5hpf persists at
36hpf
After treatment with CyA the other anterior markers, fgf3, fgf8a and pax5 showed a clearly de-
fined ectopic duplication of expression within the posterior domain by 36hpf (Figure 6.3). It was of
therefore of interest to see whether the broad ventromedial domain of hmx3a expression observed
by 22.5hpf (Figure 6.5) would later refine into two separate patches of expression at the anterior
and posterior. Embryos were therefore treated with 100µM CyA between 14-15 and 22.5hpf, reca-
pitulating the treatments used in Figures 6.3 but were grown on to 36hpf before being fixed.
To observe the otic expression of hmx3a in relation to the nascent utricular and saccular sen-
sory domains, a double in-situ hybridisation was carried out with hmx3a (in red) and atoh1a, to
mark developing otic sensory patches (in blue) (Figure 5.7) (Millimaki et al., 2007). In 100µM
CyA-treated embryos, there is clear hmx3a staining across the entire otic ventral floor (Figure
6.7D-F’) with expression persisting within the posterior otic domain (Figure 6.7E’, white arrow)
not seen in the vehicle controls (Figure 6.7A-C’). To observe whether this expansion was consis-
tent across a sample (n=6) of the experimental population, the percentage of the posterior domain
defined as the distance from the posterior of the anterior sensory domain marked by atoh1a to
the most posterior point within the lumen with hmx3a staining was measured (Figure 5.7H) for
both ears. This confirmed that the treated embryos showed a consistent significant expansion
across almost the entire (treated mean; 96.55% ±1.114 vs vehicle control mean; 24.93% ±1.660)
posterior domain when compared to the vehicle controls (Figure 6.7G). In the treated embryos,
the anterior domain of atoh1a staining did not appear expanded compared to the vehicle controls
and the posteromedial domain of atoh1a staining appears weakly in a more posterolateral position
when compared to the vehicle controls (Figure 6.7D, F compared to A, C - white arrow).
In treated embryos, hmx3a staining also appears to be expanded medially (Figure 6.7F and F’)
relative to staining in the vehicle controls (Figure 6.7C and C’). Given the transient nature of
the CyA inhibition of Hh signalling, this result suggests that loss of Hh signalling between 14-15
and 22.5hpf leads to changes within the otic vesicle that induce the persistence of hmx3a in a
posteroventral region independently of the sensory domain.
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Figure 6.7: Inhibition of Hh signalling with 100uM CyA between 14/15 and 22/23 hpf
result in a broad ventral domain of hmx3a by 36hpf
(A–F’) Double in-situ for hmx3a (dark purple) and the sensory marker atoh1a (red) imaged using both
DIC and fluorescent imaging (A’–F’) to highlight hmx3a staining. (A–C’) In vehicle control embryos, otic
hmx3a is strongly localised to an anterior domain covering the anterior macula as marked by atoh1a but
does not show co-localised staining with the posterior-medial sensory domain of atoh1a. (D–F’) In
CyA-treated embryos, hmx3a but not atoh1a staining shows an expansion across the entire
anterior-posterior length of the ventral floor (D–E’, white arrow). Atoh1a expression also appears to be
lost in the posterior-medial domain (F, D). (G) Quantification of hmx3a staining in the posterior otic
domain shows a significant increase in treated embryos compared to the vehicle controls (t-test
p=<0.0001, t=35.83 df=19.24) (H) Diagram of method used to quantify staining in the posterior otic
domain. N= number of individual embryos. For G, both ears were measured from dorsal images. A, A’
D, D’ are dorsal views with all others being lateral views at di↵erent z-planes through the ear. Anterior
is to the left in all images. Images were taken using DIC or epifluorescence microscopy with a 40x
objective. Scale bars: 50µM.
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6.2.5 Aberrant activation of Hh signalling does not lead to strong down-
regulation of hmx3a by 14-16ss
As loss of Hh signalling, either through transient-treatment with CyA or in Hh loss-of-signalling
mutants, leads to an expansion of hmx2 and hmx3a expression that, for hmx3a, persists at 36hpf.
I wanted to observe whether the converse, over-activation of Hh signalling, would lead to a loss
of otic hmx2 and hmx3a expression. It has previously been shown that when Hh signalling is
elevated in either shh RNA injected embryos or ptch1 –/–; 2 –/– mutants, hmx3a is reduced within
the anterior otic domain (Hammond et al., 2003, 2010). However, this has been through observa-
tion of their expression at 30hpf and could reflect other transcriptional changes occurring prior to
this within the anterior otic domain, as expression of both fgf8a and pax5 have been show to be
down-regulated under these conditions by this time point (Hammond et al., 2003, 2010). Therefore
ptch1 –/–; 2 –/– mutants, in which Hh is aberrantly activated and their siblings were fixed at the
14-16ss ( 16-17hpf) before being assayed for hmx2 and hmx3a expression via in-situ hybridisation
(Figure 6.8).
At this stage pax5 expression is only just detectable (Kwak et al., 2006) and neither of the strong
anteriorising factors, fgf3 (Millimaki et al., 2007) (own data) or fgf8a (Léger and Brand, 2002) are
expressed within the otic vesicle so any changes in the expression of hmx2 or hmx3a should be a
consequence of an over-activation of Hh signalling. In the ptch1–/–; 2–/– mutants at 14-16ss, hmx3a
staining appears remarkably similar to that seen in the siblings (Figure 6.8A,A’ compared to B,B’),
although the medial staining in the ptch1–/–; 2–/– mutants appeared slightly weaker. Measurement
of the medial length of staining, as determined both by a calculated-threshold (Figure 6.8C and G)
and by eye (data not shown), showed no significant di↵erence between the siblings and identified
double mutants. Interestingly, otic hmx2 staining was visibly weaker in the ptch1–/–; 2–/– mutants
compared to the siblings (Figure 6.8D, D’ compared to E, E’). However, measurement of hmx2
staining using both threshold-calculated and by eye measurements again appeared to show no sig-
nificant decrease in the length of medial staining, although the reduction in mean and standard
deviation were greater than that of hmx3a in ptch1–/–; 2–/– mutants (hmx2 mean=45.69±3.942,
S.D 15.77 vs hmx3a mean=51.34±2.787, S.D 10.43).
As hmx3a expression does not appear drastically reduced at 14-16ss ( 16-17hpf) when Hh sig-
nalling is aberrantly active in ptch1–/–; 2–/– mutants but does later at 30hpf (Hammond et al.,
2003), this gradual reduction implies that any inhibitory e↵ect of Hh on hmx3a may be relatively
weak compared to the response seen to changes in Fgf signalling (Hammond and Whitfield, 2011).
It is also interesting that hmx2 staining in ptch1–/–; 2–/– mutants appears weaker than hmx3a
under the same conditions. During normal development hmx2 is expressed after hmx3a in the
zebrafish otic placode (Hammond and Whitfield, 2011) (own data), and therefore this di↵erence
in expression might reflect a regulatory relationship between hmx2 and hmx3a, that is a↵ected by
Hh signalling.
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Figure 6.8: Aberrant activation of Hh signalling in ptch1:2-/- double mutants does not
significantly alter the domain of hmx3a but does result in an obvious weakening of hmx2
expression at 14-16ss
(A–B’) Expression of hmx3a in ptch1:2 -/- mutants does not appear obviously di↵erent from the siblings.
(C) Despite a reduced mean, there was no significant di↵erence in the threshold-length of medial staining
between ptch1:2-/- mutants and their siblings (t-test p=0.4765, t=0.7225 df=25.56) (D, E’) Expression of
hmx2 in ptch1:2-/- mutants appears clearly weaker relative to the siblings. (F) Despite hmx2 staining
appearing weaker and having a reduced mean, there was no significant di↵erence in the threshold-length
of medial staining between ptch1:2-/- mutants and their siblings (Mann-Whitney p=0.3605, U=117) (G)
Method for determining the threshold-calculated length of medial staining. N= number of individual
embryos. For C and F, both ears were measured from dorsal images. Dotted lines outline the otic
placodes with A–D being dorsal views and A’–D’ being lateral views. Images were taken using DIC
microscopy with a 40x objective. Scale bars: 50µM.
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6.2.6 Over-expression of fgf3 leads to an initially broad expansion in ex-
pression of anterior transcription factors which gradually resolves
to the anterior and posterior otic poles
When Hh signalling was transiently inhibited, pax5 along with fgf3 and fgf8a did not show any pos-
terior ectopic or expanded expression by 22.5hpf (Figure 6.2). Whereas hmx2 and hmx3a showed
a posterior expansion but were not strongly up-regulation within the posterior domain itself by
22.5hpf (Figures 6.4 and 6.6).Therefore to test whether the posterior otic domain is competent to
express anterior factors at 22.5hpf and to also characterise expression of anterior factors at this
time point after misexpression of fgf3, the heat-shock inducible, hs:fgf3 transgenic line was used.
Fgf misexpression was induced by a 39oC, 30 minute heat shock at 14-15hpf, a stage at which
over-expression of fgf3 has been shown to induce a duplication of anterior otic identity (Hammond
and Whitfield, 2011), with embryos subsequently being fixed at 22.5hpf (Figure 6.9K).
The expression of the three fgfs that have been previously reported as influencing assignment
of anterior otic character in zebrafish, fgf3, fgf8a and fgf10a were all observed after heat-shock in-
duced over-expression of Fgf3 (Hammond and Whitfield, 2011; Léger and Brand, 2002; McCarroll
and Nechiporuk, 2013). Fgf3 staining in the majority of transgenic embryos appeared weak across
the dorsomedial otic domain with two stronger patches of staining at either pole (Figure 5.9B and
B’), unlike the siblings which showed a single strong anterior domain of staining (Figure 6.9A and
A’).
In the transgenic embryos it was also observed that the expression of fgf3, normally observed
within the pharyngeal pouches ventral to the ear is perturbed (Figure 6.9B’ when compared to
A’). fgf8a staining in the transgenic embryos was similar to fgf3 with a clear anterior otic patch of
staining along with patchy staining within the dorsoventral and posterior otic domain (Figure 6.9F
and F’). Interestingly, the overall fgf8a staining in the transgenic embryos seemed weaker when
compared to the siblings (Figure 6.9F, F’ compared to E, E’), which may also account for why
fgf8a staining in the posterior domain does not appear stronger. In contrast, fgf10a staining in
transgenic embryos appears stronger across the dorsomedial edge and within the anterior-posterior
otic pole domains (Figure 6.9J and J’) when compared to the siblings (Figure 6.9I and I’).
For pax5 and hmx3a, staining within the transgenic embryos is consistently strong across the en-
tire medial edge (Figure 6.9D, D’ and H, H’, respectively) rather than localised within the anterior
domain as in the siblings (Figure 6.9C, C’ and G, G’). Although at this stage, pax5 staining
does appear to be localised more dorsally than hmx3a (Figure 6.9D’ vs H’). This result for pax5
replicates that seen by Hammond et al, 2011 at 24hpf, after a similar over-expression of fgf3.
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Figure 6.9: Over-expression of fgf3 can result in up-regulation of fgf10a, pax5 and hmx3a
across the entire AP axis of the medial otic edge by 22.5hpf
(A–B’) Expression of fgf3 in heat-shocked transgenic (hs:fgf3) embryos at 22.5hpf shows staining in a
patchy dorsomedial domain, strengthened at the anterior-posterior poles. (C–D’) Fgf8a staining in
transgenic embryos appears similar to fgf3 spatially, although overall weaker. (E–F’) Fgf10a staining, is
stronger across the whole medial otic domain in transgenic embryos compared to their siblings. (G–H)
Pax5 expression appears as a broad dorsomedial domain in the transgenic embryos compared to a defined
anterior domain in the siblings. (I–J) Hmx3a shows a similar broad medial expression to pax5 in the
transgenic embryos. (K) Schematic of heat-shock treatment. A-J are dorsal views with A’-J’ being
lateral. Images were taken using DIC microscopy with a 40x objective. Scale bars: 50µM.
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Following the results observed at 22.5hpf after the over-expression of fgf3 (Figure 6.9), where
fgf3 and 8a showed primarily pole-localised expression compared to a broad, medial expression
for pax5 and hmx3a. I wanted to observe how over time this broad, medial expression of hmx3a,
as the earliest anterior otic marker, resolves to form two separated domains of expression. There-
fore progeny from a hs:fgf3 +/- identified x AB-wildtype cross were heat-shocked using the same
method and timings as used for Figure 5.9 (39oC, 30 minute heat shock at 14-15hpf) and fixed at
22, 24 and 26hpf (Figure 6.10).
In-situ hybridisations for hmx3a were carried out for these time points and plot profiles of staining
within the medial edge for four embryos were plotted to clearly show any changes in expression
and the consistency of these. In the transgenic embryos, at 22hpf, hmx3a shows strong expression
across the entire medial otic domain with no clear di↵erence in staining intensity between the
anterior-posterior poles and centre when viewed dorsally (Figure 6.10D). At 24hpf, hmx3a staining
still appears broadly across the medial edge, although appearing weaker than at 22hpf (Figure
6.10E) and also more ventrally-localised when viewed laterally. At 26hpf, the hmx3a staining
still appears strong at the anterior and posterior poles but weaker within the central region of
the medial edge (Figure 6.10D), a trend that is apparent in the majority of the staining profiles
plotted. Compared to the transgenic heat-shocked embryos, siblings at all three time points show
a consistent anterior domain of hmx3a staining (Figure 6.10A, B and C).
The data shown in Figure 6.10 suggests that after a broad otic induction of hmx3a expression,
approximately 12 hours after over-expression of fgf3, expression of hmx3a is no longer maintained
within the middle dorsomedial domain but is maintained at the AP poles and the ventral domain,
similar to that seen after inhibition of Hh (Figure 6.7). As the expression of fgf3 and fgf8a appear
to be maintained at the poles at 22.5hpf after heat-shock induction of fgf3 rather than the mid-
dle medial domain, this could explain why hmx3a expression persists in these domains given its



































































































































































































































































































































































































































































































































































































6.2.7 Localisation and maintenance of fgf expression within anterior
and posterior otic domains
Given the localisation of fgf3 and fgf8a expression to the anterior and posterior poles after misex-
pression of fgf3 (Figure 6.9) and also for fgf8a, transiently during normal development (own data
and (Léger and Brand, 2002)), the question arises of how the anterior and posterior pole domains
di↵er from the middle medial otic domain. One mechanism could be that components of the Fgf
signalling pathway are abundantly present or strongly maintained within the otic poles allowing
indirect positive feedback on their expression, for example through hmx2 and hmx3a (Feng and
Xu, 2010). The expression of the known Fgf receptors has been studied in the vertebrate ear with
fgfR2 and fgfR4 being suggested to show localised expression within the anterior and posterior otic
domains in zebrafish (Ota et al., 2010; Maier and Whitfield, 2014). To confirm this, in-situ hybridi-
sation using probes for both fgfR2c and fgfR4 in wild-type embryos fixed at 26hpf were carried
out. This showed fgfR2c is expressed within a posteromedial domain of the ear (Figure 6.11A-B’)
but not the anterior and that fgfR4, contrary to previous reports, has no obvious expression within
the otic vesicle at this time (Figure 6.11C-D’).
Figure 6.11: Fgfr2, fgfr4 and sulf1 do not show localised expression at both the anterior
and posterior otic poles by 26hpf
(A–B’) In situ hybridisation for fgfr2 in 26hpf embryos shows expression within the hindbrain adjacent to
the OV and weakly within the posteromedial otic domain (B–B’). (C–D’) Fgfr4 in 26hpf embryos shows
weak expression anterior to the OV but none within the OV itself (D–D’). (E–G) Sulf1 in 24hpf embryos
shows weak expression in the anterior otic vesicle (white arrow) along with strong expression within the
floor plate adjacent to the OV and weakly in a domain in the underlying mesoderm. White asterisks in
A, C and E mark the position of the otic vesicle. Images A, C and E were taken using brightfield with a
4x objective (2x magnification). All other images were taken using DIC with a 40xW objective. Scale
bar: A; 200µM for B, B’ and F; 50µM.
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As expression of the fgf receptors appear to have no obvious localisation to the anterior-posterior
poles, expression of another Fgf signalling modulator, the heparan sulphate proteoglycans (HSPGs)
were looked at. HSPGs are thought to form a ternary complex with Fgf receptors and ligands at
the cell membrane during Fgf signalling and the glycosaminoglycan chains of HSPGs can be mod-
ified through sulfation resulting in structural and binding heterogeneity (reviewed in Brewer et al.
2016). In zebrafish this modulation of HSPG sulfation is achieved by the 6-O-endosulfatases, Sulf1
and Sulf2, with expression of sulf1, which has been implicated in modulating Fgf signalling in the
lateral line, having also been observed in the otic vesicle (Meyers et al. 2013 and personal com-
munication with Dr B Pownall). However, in-situ hybridisation against sulf1 did not show any
strong otic expression localised to both poles by 26hpf with only a weak anterior patch of anterior
staining observed (Figure 6.11E-G, white arrow). Sulf1 and 2 have been reported to be expressed
in the otic tissue of chick and mice with double knock-outs in mice leading to an increase in hair
cell number (Freeman et al., 2014). Therefore the anterior expression of sulf1 seen in zebrafish at
prim-5 (24hpf) may reflect a later role in regulating the sensory epithelium, possibly through Fgf
signalling.
Another potential mechanism by which the expression of fgfs, and subsequently other anterior
markers, could be localised to the poles is through localised regulation of transcription. As ex-
pression of atoh1a/b show early restriction to the anterior and posterior poles of the otic placode,
specifying the sensory domains, a feedback loop between Atoh1a and anterior markers such as fgf3
and fgf8a may account for why expression of these anterior markers are maintained within these
discrete domains (Figure 1.6) (Millimaki et al., 2007; Sweet et al., 2011).
Mindbomb (mibta52b) mutants carry a missense mutation in the gene coding for a mis-sense RING
E3 ubiquitin ligase required for Notch activation (Itoh et al., 2003) and in these mutants the early
expression of atoh1a and atoh1b within the otic placode fails to restrict to the anterior and poste-
rior poles and ectopic hair cells form (Millimaki et al., 2007). To observe if the broad expression
of atoh1a is maintained at later stages in mib mutants and as a result, whether expression of
fgf3, fgf8a and hmx3a are no longer localised, identified mib mutants were fixed alongside their
siblings at 26hpf and assayed by in-situ hybridisation (Figure 6.12). Interestingly in the mib mu-
tants, expression of atoh1a is maintained within the otic vesicle with two, slightly larger, pole
patches of staining observed stereotypically positioned along the mediolateral axis (Figure 6.12B
and B’). However, atoh1a staining within the dorsal hindbrain was strikingly absent in the mutants
compared with their siblings (Figure 6.12B’ compared to A’). Fgf3 and fgf8a staining in the mib
mutants, rather than showing ectopic or enlarge domains, appeared severely reduced within the
anterior otic domain but not within the underlying branchial pouches (Figure 6.12E-F’ and G-H’,
respectively) suggesting an otic-specific response.
For hmx3a, in the mib mutants, whilst the dorsoventral patterning of hmx3a appeared consistent
with that seen in the siblings (Figure 6.12D’ and C’, respectively) the ventral domain of staining
appeared both slightly less posteriorly expanded and appeared lost within a small anteroventral
otic domain. A loss of staining within the cells anterior to the otic vesicle, presumed to be the
anteroventral lateral line ganglion (gAV) (Figure 6.12D’, white arrow) (Feng and Xu, 2010), was
also observed in the mutants along with an drastic strengthening of staining in the dorsal trunk
(not shown) compared to their siblings.
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Figure 6.12: fgf3, 8a and hmx3a expression in mindbomb E3 ubiquitin protein ligase (mib)
mutants
Expression of fgf3, 8a and hmx3a in 26hpf mib +/+ mutants, where notch signalling is perturbed.
(A–B’) atoh1a expression in mib mutants is reduced in the dorsal hindbrain but expression domains with
the OV appear slightly expanded and strengthened. (C’–D’) Hmx3a expression in mib mutants appears
to be lost in the anteroventral domain of the OV and SAG (D’ white arrow). (E–F’) fgf3 expression in
the anterior OV appears clearly reduced in mib mutants although expression in the pharyngeal pouches
is similar to that in the siblings. (G-H) fgf8a expression in the anterior OV appears reduced in mib
mutants and any changes in posterior OV expression were not obvious. All images were taken with DIC
with a 40xW objective. Scale bars: 50µM.
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6.2.8 Both fgf3 or fgf8a have the ability, when over-expressed at 14hpf,
to result in morphological duplications of anterior otic identity
which is reduced by >18hpf
Whilst the ability of Fgf3 when over-expressed to induce a transcriptional and morphological dupli-
cation of anterior otic identity has been well characterised in zebrafish (Hammond and Whitfield,
2011) the same cannot be said for fgf8a, despite having a clear, although possible distinct, role
in defining anterior otic identity (Phillips et al., 2001; Maier and Whitfield, 2014). Sweet et al,
demonstrated that using a heat-shock promoter to drive over-expression of fgf8a can produce ec-
topic duplicated domains of fgf3, pax5 and hmx3 across the otic AP axis (Sweet et al., 2011).
However to confirm whether over-expression of fgf8a also results in a morphological duplication of
the anterior domain as seen with fgf3, embryos from a hs:fgf8a +/- incross and hs:fgf3 +/- incross
were heatshocked at 14-15hpf at 39oC for 30 minutes before being raised to 3dpf and fixed for phal-
loidin staining (Figure 6.13A-D’). This treatment resulted in a loss of posterior otic morphology
for both transgenic lines, with the posterior sensory patch being positioned more ventrolaterally.
The phenotypes seen after over-expression of fgf8a appear to be milder than those observed after
over-expression of fgf3, with a reduced distance between what appears to be a remnant of the
posterior macula and the now ventrolaterally-positioned majority of the posterior sensory patch
(Figure 6.13D-D’).
Given these di↵ering phenotypes and also that fgf3 and fgf8a may be working in slightly di↵ering
ways during otic patterning, I also wanted to confirm whether onlyfgf8a misexpression within a
particular time window would result in a duplication of anterior morphology, as is the case for fgf3
(Hammond and Whitfield, 2011; Léger and Brand, 2002; Maier and Whitfield, 2014). Therefore
using the same hs:fgf8a +/- and hs:fgf3 +/- crosses as previously, embryos were heat-shocked for
the same period and temperature but at 18hpf rather than 14hpf. The result confirmed that over-
expression of fgf3 (Figure 6.13E-H) or fgf8a (Figure 6.13I-L) at time points >16hpf results in the
majority of transgenic embryos having a grossly normal otic morphology similar to that of their
siblings and clearly di↵erent from transgenics heat-shocked at 14hpf. From these results it appears
that the competence of the otic placode to adopt an anterior sensory morphology in response to
over-expression of fgf is lost at later stages (>18hpf) and is not specific to either fgf3 or fgf8a.
To ask the question of whether this inability of the otic placode to produce an anterior dupli-
cation in response to a late over-expression of fgf3 or 8a is due to a loss of competence to respond
at the transcriptional level, 18hpf heat-shocks were carried out as before on hs:fgf3 incross embryos
but were fixed at 22/23hpf (Figure 6.14H) before being assayed by in-situ hybridisation. Pax5,
hmx3a and fgf10a (Figure 6.14) were previously shown to respond to over-expression of fgf3 at
14hpf (Figure 5.9) and surprisingly, in the 18hpf heat-shocked transgenic embryos, pax5 (Figure
6.14B and B’) and hmx3a (Figure 6.14D and D’) showed a similar staining across the entire medial
edge. Fgf10a also showed broad staining along the medial edge of the otic vesicle but only in
5/28 embryos (23%) (Figure 6.14G) with the remaining transgenic embryos only having stronger
staining within the posterior domain compared to the siblings (Figure 6.14F, F’ compared to E,
E’).
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Figure 6.13: fgf3 and fgf8a, when over-expressed, result in di↵ering otic phenotypes but
both show a reduction in ability to duplicate anterior otic morphology when heat-shocked
at  18hpf
(A–B’) Transgenic hs:fgf3 transgenic embryos heat-shocked at 14hpf show a clear loss of the stereotypical
posterior macula morphology seen in the siblings (A) and two closely-positioned ventrolateral maculae
(B–B’). (C-D’) Hs:fgf8a embryos heat-shocked at 14hpf show abnormal patterning of the posterior
macula, with the posterior most region of the sensory patch appearing to be laterally positioned to
varying degrees (D&D’, white lines). (E–H) Hs:fgf3 embryos heat-shocked at 18hpf (H) rather than 14hpf
(G) show a largely normal positioned posterior otolith, resembling the siblings (E–F). (I–L) Similarly,
hs:fgf8a embryos heat-shocked at 18hpf (L) show a grossly normal positioning of the posterior otolith
unlike in transgenic embryos heat-shocked at 14hpf (K) All images are lateral views. A-D were taken
using confocal microscopy with a 40x oil objective. E–L were taken using DIC with a 20x objective.
Scale bars: A; 25µM, E&I; 50µM.
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Figure 6.14: pax5, hmx3a and fgf10a at 22.5hpf are broadly expressed across the otic
medial edge after over-expression of fgf3 from 18hpf (A–B’) Expression of pax5 in transgenic
(hs:fgf3) embryos heat-shocked at 18hpf show staining in a broad medial domain at 22.5hpf (B–B’) unlike
in the siblings (A–A’).(C–D’) hmx3a staining in transgenic embryos appears similar to pax5, being
present strongly present across the medial otic domain (D–D’) rather than in a discrete anterior domain
as seen in siblings (C–C’). (E–G) Fgf10a staining, is stronger across the whole medial otic domain in a
subset of transgenic embryos (G) but the majority show an up-regulation in the posterior otic pole but
not the middle medial domain (F–F’). (H) Schematic of 18hpf heat-shock treatment. A-G are dorsal
views and A’-F’ are lateral. Images were taken using DIC microscopy with a 40x objective. Scale bars:
50µM.
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Based on the previously studied roles of pax5 and hmx3a in anterior otic identity and that the
medial expansion seen in the 18hpf heat-shocked embryos is similar to that in 14hpf heat-shocked
embryos, this expansion appears at odds with the lack of a morphological duplication observed
(Figure 6.13). Anterior and posterior otic identity can also be distinguished based on the hair
cell polarity patterns of the respective macula, using phalloidin to mark the stereocilia and anti-
acetylated tubulin to mark the kinocilia (see Section 1.4.3) (Haddon et al., 2000).
Therefore to observe whether the lack of a strong morphological duplication after an 18hpf heat-
shock was accompanied by a stereotypical posterior hair cell polarity pattern hs:fgf3 incross em-
bryos were heat-shocked at 18hpf as before (Figure 6.13 and 14) but were grown on to 3dpf
(approximately 75hpf) before being imaged and subsequently fixed for staining (Figure 6.15K). In
live, 3dpf embryos dorsally imaged, the majority (25/34, 74%) of transgenic, heat-shocked embryos
showed a posterior otolith at a similar medial position to the non-transgenic, heat-shocked siblings
but this was more ventrally located (Figure 6.15B compared to A). The remaining transgenic em-
bryos (9/34, 26%) showed a stronger ventralisation in the position of the posterior otolith, although
still remaining medial to the anterior otolith (Figure 6.15C).
Interestingly, the hair cell polarity of the posterior macula in heat-shocked, transgenic embryos
showed the posterior ’pan’ domain of the macula positioned, at varying degrees, in a separate and
ventral location, which was not observed in the non-transgenic siblings (Figure 6.15E-I compared
to D and D’). This ventral posterior domain of the macula in transgenic embryos also showed a
loss of the stereotypical dorsoventral opposing hair cell polarity (Figure 6.15H-I). In contrast to
this, the remaining anterior handle domain in most of the transgenic embryos imaged maintained
a similar AP opposing hair cell patterning to that observed in the corresponding domain of the
non-transgenic siblings.
Comparison of the number of hair cells within the handle domain displaying such anterior/posterior
polarity showed no significant di↵erence between the transgenics and their non-transgenic siblings
(Figure 6.15J) and similarly no significant di↵erence in the overall number of hair cells (defined in
the non-transgenics as any hair cell anterior of and including, those marked in red - Figure 6.15D’)
was observed. This data suggests that despite appearing grossly morphologically normal after
an 18hpf heat-shock, reported both in this project and previously, Tg(hs:fgf3 ) embryos actually
do have a perturbed posterior macula morphology and hair cell patterning that might reflect the
broad, medial ectopic otic expression of anterior factors such as hmx3a seen at 22.5hpf in such
embryos.
115
Figure 6.15: Over-expression of fgf3 from 18hpf leads to a disrupted posterior macula with
some anterior characteristics at 3dpf
Imaging of live and actin/acetylated-tubulin stained 3dpf (75hpf) embryos, heat-shocked at 18hpf. (A–C)
Live, dorsally imaged embryos. (A) non-transgenic (Tg) embryos. (B) The majority of Tg(hs:fgf3)
embryos had a posterior otolith positioned medially but at a more ventral location than the
non-transgenic siblings.(C) A subset of Tg(hs:fgf3) embryos showed a more strikingly ventral posterior
otolith. (D-I) Staining with phalloidin (purple) to mark the sensory stereocilia and anti-acetylated
tubulin (green) to mark the kinocilia, allowing the polarity of the posterior macula to be mapped. In
non-Tg siblings this shows a stereotypical pan morphology (D&D’), whereas Tg embryos display a range
of perturbed patterning, with the posterior region of the macula generally more ventrally positioned
(E–I). (J) The number of hair cells with a stereotypical anterior and posterior orientation within the
handle region (hair cells left and including those highlighted in red D’) is higher in the Tg embryos but
not significantly (t-test p=0.4337, t=0.8732 df=3.844 ) with the total number of hair cells in this region
also being higher but again not significantly (p=0.1675, t=1.612 df=5.025 ). (K) A schematic of
experimental timings. N= number of individual embryos. Images A-C were taken using brightfield
microscopy with a 10x (2xMag) objective and all others using confocal microscopy with a 60x oil lens.
A–C are dorsal views with anterior to the top whereas D and E are lateral views with the anterior to the
left. Scale bar: A; 100µM
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6.2.9 Inhibition of retinoic acid signalling weakly potentiates the early
loss of Hedgehog signalling transcriptional phenotype in the ear
Another signalling pathway that has been implicated in the anterior-posterior axial patterning
of the vertebrate ear is Retinoic Acid (RA) (Bok et al., 2011). In zebrafish, during early otic
development (>26hpf), RA has been shown to act within a negative feedback loop with Fgf to
determine boundaries between sensory and neurogenic otic populations (Maier and Whitfield,
2014). At 20hpf in-situ hybridisation for the RA synthesising enzyme, Aldh1a2 shows expression
is within a region posterior ventral to the otic vesicle (Figure 6.16 A, A’) which persists at 24hpf,
although as a smaller domain (Figure 6.16 B, B’).
Figure 6.16: Aldehyde dehydrogenase 1 family, member A2 (aldh1a2) is expressed strongly
in a domain adjacent to the posterior otic vesicle
In-situ hybridisation for aldh1a2 in 20 and 24hpf AB wild-type embryos. (A-B’) The RA synthesising
enzyme, Aldh1a2, is expressed in a domain posterior-ventral to the otic vesicle at 20hpf (A & A’) which
although smaller, persists at 24hpf, with staining also starting to be observed anterior to the otic vesicle
(B & B’). A–B are lateral views and A’–B’ are dorsal views with the anterior to the left or top of the
image, respectively. All images were taken using DIC microscopy with a 40x objective. Scale bar: 50µM.
RA and Fgf have been previously been reported to have negative regulatory relationship in the
anterior otic domain around prim-5 (24hpf) but localised expression of aldh1a2 adjacent to the
posterior of the otic vesicle also makes it likely that high levels of free RA are also acting within
the posterior otic domain (Figure 6.16) (Maier and Whitfield, 2014). This led to the hypothesised
that sources of RA within the posterior otic domain could be inhibiting the up-regulation of any
posterior fgf expression, possible contributing to the delayed ectopic expression of anterior mark-
ers observed after loss of hedgehog signalling (Figures 6.2-6.6). To test this, embryos from a loss
of Hh signalling, smohi1640–/– mutant incross were treated either with a competitive inhibitor of
RA synthesis, N,N-diethylaminobenzaldehyde (DEAB) (Russo et al., 1988) at 50µM or a vehicle
control between 14-15 and 22.5hpf before being fixed (Figure 6.17H). These embryos were then
assayed by in-situ hybridisation for fgf3, fgf8a and pax5 expression.
In the treated embryos assayed for fgf3 expression, 3/27 (11%) showed staining within the posterior
otic domain alongside the expected staining within the anterior (Figure 6.17B and B’), whereas
none of the vehicle control treated embryos showed posterior staining (Figure 6.17A).
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For fgf8a the majority of DEAB treated embryos had weak or no staining within the posterior
otic domain and a strong anterior domain of staining (Figure 6.17D) with 9/26 (35%) having strong
posterior staining alongside the expected anterior otic staining (Figure 6.17D’). However, within
the fgf8a vehicle controls 9/28 (32%) embryos were also classified as having strong staining in the
posterior otic domain (Figure 6.17C). In the DEAB-treated embryos assayed for pax5 expression,
the majority showed strong staining in the anterior otic domain with no obvious staining in the
posterior (Figure 6.17F) with a similar phenotype observed for all the vehicle controls (Figure
6.17E). In contrast, 4/29 (14%) DEAB-treated embryos showed strong pax5 staining in the poste-
rior domain alongside that in the anterior (Figure 6.17E’).
Despite there appearing to be a trend towards more embryos having strong anterior and pos-
terior expression of fgf3 and pax5 after DEAB-treatment compared with the vehicle controls, this
di↵erence does not appear to be significant when tested with a Fisher’s exact test (fgf3 ; p= 0.1055,
odds ratio= 0.1186 and pax5 ; p= 0.0522, odds ratio= 0.09290) (Figure 6.17G). For fgf8a, the lack
of di↵erence in the groups observed between the DEAB-treated and vehicle controls was also con-
firmed to be highly non-significant (p= 0.7734, odds ratio= 0.7953) (Figure 6.17G).
To identify if the weak trend for posterior expression of the anterior markers fgf3 and pax5 after
treatment with DEAB was associated with a loss of Hh signalling background, embryos defined as
showing strong ectopic posterior expression were genotyped. For both fgf3 and pax5, those em-
bryos showing strong posterior expression were also confirmed as being homozygous for smohi1640–/–
(Figure 6.17G). However, the number of embryos showing this phenotype was clearly below the
25% (red line) expected for Mendelian inheritance suggesting the phenotype is not fully penetrant
in these mutants. For fgf8a, despite the number of embryos classified as having strong posterior
expression for both treated and vehicle controls being closer to the expected 25% (35% and 32%,
respectively), these embryos for both conditions appear to be comprised of both mutants and
siblings (Figure 6.17G). This suggests that for fgf8a RA and Hh likely have a negligible direct
influence on expression of fgf8a within the posterior domain before 22.5hpf.
As inhibition of RA synthesis in combination with loss of Hh signalling appeared to result in
a partial up-regulation of factors known to drive anterior otic within the posterior otic domain, I
wanted to test whether treatment with a high concentration of RA would conversely reduce expres-
sion of these factors within the anterior otic domain. This would then support the hypothesis that
posterior sources of RA might be inhibiting establishment of anterior otic character in the posterior
otic domain of wild-type embryos, resulting in the transient expression of anterior markers seen
around prim-5 (24hpf) (Léger and Brand, 2002; Kwak et al., 2006).
Treatment of zebrafish with lower doses (10nM) of RA, starting at a slightly early time point
of 20ss (19hpf) have been reported to result in a reduction in fgf3 and fgf8a expression with the
anterior otic domain (Maier and Whitfield, 2014). Therefore, I predicted that treatment with a
higher concentration (50nM) of RA at a time point that is slightly later starting but within the
previously reported treatment timeframe, might result in reduced expression of fgf3 and 8a along
with a concomitant reduction of other anterior factors that are known to be dependent on anterior
Fgf signalling within the anterior otic domain. To test this, wild-type embryos were treated with
a high concentration (50nM) of exogenous RA over an 6 hour period between 22.5 and 28-29hpf
before being washed and grown on to 36hpf (Figure 6.18I).
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Figure 6.17: Inhibition of RA synthesis with 50µM DEAB partially potentiates expression
of anterior markers in the posterior domain but only in a loss of Hh background
(A–B’) Expression of fgf3 in the posterior otic domain is not seen in embryos from a smuhi1640 +/- incross
treated with a vehicle control (A) but is strongly expressed in the posterior otic domain of a subset (B’)
of those treated with 50µM of DEAB. (C–D’) Expression of fgf8a in vehicle control treated embryos
shows strong anterior otic staining also clearly present in the posterior domain (C). In DEAB-treated
embryos, the posterior otic fgf8a staining appears stronger in some embryos (D’) but is also seen weakly
in the majority (D). (E–F’) pax5 expression in the posterior otic domain is not seen in the vehicle
controls (E) but is strongly expressed in the posterior otic domain of a subset (F’) of those treated with
50µM DEAB. (G) Quantification of phenotypes and genotyping of those with strong posterior otic
expression. A two-tailed Fishers exact test was used to separately compare the count data for DMSO and
DEAB treatments for each probe. The red dotted line represents 25%, the expected number of
homozygous mutants from a smuhi1640 +/- incross. (H) Schematic of DEAB treatment. N= number of
individual embryos. All are dorsal views with anterior to the left. Images were taken using DIC
microscopy with a 40x objective. Scale bars: 50µM.
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Figure 6.18: Application of exogenous RA alone after 22.5hpf does not appear to weaken
anterior identity or induce expression of anterior markers within the posterior domain
Anterior otic expression of (A–B”) fgf3, (E–F”) fgf8a and (G–H”) pax5 at 36hpf appears unaltered after
treatment with 50nM of exogenous RA between 22.5 and 28-29hpf. (B–D”) Hmx3a staining in the
anterior otic domain does not appear expanded along the medial edge after RA treatment but does show
expanded staining along the lateral otic edge (D–D’). A–H are dorsal views with all others being lateral
views at di↵erent z-planes through the ear. Images were taken using DIC microscopy with a 40x
objective. Scale bars: 50µM
.
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Expression of fgf3 and fgf8a in 50nM RA-treated embryos (Figure 6.18B-B” and F-F”, respec-
tively) appeared similar in anterior localisation and strength of staining relative to the vehicle
controls (Figure 6.18A-A” and E-E”). However, RA-treated embryos assayed for fgf3 expression
did show a consistent change in expression within the ventral branchial pouches with this ex-
pression domain appearing as a single broad domain abutting the ventral edge of the otic vesicle
rather than discrete domains (Figure 6.18B’). Expression of pax5 also showed no obvious changes
in either positioning along the anterior-posterior axis or staining strength (6.18H-H”) compared
to the vehicle controls.Hmx3a staining in RA-treated embryos did appear to be expanded slightly
along the ventrolateral domain in 30/32 embryos (94%) when compared to the vehicle controls
(Figure 6.18D, D’ compared to C, C’) and staining in the dorsal hindbrain and within the domain
just anterior to the otic vesicle was also stronger in treated embryos (Figure 6.18D-D”). Therefore,
my predictions were not fulfilled as none of the anterior markers, including fgf3 and 8a, showed a
persistent reduction in their anterior otic expression.
A batch of embryos treated with 50nM of RA alongside those fixed at 36hpf were grown on
to 3dpf. These RA-treated embryos showed a strong pectoral fin overgrowth phenotype (27/27,
100%), which was not observed in untreated embryos (30/30) and supports the activity of the
exogenous RA treatment (Grandel et al., 2002).
6.3 Discussion
The morphological and transcriptional duplication of anterior otic identity in response to a loss
of Hedgehog (Hh) signalling or increase in Fgf signalling has been previously reported later than
24hpf. Strikingly, the duplication of anterior otic morphology observed in response to manipula-
tion of these two pathways appears remarkably similar. However, despite determination of AP otic
identity occurring early during otic development, the transcriptional response of anterior factors,
such as fgf3, fgf8a, hmx2, hmx3a and pax5 prior to 24hpf and how this di↵ers between manipula-
tions of the two pathways has not been studied.
I have shown that under loss of Hh conditions, which are su cient to produce a duplication of
the anterior otic morphology, the anterior factors pax5, fgf3 and fgf8a show a slow transcriptional
response. In contrast, hmx2, hmx3a and fgf10a show a robust expansion of expression into the
posterior otic domain by 22.5hpf. As fgf10a and its paralogue, fgf10b, do not have a strong impact
on anterior identity (Maulding et al., 2014), hmx2 and hmx3a were focused on.
The posterior expansion of hmx2 and 3a in response to a loss of Hh signalling appeared to be
direct rather than reflecting any reduction in the size of the otic tissue or elevated Fgf signalling.
A similar up-regulation of hmx3 along the otic DV axis in chick has been reported in response to
Gli3R, which is associated with low Hh signalling (Ohta et al., 2016). Therefore it was unexpected
that early otic expression of hmx3a appeared only weakly reduced in ptch1 -/-; 2-/- mutants, where
Hh signalling is constitutively active, yet expression of hmx2 was almost lost. This could suggest
hmx3a expression is more sensitive to anterior extra-otic Fgf signalling than hmx2, which may
initially o↵set the inhibitory e↵ect of increased Hh signalling. Such a di↵erence in regulation is
supported by reduced hmx3a expression in ptch1-/-; 2-/- mutants by 30hpf and its earlier induc-
tion in the anterior otic domain compared to hmx2 during wild-type otic development (Hammond
et al., 2010; Feng and Xu, 2010).
121
Early over-expression of fgf3 has previously been shown to produce a similar anterior duplica-
tion to that seen in a loss of Hh signalling background. This duplication was also reflected in the
duplicated expression of a number of known anterior otic factors such as hmx2 and pax5 (Ham-
mond and Whitfield, 2011). I showed that in 22.5hpf embryos, after over-expression of fgf3, hmx3a
and fgf10a show a stronger posterior expansion of expression than observed at 22.5hpf after loss of
Hh signalling. In contrast, while pax5 shows no posterior otic expression after loss of Hh at 22.5hpf,
over-expression of fgf3 leads to an expansion of pax5 expression across the AP axis. Similarly, fgf3
expression also appears up-regulated in a discrete posterior otic domain at 22.5hpf after its earlier
over-expression. This is in contrast to the slow up-regulation occurring by 36hpf observed after
loss of Hh. These di↵ering responses represent a clear di↵erence in the transcriptional response to
manipulation of Hh compared to Fgf signalling, even though the morphological outcome is similar.
I have also expanded upon previous data from Hammond et al, 2011 by showing that the stereotyp-
ical morphology of the posterior macula is altered after over-expression of fgf at time points greater
than 16hpf. However, this is milder than the phenotypes observed after over-expression of fgf at
14hpf, making this change in posterior morphology less clear in live embryos. This loss of stereo-
typical morphology was also confirmed to be concomitant with a posterior expansion of anterior
factor expression. These data support the posterior otic placode becoming progressively less able
to adopt anterior identity during development, highlighting the requirement for early (<18hpf)
transcriptional changes in determining the anterior otic domain. It would be interesting to identify
whether the transcriptional response of anterior factors in response to fgf over-expression reflects
the weaker phenotype seen at these later developmental time points.
Based on these observations, I propose a model where otic hmx3a expression is dependent on
integrating both Fgf and Hh signalling to define the extent of the anterior otic domain during
early otic development. This model would support the early expansion of hmx3a expression in
loss of Hh embryos inducing anterior identity within the posterior domain. However, the current
data do not identify whether hmx3a and/or hmx2 are su cient to induce anterior identity in-
dependently of Fgf signalling. Therefore further work to identify whether, when Fgf signalling is
inhibited, over-expression of hmx3a is su cient to rescue the posterior duplication phenotype seen.
It is also possible that other signalling pathways may be later impact upon otic AP identity, as
discussed later.
A previous model for patterning along the otic AP axis in zebrafish suggested the presence of
a pre-pattern upon which either anterior or posterior identity is assigned (Hammond and Whit-
field, 2011). I have shown that when fgf3 is over-expressed, the otic expression of both fgf3 and
fgf8a appears strengthened in two domains located at the anterior and posterior poles. A similar
maintenance within these two AP pole domains is seen with hmx3a following its initially broad ex-
pression across the medial otic edge in response to fgf3 over-expression. This restriction of hmx3a
to these domains and its loss within the middle dorsal domain may reflect the localised expression
of fgf3 expression at either pole under these duplicating conditions.
In wild-type embryos, I have shown that three regulators of the Fgf signalling pathway, Fgf Re-
ceptors 2, 4 and Sulf1, do not show any spatial restricted expression to both poles, suggesting
that Fgf signalling is unlikely to be tightly restrained to these pole domains either by localization
of receptors or correctly sulfated HSPGs. This is despite wild-type embryos having expression of
both fgf8a and fgf10a in the posterior otic domain around prim-5 (24hpf). However, it would
be interesting to confirm whether fgfR4 or sulf1 show any posterior expression in embryos after
over-expression of fgf3. It is also possible that other FgfRs, such as FgfR1 may be localised to the
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poles, although this is not seen in their wild-type expression (Maier and Whitfield, 2014). Given
the importance of FgfRs in otic patterning it could also be that their transcripts, if localised to
the AP poles, may be present at sub-detection levels (Hammond and Whitfield, 2011).
Another mechanism by which fgf expression could be localised is through its interaction with
Atoh1a. Atoh1a is expressed in two discrete pole domains during early otic development and has
been shown to act in a positive feedback loop with Fgf signalling (Sweet et al., 2011). Atoh1a has
previously been shown in 14hpf mind bomb mutants, where Notch signalling is lost, to be broadly
expressed across the otic placode rather than refining into two domains (Millimaki et al., 2007).
Therefore to explore whether otic fgf expression is broadened in response to ectopic otic atoh1a
expression, 26hpf mib mutants were observed. However, in these mutants at 26hpf, atoh1a did not
show broad expression and instead appeared resolved into two discrete domains. Interestingly, otic
expression of fgf3 and fgf8a was lost in these mutants yet an anterior domain of hmx3a expression
was still present. This highlights that by 26hpf, otic expression of fgf3 and fgf8a is dependent on
the presence of a di↵erentiated otic population, likely the supporting cells of the sensory domain,
which are lost in mib mutants (Haddon et al., 2000). It also presents the possibility that there
is still su cient extra-otic Fgf signalling at this time to maintain anterior otic expression of hmx3a.
RA has been shown to play a role in otic patterning in chick (Bok et al., 2011), mouse (Niederrei-
ther et al., 2000; Romand et al., 2013) and zebrafish (Hans et al., 2007; Maier and Whitfield, 2014;
Radosevic et al., 2011), where it is thought to be initially present as a posterior (high) to anterior
(low) gradient across the otic tissue. In zebrafish, RA has been suggested to regulate the balance of
sensory, neurogenic and non-neural otic tissue through negative feedback regulation of anterior Fgf
signalling between 18- 26hpf (Maier and Whitfield, 2014). A similar negative regulation by RA on
fgf expression within the otic tissue has also been observed in mice (Cadot et al., 2012; Frenz et al.,
2010). I therefore hypothesised that posterior RA could be contributing to the delayed duplication
of anterior factors seen when Hh signalling is lost. However, reduction of RA synthesis using DEAB
only partially potentiated the up-regulation of duplicated anterior factors at 22.5hpf and only when
hedgehog signalling was also lost. This suggests that any repression by RA on the posterior otic
domain before 22.5hpf is weak. As treatment with DEAB has variable e ciencies in producing
the same otic phenotype (Maier and Whitfield, 2014; Radosevic et al., 2011), I also tried to con-
firm this result using a dominant-negative Retinoic acid receptor transgenic line (Kikuchi et al.,
2011). This line has been used previously to study RA signalling during otic development (Maier
and Whitfield, 2014; Rubbini et al., 2015); however, attempts at using this transgenic resulted in
embryo lethality and no clear e↵ect on RA patterning. An unexpected embryo-wide up-regulation
of pax5 was observed, although this may be an o↵-target e↵ect (Supplementary Figure 9).
Application of a high concentration of exogenous RA after 22.5hpf did not appear to strongly
influence the expression of anterior factors supporting a weak e↵ect of RA on determining otic
AP identity. Interestingly, this is contrary to the loss of anterior otic fgf3 and fgf8a expression
reported when 10nM of RA was applied from a slightly earlier time point (Maier and Whitfield,
2014). However, embryos treated with 50nM of RA embryos were not fixed after treatment but
rather were washed and grown on to 36hpf. Therefore, an earlier reduction in the expression of
anterior factors may have occurred but subsequently recovered. Alternatively, the anterior otic
tissue may have lost its competence to respond to elevated RA by 22.5hpf, result in no change in
the anterior expression. Despite these possible explanations, the result seen suggests that transient
treatment with 50nM of RA from 22.5hpf does not alter anterior otic character. Further work to




• Transient inhibition or loss of Hedgehog signalling leads to a progressive duplication of the
otic anterior factors fgf3, fgf8a and pax5 between 22.5hpf and 36hpf but an early expansion
of hmx2 and hmx3a across the medial otic domain.
• After transient inhibition or loss of Hedgehog signalling, hmx3a expression persists across
the entire ventral otic floor at 36hpf.
• Despite leading to an expansion of otic hmx3a expression, aberrant Hedgehog signalling does
appear to directly lead to a reduction of anterior otic hmx3a expression by 16-17hpf (14-16ss)
but does reduce hmx2 expression.
• Misexpression of fgf3 at 14hpf results in a broad medial expression of hmx3a, pax5 and fgf10a
by 22.5hpf with fgf3 and fgf8a expression being localised to the anterior and posterior otic
poles. Subsequently, the broad medial expression of hmx3a progressively resolves into two
domains at the anterior and posterior otic poles, and is not maintained within the central
region of the medial otic domain.
• Components known to regulate the Fgf signalling pathway do not show any expression lo-
calised to both the anterior and posterior otic domains in wildtype embryos.
• Inhibition of Notch signalling in mind bomb mutants results in an atoh1a-independent loss
of otic fgf3 and fgf8a expression, which does not a↵ect the otic anterior-posterior profile of
hmx3a expression by 26hpf.
• Misexpression of fgf8a at 14hpf results in a weaker loss of posterior identity at 3dpf compared
with embryos where fgf3 has been over-expressed at the same time point.
• The response of the otic tissue to over-expression of either fgf3 or fgf8a at 18hpf is far weaker
than that seen at 14hpf; however, over-expression of fgf3 at 18hpf does still result in a similar
broadened expression of hmx3a and pax5 across the medial otic domain and also a disruption
of the posterior-most region of the posterior macula.
• Inhibition of RA synthesis weakly potentiates the transcriptional anterior duplication pheno-
type seen after loss of Hedgehog signalling at 22.5hpf, but a high concentration of exogenous




7.1 Overview of Results
This thesis presents data characterising the early patterning dynamics that occur across the AP
axis of the developing zebrafish otic placode. In an attempt to better model how the polarity in
otic anterior and posterior character is established. In Chapter Three, I reported the expression
of two new early markers of the posterior otic domain, nav3a, which is expressed from 16hpf in
a posteromedial domain, later spreading dorsally and cdr2l, which is initially expressed broadly
across the otic placode but is then successively lost from the anterior and then the posterior do-
mains. Given the stronger expression and dynamic nature of otic cdr2l expression, this marker was
explore further, with otic cdr2l expression identified as being negatively regulated by Fgf signalling
early during otic development.
In Chapter Four, I built upon this previous characterisation of otic cdr2l expression by testing the
function of cdr2l in the otic epithelium through morpholino knock-down and CRISPR-generated
mutants. This showed that loss of cdr2l does not appear to a↵ect otic AP patterning, although the
posterior marker fsta may show a slight reduction in its otic expression in the cdr2l morphants.
In the cdr2l morphants, a possible reduction in the population of di↵erentiated neurons within
the anterior hindbrain, as marked by neurod1, was observed. It was also noted that both the ears
of cdr2l morphants and mutants showed a slight reduction in otic AP length, accompanied by an
increase in variation, compared to the controls. This led to the hypothesis that Cdr2l may play a
either play a role in regulating proliferation/maturation of the zebrafish otic placode.
In Chapter Five, I have also discussed developing approaches to isolate the otic tissue for identifi-
cation of the transcriptional di↵erences that define anterior and posterior otic character through
subsequent transcriptomics. However, due to technical issues and time constraints, ultimately this
was not pursued.
Finally in Chapter Six, I present data showing the di↵ering early transcriptional responses of
know anterior markers, within the otic tissue, in response to a loss of Hh signalling. This was to
identify the early transcriptional changes that likely drive the duplication around the otic AP axis
under such conditions. This highlighted hmx3a and hmx2 as showing an early (prior to 22.5hpf)
posterior expansion, with the other known markers showing a delayed duplication of expression.
This was in contrast to the expression of the anterior markers after over-expression of fgf3, which
showed an up-regulation of the majority of anterior markers within the posterior otic domain by
22.5hpf.
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I also confirmed that the whole medial edge of the otic placode is competent to express these
anterior markers after their broad up-regulation by fgf3 over-expression. However, this broad ex-
pression, as demonstrated with hmx3a, is only maintained in two domains at the AP poles, which
I propose reflects a positive feedback between Fgf and Atoh1a along with di↵erentiation within
these regions.
Within Chapter Six, I also present preliminary data integrating the role of Retinoic Acid (RA) and
Hh signalling in the regulation of posterior otic character. This suggests that RA may be acting to
weakly inhibit fgf expression within this domain, as has been shown in the anterior otic domain,
possibly in combination with a Hh mediated inhibition of other anterior factors. I also present
data showing that the application of a high concentration of RA after 22.5hpf does not have the
ability to alter anterior otic identity, despite its previously published role in regulating anterior fgf
expression (Maier and Whitfield, 2014).
In the discussion below, I have attempted to place these data in the context of what is already
know in relation to early otic development in zebrafish and also otic development across other ver-
tebrates. Finally, I also propose a model, which looks to expand upon those previously previously
proposed for patterning across the otic AP axis, in light of my data.
7.2 Early markers of the posterior otic domain; a role for
Cdr2l in otic development?
While a number of early (>24hpf) transcriptional responses have been linked with anterior otic
identity in zebrafish, none have been found for the posterior. This led to a search for markers which
showed an early and localised expression profile within the posterior domain (Chapter Three). I
identified two candidate posterior markers but focussed on cdr2l due to its initially strong expres-
sion across the otic placode at 14hpf (10ss) and the novel dynamics observed in its progressive loss
of expression across the AP axis of the otic domain.
7.2.1 Dynamic expression of cdr2l across the early otic AP axis, reflec-
tive of maturation?
As shown in Chapter Four, loss of cdr2l does not appear to alter AP patterning within the ear.
This supports data from Chapter Three, where expression of cdr2l failed to persist in either the
anterior or posterior domains of wild-type or loss of Fgf signalling embryos, as would be expected
if it were associated with AP identity (Hammond and Whitfield, 2011). Therefore the progressive
loss of cdr2l expression across the AP axis (Chapter Three) could be reflecting transcriptional
changes associated with assignment of anterior and posterior identity at either end along the
otic AP axis, which is supported by the asynchronous development of the anterior and posterior
maculae reported in zebrafish (Sapède and Pujades, 2010). The onset of anterior otic hmx3a ex-
pression at 14hpf (10ss) represents the earliest known di↵erential expression within the anterior
otic domain (Feng and Xu, 2010) with expression of pax5, a down-stream target of hmx3a and
hmx2, observable within the anterior domain at around 16hpf (Feng and Xu, 2010; Kwak et al.,
2006). This progressive induction of anterior markers between 14-16hpf, coincides with the loss
of anterior cdr2l expression. In the posterior otic domain, expression of nav3a, the other early
posterior marker characterised in this thesis, was observed from 16hpf (Chapter Three). This is
prior to the loss of cdr2l expression within the posterior otic domain at 18-19hpf and therefore
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could support the hypothesis that the progressive loss of otic cdr2l expression is in response to
maturation/specification of the anterior and posterior domains. However, as onset of all other
posterior markers, such as fsta and pou3f3b occur around 24hpf, it cannot be confirmed that pos-
terior character has been established prior to this at 18-19hpf (Kwak et al., 2002b; Hammond and
Whitfield, 2009). However, even if nav3a is not regulating posterior otic character, it must mark
an event that induces its localised expression within a posterior domain. This therefore supports
a model where the progressive loss of cdr2l expression across the otic AP axis is mirroring mat-
uration or commitment of the otic placode across the AP axis, as supported by the expression
of the known AP markers. A similar idea of the otic tissue undergoing progressive commitment
has also been suggested to occur in chick explants, although not across an axis (Freter et al., 2008).
To identify whether Cdr2l does play a role in maturation of the otic tissue, further work looking at
whether expression of pax5 and neurog1 show delayed induction after injection of cdr2l RNA would
be interesting. Especially as cdr2l expression within the anterior domain is lost around the time of
their onset. Conversely, observing whether otic cdr2l expression is lost after over-expressing hmx3a
or pax5 early on during otic development could support cdr2l expression reflecting otic maturation.
Identifying if nav3a does reflect posterior identity, through knock-down and characterisation of its
expression in duplicated ears would also be of interest to confirm whether assignment of posterior
identity does occur as early as 16hpf.
7.2.2 A role for otic Cdr2l in proliferation?
Recent work in mature rat cerebellar tissue has linked CDR2L and another CDR family member,
CDR2 with calcium homeostasis within the synapses of Purkinje cells. Here it is proposed that the
disruption of this homeostatic role of CDR2L and CDR2, due to the autoimmune response against
an epitope shared by CDR2 and CDR2L, contributes to the PCD pathology (Schubert et al., 2014).
However, regulation of cellular calcium levels have not been implicated in otic development, despite
elevated levels of Ca2+ reported within the otic placode at 14hpf (Créton et al., 1998).
Another possible role for otic Cdr2l could be in regulating proliferation within the early otic
placode. Whilst the function of Cdr2l during embryonic development has not been studied, its
function in tumours, which as they develop share some similarities with embryonic development
(reviewed in Ma et al. 2010), has been linked to cell-cycle regulation (O’Donovan et al., 2010).
As CDR2 has been shown to co-precipitate with the positive cell-cycle regulator, C-MYC, its was
suggested CDR2 may negatively regulate proliferation through this (Okano et al., 1999). However,
the most recent study by O’Donovan et al. suggested loss of CDR2 in cancer cell lines results in
reduced proliferation and increased apoptosis (O’Donovan et al., 2010). Although it is not clear
if CDR2L is present in cancerous tissues associated with PCD, it shares a high peptide sequence
homology with CDR2 (Corradi et al., 1997; Eichler et al., 2013). The highest homology is within
a region previously proposed to interact with C-MYC (Fathallah-Shaykh et al., 1991), of which
a paralogue, mycb, is expressed during early development of the zebrafish otic placode (Chapter
Four). However, loss of cdr2l did not appear to robustly alter otic expression of mycb, which has
been linked to hair cell proliferation and regeneration in neuromasts (Lee et al., 2016). As CDR2
has not been shown to regulate C-MYC expression directly, altered expression of mycb in the cdr2l
mutants may not be expected. The apparent lack of regulation of mycb by Cdr2l, could also reflect
di↵erences in localisation with CDR2. As CDR2L in cell culture has been shown to localise to the
cell membrane, whereas CDR2 appeared localised to the cytoplasm (Eichler et al., 2013).
127
Despite not showing any clear regulation of mycb, both the cdr2l morphants and mutants did
show a non-significant but consistent decrease in otic AP length, generally with greater variability,
when compared to the controls (Chapter Four). Although this needs further confirmation from
further measurement of homozygous mutants, it could be indicative of a role in regulating prolif-
eration within the ear. Directly studying proliferation and apoptosis in early cdr2l mutants using
techniques such as using a phospho-histone H3 antibody and TUNEL staining would help directly
confirm any changes that may not be reflected in mycb expression.
7.2.3 Does expression of cdr2l in other neural cell types provide an
indication of a possible function?
In contrast to the proposed loss of cdr2l expression during maturation of the otic placode, the
neural expression of cdr2l from 20hpf onwards appears to be in structures thought to be in the
process of di↵erentiating. Within the trigeminal placode, in which cdr2l appears to be expressed,
di↵erentiation is thought to peak with neurog1 at 16hpf, with little neurog1 expression observed in
these cells at 26hpf (Andermann et al., 2002). Similarly, the ventrolateral expression of cdr2l within
the hindbrain marks a domain thought to contain di↵erentiating neurons moving from the dorsal
ventricular zone (Nikolaou et al., 2009). The puncta of cdr2l expression within the dorsal trunk
observed from 18-20hpf (Chapter Three), presumed to be Rohon-Beard neurons, also represents
a di↵erentiated neuronal cell type marked by cdr2l expression. Di↵erentiation of Rohon-Beard
neurons is thought to occur early in development, as they express neurod1 and elavl3, both canon-
ical markers of di↵erentiating neurons, from 14hpf (10ss) onwards (Park et al., 2000; Korzh et al.,
1998). Interestingly the otic placode, trigeminal placode and Rohon-Beard neurons do share early
developmental similarities. All three have been shown to require Dlx3b and Dlx4b for their specifi-
cation and Tfap2 has also been shown to be required to varying degrees during their development.
This could suggest the loss of cdr2l expression is reflecting changes either in BMP signalling or
neural crest contributions; although either would still support the loss of cdr2l expression in the
otic placode reflecting maturation of this tissue as previously proposed (Hans et al., 2013; Kaji
and Artinger, 2004; Barrallo-Gimeno et al., 2004; Li and Cornell, 2007).
Other possible reasons for a weak otic phenotype after loss of cdr2l
Despite cdr2l showing strong and dynamic expression during early otic development, data from
the morphants and mutants do not identify a clear otic phenotype associated with a loss of cdr2l.
This lack of a strong phenotype could reflect a robustness in the process cdr2l regulates, possibly
the cell-cycling, to being perturbed. In mice, despite being expressed in the ear, loss of a putative
regulator of cell proliferation and the cell cycle, c-Myc does not disrupts otic morphology but loss
of another Myc family member, n-Myc, does (Domı́nguez-Frutos et al., 2011). Another possibility
is that despite cdr2l being expressed in the otic placode, the corresponding peptide may not be
translated. Whilst murine CDR2 has been shown to be widely expressed in a number of tissues,
the peptide is thought only to be present in the testis and neurons, which has been suggested to
be due to these tissues being immune privileged. (Corradi et al., 1997). The early nature of otic
cdr2l expression makes it unlikely that either and innate or adaptive immune response to the otic
Cdr2l peptide is occurring (reviewed in Meijer and Spaink 2011). However, confirming the presence
of the peptide within the placode during early development would rule out a lack of peptide as
causing in the weak otic phenotype seen after a loss of cdr2l.
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7.3 Early integration of extra-otic signalling in defining the
anterior and posterior otic domains during otic devel-
opment
Previous work by Hammond et al. identified the otic placode in zebrafish as being equipotent
in its ability to adopt either anterior or posterior morphology in response to Fgf or Hh, respec-
tively (Hammond and Whitfield, 2011). Whilst a posterior duplication in response to RA has been
reported in chick and mouse, neither the otic placode in chick or mice show a similar response
to Fgf or Hh manipulation or the same propensity for duplication of either anterior or posterior
sensory character reported in zebrafish (Bok et al., 2011). However, the anterior-posterior axis of
all vertebrate models has been reported to show a restricted period over which changes to anterior
and posterior character can be made (Hammond et al., 2010; Hammond and Whitfield, 2011; Bok
et al., 2005, 2011). Therefore, early transcriptional changes across the AP axis under duplicating
conditions are likely necessary for producing a strong morphological duplication for all vertebrates,
even if this only prevents di↵erentiation.
In this thesis I have shown that out of the previously characterised regulators of anterior otic
character, only hmx3a, and hmx2 show an early posterior expansion under loss of Hh conditions
that result in anterior duplication. In contrast to this early posterior expansion, the other known
otic anterior factors, pax5, fgf8a and fgf3 show a slower up-regulation of expression in the posterior
domain of these duplicated ears (Chapter Six). From this I proposed a model whereby the early
posterior expansion of hmx3a and hmx2 is the key determinant in driving the anterior duplication
phenotype. This sequential up-regulation of anterior otic factors within the posterior domain after
a loss of Hh, with hmx3a and hmx2 showing the earliest response, is strikingly similar to the
progressive establishment of the anterior otic domain observed in wild-type embryos (Figure 7.1).
Therefore I propose this early posterior expansion of hmx3a and hmx2 is the key determinant in
e↵ecting the extent of the anterior domain established and therefore also duplication of the anterior
under perturbed conditions.
The early otic expression of hmx2 and hmx3 in chick and mouse have a number of similarities
with zebrafish, being expressed early during otic development and initially localised to the anterior
otic domain (Herbrand et al., 1998; Wang et al., 1998). Yet their later expression in the chick and
mice otocyst are primarily thought to direct patterning of the DV axis (Riccomagno et al., 2005;
Hatch et al., 2007). However, as mention previously in the general introduction, hmx2 and hmx3
in chick and mouse may play a role in sensory AP patterning, albeit possibly not to the same
extent as seen in zebrafish (Wang et al., 2004). The early expression of hmx2 and hmx3 with the
anterior otic domain could therefore represent a conserved early state of otic patterning between
vertebrates which subsequently diverges. This may reflect the proposed ancestral function of the
Hmx gene family in patterning, highlighted by the ability of the Drosophila hmx CDS to replace
hmx2 and hmx3 in mice (Wang et al., 2004).
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Figure 7.1: Timeline showing sequential onset of expression within the anterior otic placode
7.3.1 Are hmx3a and hmx2 su cient to assign posterior identity?
When fgf3 is over-expressed, a di↵erent early transcriptional response is seen compared to when Hh
signalling is lost, with all the anterior otic factors appearing up-regulated either across the whole
medial otic edge or at the AP poles (Chapter Six). This is consistent with Fgf3 being up-stream
of hmx3a, hmx2 and pax5 and capable of producing duplications of anterior otic character when
over-expressed (Hammond and Whitfield, 2011). It has been proposed that an anterior to posterior
gradient of Fgf3 and 8a emanating from rhombomere 4 is likely present across the otic placode
from the initial establishment of the otic placode onwards, which is likely augmented by a ventral
source of Fgf signalling in the endoderm of the epibranchial pouches (Hammond and Whitfield,
2011; McCarroll and Nechiporuk, 2013). Such a gradient of Fgf signalling across the otic placode
is supported by the expression of canonical Fgf signalling readout genes such as dusp6, etv4 and
spry4, which show graded expression from the anterior of the placode. However, at around 24hpf,
weak etv4 expression within the posterior is apparent (data not shown). This expression may
reflect a the transient expression of fgf8a reported within this domain around 24hpf, possibly in
combination with the more persistent posterior fgf10a expression (Léger and Brand, 2002) (own
data).
Data from Chapter Six confirmed that a loss of Hh signalling does not appear to e↵ect Fgf signalling
in or around the otic placode, with a weak domain of etv4 still observed at 22.5hpf in CyA-treated
embryos. Therefore based on the known positive-regulation of Fgf signalling on the anterior otic
domain, the delayed duplication of anterior factors following a loss of Hh signalling may reflect the
initially weak Fgf signalling within the posterior rather than the progressive expansion of hmx3a.
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The positive feedback loop between fgf3 and fgf8a with hmx2 and hmx3a makes it di cult to
identify which of these is the key early regulator in driving duplication of anterior otic character
(Feng and Xu, 2010; Hammond and Whitfield, 2011). Therefore future work identifying whether
hmx3a misexpression alone is su cient to induce anterior character would help clarify this. If
hmx3a over-expression alone is su cient, it would support the previously proposed model where
early expansion of hmx3a is primarily responsible for establishing the extent of the anterior dupli-
cation, which is subsequently reinforced by its feedback loop with Fgf.
7.3.2 Is posterior otic identity duplicated after knock-down of hmx3a
and hmx2?
If hmx2 and hmx3a are the key early regulators of defining the extent of the anterior otic domain
then it would also be expected that knocking these down would lead to a duplication of posterior
otic identity. Knock-down of hmx2 and hmx3a in zebrafish, previously reported by Feng et al.
showed in these morphants the ear has a merged medial sensory patch retaining primarily saccular
identity but not a duplication (Feng and Xu, 2010). However, in these double morphants and also
the mouse hmx2 ;hmx3 mutants, there is a reported loss of anterior hair cells , which could mask
any posterior morphology present in the remaining anterior sensory patch (Feng and Xu, 2010;
Wang et al., 2004). Interestingly, the merger of the utricle and saccule seen in the hmx2 ;hmx3
morphants is similar to that seen in the hmx3 mouse mutants, whereas loss of both hmx2 and
hmx3 in mice resulted in a progressive loss of both the utricle and saccule (Wang et al., 1998,
2004). Despite the hmx2 ;hmx3 morphants not showing an obvious morphological loss of anterior
otic identity, at the transcriptional level a clear loss of the otic anterior factors, fgf3, 8a, 10a and
pax5 was reported (Feng and Xu, 2010).
A possible explanation for these di↵ering phenotypes is that in zebrafish, hmx3 appears to be
duplicated with two paralogues, hmx3a (NM 131634.2) and a predicted hmx3b (XM 017358610.1).
Feng et al. reported that hmx3a and hmx2 have functional redundancy within the zebrafish ear
and the previously mentioned ability of the Drosophila hmx CDS to replace hmx2 and hmx3a in
mice supports a strong conservation of function in this transcription factor family (Feng and Xu,
2010; Wang et al., 2004). Zebrafish hmx2,hmx3a and hmx3b all contain a highly conserved region
(Figure 7.2) and therefore based on this hmx3b is likely to be acting redundantly with hmx3a if
expressed within the ear.
Figure 7.2: Blastn alignment of zebrafish hmx3b and hmx2 against hmx3a mRNA sequence
shows homology within an overlapping region 47% of the predicted hmx3b coding sequence shares
80% of its sequence identity with that of hmx3a. Hmx2, which has been shown to act redundantly with
hmx3a during otic development, has 28% of its coding sequence sharing 76% sequence identity with that
of hmx3a. This sequence homology appears to be within the same region for both hmx2 and hmx3a.
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7.3.3 Insight into assignment of posterior otic identity in zebrafish
Data in this thesis, along with that already published, seem to suggest that despite Hh being
required for posterior otic identity in zebrafish, its e↵ect appears weak when compared to that
of Fgf (Hammond et al., 2010) (Hammond and Whitfield, 2011). In chick and mouse, as Hh is
still expressed primarily within the ventral midline structures, it has been suggested to manifest
as a ventral to dorsal gradient across the hindbrain adjacent to the otocyst. This has also been
suggested to be reflected in a similar gradient of the Hh transcriptional e↵ector, Gli3A across the
DV axis (Bok et al., 2005, 2007b; Ohta et al., 2016). Aberrant Hh signalling in zebrafish also
results in ventralised otic tissue, possibly suggesting a conservation of Hh’s function during otic
development between vertebrates. However, a converse loss of Hh does not expand the dorsal
domain (Hammond et al., 2010, 2003).
As previously mentioned, RA has been shown to play a greater role in AP otic patterning in
chick and mouse than appears to be the case in zebrafish (Bok et al., 2011). However, despite only
chick showing a strong posterior duplication in response to RA, all three vertebrate models show
a similar transcriptional response in the anterior expansion of tbx and reduction in neurod1 (Bok
et al., 2011; Radosevic et al., 2011; Maier and Whitfield, 2014). In zebrafish and mice, RA has
also been shown to negatively regulate fgf expression within the otic tissue (Maier and Whitfield,
2014; Cadot et al., 2012; Frenz et al., 2010). Another interesting characteristic of RA signalling
during otic development is how its regulatory e↵ect appears to di↵er dependent upon its levels
and the time at which these are increased or decreased (Chapter Six) (Maier and Whitfield, 2014;
Frenz et al., 2010). Therefore, whilst RA may appear to have strikingly di↵erent e↵ects on otic
development between vertebrates, it may highlight temporal and spatial di↵erences in transcription
between these rather than the way in which RA is acting.
In zebrafish, Shh and RA appear to positively regulate posterior identity, although this appears
weak relative to the anteriorising e↵ect of Fgf signalling on the placode (Chapter Six). Therefore
their combined action may be required to counter the strong anteriorising e↵ect that Fgf exerts.
Shh and RA are likely regulation of di↵erent targets, given RA is a known inhibitor of fgf ex-
pression during early otic development and Hh does not appear to directly influence Fgf signalling
(Maier and Whitfield, 2014; Hammond and Whitfield, 2011). Interestingly, this potential combi-
natorial regulation of posterior otic identity by Hh and RA is in contrast to their opposing e↵ect
in patterning the ventral otic floor (Radosevic et al., 2011).
7.3.4 A new model for patterning of the otic AP axis in zebrafish
Building upon the model previously put forward by Hammond et al. for otic AP patterning with
the data presented in this thesis, I propose a new model for patterning the otic AP axis in ze-
brafish. This supports an anterior to posterior gradient of Fgf but which drives early expression of
hmx3a and hmx2 in a similar gradient across the otic placode. When Hh signalling is present as
a dorsoventral gradient originating from ventral midline structures this inhibits hmx3a and hmx2
expression weakly but enough to limit its expression to an anterior domain. However, when Hh
signalling is lost this inhibition is lifted, allowing a posterior expansion of hmx3a and hmx2 expres-
sion. The positive feedback loop between otic hmx3a and hmx2 with fgf3 and fgf8a subsequently
leads to reinforcement of anterior identity within the posterior domain leading to a duplication.
The reinforcement of this network is likely also driven by the positive feedback relationship between
fgf3 and fgf8a and the localised atoh1a at either AP pole (Figure 7.3).
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Within the posterior otic domain, RA appears to contribute to preventing adoption of anterior
character, likely by inhibiting expression of fgf alongside the action of Hh in inhibiting hmx3a and
hmx2. The combined e↵ect of RA and Hh allows posterior expression of markers, such as nav3a,
from 16hpf onwards; progressively defining posterior character.This progressive maturation of the
anterior and posterior domains as outlined in the model above is also reflected in the loss of cdr2l
expression, initially from the anterior but also from the posterior otic domain from 18hpf.
Figure 7.3: A new model for patterning of the otic AP axis in zebrafish
1. High levels of extrinsic Fgf signalling induces expression of hmx2 and hmx3a, overcoming any
inhibitory e↵ect of Shh, which in turn establish anterior identity early on and subsequently driving
expression of fgf3 and fgf8a within the anterior. Maintenance of fgf expression within the anterior is also
dependent on establishment of the sensory domains due to its positive feedback with Atoh1a in this
region and expression from within the supporting cells. 2. In the posterior under normal conditions, due
to the weaker presence of Fgf signalling early in development, expression of hmx2 and hmx3a is inhibited
by Hh. Within this region, early posterior RA may also inhibit fgf expression, which also dampens any
positive reinforcement through either Hmx2, Hmx3a or Atoh1a. 3. At 16hpf, nav3a is induced within the
posterior domain that later extends dorsally, which could reflect a response to dorsal hindbrain sources of
Wnt signalling. Whether this impacts posterior otic identity is unclear. The establishment of the anterior




While the model defined in Figure, based upon the data presented in this thesis begins to give a
better overview of the transcriptional relationships and dynamics likely to be patterning the ze-
brafish ear during early development, a number of questions still remain. Three in particular would
be the initial focus of any future work; the first is identifying if hmx3a over-expression is su cient
to assign anterior identity without Fgf signalling. The second would be understanding how the
persistence of anterior hmx3a expression after constitutive activation of Hh can be accounted for
by the proposed model. One possible explanation could be that Hh signalling indirectly prevents
the activity of Hmx3a, which could account for why expression of hmx2, a target of Hmx3a, ap-
peared more strongly reduced in the gain-of-function Hh mutants compared to hmx3a (Chapter
Six). The third focus would be confirming whether nav3a regulates posterior otic character or
is only a marker. If nav3a is associated with posterior identity, it would clearly indicate that
di↵erentiation of the posterior otic domain is occurring earlier than signified by the other known
posterior markers. This would support the proposed model, including cdr2l reflecting maturation
of the otic tissue.
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Supplementary data
S1: Localisation of cilia at the otic AP poles in 14-15hpf embryos
Cilia labelled using the tg(arl13b:GFP) line at 14-15hpf, prior to the formation of the otic lumen.
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S2: Full ZFIN search using search terms: ”otic placode” between 1-4 to 10-13 somites
Full results from a search of the ZFIN gene expression database. Genes previously characterised as
having an otic function are highlighted in orange.
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S3: Full ZFIN search using search terms: ”posterior otic placode” between 10 to 20 somites
Full results from a search of the ZFIN gene expression database.
S4: Otolith phenotypes in 0.5nl 0.9mM cdr2l MO-injected embryos and control otx1b
morphants
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S5: % AP length of the hmx2 domain in cdr2l morphants
n = 6 x dorsally imaged embryos per condition. One-way Anova (Non significant, p=0.5882) with Dunn’s
multiple comparison to the uninjected (both non significant. Adjusted p; Non-specific MO = 0.4850 and
cdr2l MO = 0.8137)
S6: % AP length of the otx1b domain in cdr2l morphants
n = 6 x laterally imaged embryos per condition. One-way Anova (non-significant, p=0.7917) with
Dunnett’s multiple comparison to the uninjected (both are non-significant. Adjusted p ; MM MO =
0.7698 and cdr2l MO = 0.9994)
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S7: Mortality curves for -4bp del incross and 5/1bp InDel incross over the first three days
of development
-4bp del incross n = 75, 5/1bp InDel incross n= 175
S8: Flow cytometry scatter plot on dissociated cell stained with TOPRO
TOPRO stains compromised cells, which is associated with cell death. In the P3 gate only 4.2% of the
population appeared non-viable.
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S9: Expression of pax5 in Tg(hs:dnRAR) embryos and their siblings after heatshock
S10: Expression of cdr2l at 20hpf with a zoomed image to show the dorsal puncta
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